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Abstract
Native subtypes of NMDA receptors with distinct developmental and anatomical 
distribution are present in the brain. Knowledge of their function and pharmacology greatly 
helps in understanding the involvement of NMDA receptors in physiological and 
pathological processes in the central nervous system.
Multiple patch-clamping methods were carried out in my experiments. First, the 
single-channel properties of native NMDA receptors were studied in outside-out patches 
excised from neuronal cell bodies in substantia nigra pars compacta (SNc) and subthalamic 
nucleus (STN) from 7-day old rats. The steady state channel activations produced by 
NMDA (100 nM or 200 pM) and glycine (10 pM) were studied at -60 mV. The results 
showed that both large and small conductance channels are present on STN and SNc 
neurons. These large conductance NMDA channels from SNc and STN display a high 
ifenprodil sensitivity, suggesting NR2B-containing NMDA receptors are present on SNc 
and STN neurons. In addition, direct transition analysis suggests that the small 
conductance channels may be due to NR2D-containing NMDA receptors.
Second, whole-cell patch-clamp recording of bath application-induced NMDA 
receptor-mediated currents (Inmda) in dopaminergic neurons of SNc in brain slices from P7 
rats was used to characterize the ifenprodil inhibition and voltage-dependence of Mg2+ 
block of NMDA receptors. The NMDA-induced whole-cell currents were evoked by 
NMDA (10 pM or 200 pM) and glycine (10 pM). There are two main findings from the 
whole-cell experiments. (1) The NMDA-induced whole-cell currents display a high 
ifenprodil sensitivity, suggesting the presence of NR2B-containing NMDA receptors on P7
rat SNc neurons. (2) The combined application of Mg2+ and ifenprodil reduced the 
voltage-dependent Mg2+ block, which is consistent with recombinant NR2D-containing 
NMDA receptors that have a lower affinity for Mg2+. This suggests that NR2D-containing 
NMDA receptors are present in P7 rat SNc.
Third, in order to evaluate the deactivation kinetics of extrasynaptic NMDARs, outside-out 
patches containing multiple channels were obtained from P7 rat dopaminergic neurons of 
SNc and stimulated with a brief synaptic-like (l-4ms) pulse of ImM glutamate. The results 
suggested that the triheteromeric NR1-NR2B-NR2D rather than diheteromeric NR1-NR2D 
NMDA receptors are present on extrasynaptic sites of SNc neurons.
In addition, in order to investigate voltage-dependent Mg2+ block and memantine block, 
several channel block models were developed to evaluate multiple Mg2+ effects on native 
NMDA receptors and competition between Mg2+ and memantine for block of NMDAR 
channels.
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Chapter 1: Introduction
1.1 Glutamate receptors
In the central nervous system (CNS), L-glutamate is major excitatory' neurotransmitter and 
mediates its actions via activation of both ionotropic and metabotropic receptor families. 
Metabotropic glutamate receptors are coupled to intracellular effector systems via 
G-proteins (Conn & Pin 1997) and ionotropic glutamate receptors are responsible for fast 
changes in membrane permeability (Ozawa et al. 1998; Dingledine et al. 1999; Kew & 
Kemp 2005).
1.1.1 Classification of glutamate receptors
1.1.1.1 Metabotropic glutamate receptors
Metabotropic glutamate receptors (mGluRs) play an important role in the transduction of 
glutamate-mediated signalling via coupling through G-proteins to intracellular second 
messenger cascades. They have been classified into groups 1, 2 and 3. Group 1 (mGluRl 
and mGluR5) receptors are coupled to phospholipase C mediating increases in intracellular 
calcium and protein kinase C activation. Group 2 (mGluR2 and mGluR3) and group 3 
(mGluR4, mGluR6, mGluR7, mGluR8) are negatively coupled to adenylate cyclase, 
producing a decrease in cAMP and reduced protein kinase A activation (Conn & Pin 1997).
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1.1.1.2 Ionotropic glutamate receptors
1.1.1.2.1 Structure of ionotropic glutamate receptors
All subunits of ionotropic glutamate receptors are listed in Figure 1.1 and they all share a 
similar structure. The transmembrane topology of ionotropic glutamate receptors is shown 
in Figure 1.2 which is different from the classic four transmembrane domain model of the 
nicotinic acetylcholine receptors (Unwin 1989; Hollmann et al. 1994). Ionotropic 
glutamate receptor subunits possess an extracellular N terminus domain followed by a first 
transmembrane domain and then a pore forming membrane-residing domain that does not 
cross the membrane but forms a re-entrant loop entering from and exiting to the cytoplasm. 
The second and third transmembrane domains are linked by a large extracellular loop and 
the third transmembrane domain is followed by an intracellular C terminus. The crystal 
structure of the iGluR ligand binding domains, which comprise polypeptides in both the 
amino terminus (SI domain) and the extracellular loop between transmembrane domains 3 
and 4 (S2 domain), has confirmed this topology model for the ionotropic glutamate 
receptor family (Armstrong et al. 1998; Mayer & Armstrong 2004; Chen & Wyllie 2006; 
Mayer 2006).
Based on pharmacology, ionotropic glutamate receptors have been classified according to 
their agonist selectivity into three major sub-classes: 
a-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptors, kainate receptors 
and N-methyl-D-aspartate (NMDA) receptors.
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NR1
—  NR2A
— NR2B 
“ NR2C
—  NR2D
 NR3A
 NR3B
—  GluR1 
- G lu R 2
—  GluR3
—  GluR4 
“ GluRS 
"GluR6 
-G lu R 7
—  KA-1
—  KA-2
 GluR delta-1
 GluR delta-2
Figure 1.1 The subunit families of ionotropic glutamate receptors (Figure is taken 
from Wollmuth & Sobolevsky, 2004)
Seven NMDA receptor subunits have been identified: NR1 subunit, a family of NR2 
subunits (NR2A. NR2B, NR2C and NR2D) and a pair of NR3 subunits (NR3A and NR3B). 
AMPARs are composed of four types of subunits, designated as GluRl, GluR2, GluR3, 
and GluR4. There are five types of kainate receptor subunits, GluR5, GluR6, GluR7, KA1 
and KA2, which are similar to AMPA and NMDA receptor subunits and can be arranged in 
different ways to form a tetramer; a four subunit receptor (Wollmuth & Sobolevsky 2004).
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iFigure 1.2 The common structure of subunits of ionotropic glutamate receptors (The 
Figure is taken from Paoletti & Neyton, 2007)
Each subunit has an extracellular N-terminus followed by the first transmembrane domain 
and then a pore-forming domain which does not cross the membrane. The second and third 
transmembrane domains have a large extra cellular S2 loop which forms the agonist 
binding site with the SI region of the extracellular N-terminus. The third transmembrane 
domain is followed by an intracellular C-terminus that contains important phosphorylation 
sites that regulate receptor distribution and trafficking
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1.1.1.2.2 NMDA receptors
NMDA receptors (NMDARs) are the most complex ionotropic glutamate receptors, 
differing from AMPA and kainate receptors in many ways. First, NMDA receptors show 
slow gating kinetics and a high permeability to calcium ions. The activation of NMDA 
receptors allows the flow of Na+ and Ca2+ ions into the cell and K+ out of the cell. The 
calcium flux through NMDARs is thought to contribute to a cascade of intracellular events 
that transduces the synaptic event into a cellular change that may trigger long-term 
potentiation (LTP) and long-term depression (LTD) of synaptic transmission. Second, 
NMDA receptors need both agonist and co-agonist to effectively activate the receptor. It 
has been suggested that endogenous agonists of NMDA receptors are L-glutamate and 
L-aspartate (Patneau & Mayer 1990) although the kinetics of aspartate-activated receptors 
do not match the kinetics of synaptic currents (Lester & Jahr 1992). Glycine was first 
reported to potentiate NMDA receptor activation (Johnson & Ascher 1987) although the 
endogenous co-agonist is thought to be D-serine (Wolosker 2006). Third, the NMDA 
receptors undergo a voltage-dependent block by physiological levels of extracellular Mg2+ 
(Ault et al., 1980; Mayer et al.. 1984; Nowak et al., 1984). The voltage-dependent Mg2+ 
block means that at resting potential, the NMDAR-mediated current is nearly fully blocked 
by extracellular Mg2+ and the blockade is relieved during cell depolarization. Therefore, 
effective activation of NMDA receptors not only needs the binding of agonist and 
co-agonist but also needs depolarization of the postsynaptic membrane. Lastly, the activity 
of NMDA receptors is highly regulated by endogenous extracellular protons, zinc and 
polyamines.
The unique characteristics of NMDA receptors suggest its important role in central nervous 
system. Under physiological conditions, signalling through NMDA receptors mediates 
processes of neuronal cell migration (Komuro & Rakic 1993), synaptogenesis
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(Constantine-Paton 1990), synaptic transmission (Herron et al.. 1986; Bliss & Collingridge, 
1993) and synaptic plasticity (Bliss & Collingridge 1993) while their excessive activation 
is thought to be a major cause of neuronal cell damage during acute neurologic conditions 
such as brain trauma, cerebral ischaemia. hypoglycaemia. hypoxia and epileptic seizures; 
as well as during chronic neurodegenerative diseases such as Parkinson's disease, 
Huntington's chorea, AIDS encephalopathy and dementia complex, and neuropathic pain 
syndromes (Choi, 1992; Arundine & Tymianski, 2003; Lipton, 2006; Lipton. 2007).
1.2 Molecular biology of NMDA receptors
1.2.1 Molecular diversity
The first cDNA encoding an NMDA receptor subunit, the NR1 subunit, was identified by 
expression cloning in 1991 by Nakanishi and colleagues (Moriyoshi et a l 1991). The 
breakthrough was rapidly followed by the subsequent identification and cloning of other 
NMDA receptor subunits (Durand et al.. 1992; Ikeda et al.. 1992; Mishina et a l. 1992; 
Monyer et al.. 1992; Ishii et a l. 1993; Planells-Cases et al.. 1993; Nakanishi et al.. 1994; 
Mori & Mishina. 1995; Dingledine et a l. 1999). To date, seven NMDAR subunits have 
been identified; NR1. a group of NR2 (NR2A, NR2B. NR2C, NR2D) and a pair of NR3 
subunits (NR3A and NR3B). which are all products of single genes. All subunits share a 
high degree of amino acid sequence similarity. There is about 20% of amino acid sequence 
identity between the NR1 and NR2 subunits. In the NR2 subunit family. NR2A and NR2B 
share about 70% identity while NR2A and NR2C or NR2D just about 55% (Stephenson
2001). In addition, all subunits have the same transmembrane topologies (Figure 1.2). The 
glutamate binding site is formed by the SI and S2 regions of NR2 subunit while the 
glycine site is formed by the SI and S2 regions of the NR1 subunit (Armstrong et a l 1998; 
Dingledine et al. 1999; Paoletti & Neyton 2007).
1.2.2 Heteromeric channels and subunit stoichiometry
Expression of NR2 subunits alone does not produce functional NMDA receptors while 
responses produced by expression of homomeric NR1 subunits in oocytes are about 100 
times smaller than those obtained when pairs of NR1 and NR2 subunits are co expressed 
(Monyer et al. 1992). It was therefore proposed that native NMDA receptor-channels occur 
as heteromeric assemblies of NR1 and NR2 subunits. The hypothesis first was proved by 
electrophysiological studies using recombinant NMDA receptors. The results showed that 
co-expression of NR1 and NR2 subunits was necessary to produce native-like recombinant 
NMDA receptors (Monyer et al., 1992; Stem et al., 1992; Wyllie et al., 1996). Moreover, 
several groups also showed similar results using biochemical approaches. This approach 
involves NMDA receptor solubilization from brain membranes using non-denaturing 
detergents followed by either immunoprecipitation or immunoaffinity purification using 
subunit specific antibodies (Sheng et al., 1994; Dunah et al.. 1996; Chazot & Stephenson, 
1997; Dunah et al., 1998). Then the isolated receptor or immune precipitate is analyzed by 
immunoblotting to determine which of the other subunits are coassociated. The 
immunoprecipitation with NR2 antibody suggested that the presence of NR1/NR2A in 
forebrain and cerebellum (Sheng et al.. 1994; Chazot & Stephenson, 1997; Luo et al., 1997; 
Abdrachmanova et al., 2000). NR1/NR2B in forebrain (Sheng et al.. 1994; Chazot & 
Stephenson, 1997; Luo et al., 1997), NR1/NR2C in cerebellum (Sheng et al. 1994; Chazot 
& Stephenson 1997) and NR1/NR2D in the forebrain and thalamus (Dunah et al. 1998).
In addition, the evidence of association between NR2 subunits has also been described for 
both electrophysiological and biochemical data. Sheng et al. (1994) were the first group to 
show that immunoprecipitation with anti-NR2A antibodies resulted also in the precipitation
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of NR2B subunit immunoreactivity, suggesting the presence of triheteromeric NMDA 
receptors NR1-NR2A-NR2B. The same combination latterly also was found by Luo et al.
(1997) in forebrain and (Chazot & Stephenson 1997) and (Didier et al. 1995) in cerebellum. 
Moreover, evidence for functional triheteromeric NMDA receptors, NR1-NR2B-NR2D, 
was found in outside-out membrane patches by (Brickley et al. 2003) and (Jones & Gibb 
2005) from both cerebellar Golgi cells and midbrain dopamine cells and Dunah et al.
(1998) found NR1-NR2B-NR2D triheteromers in midbrain using co-immunoprecipitetion. 
Furthermore, these triheteromeric complexes such as NR1/NR2A/NR2B and 
NR1/NR2A/NR2C might also be expressed at synaptic sites in cerebellar granule cells 
(Cathala et al. 2000). All evidence taken together suggests that functional NMDA receptors 
can be formed by NR1 subunits with two different NR2 subunits and these trimers are 
present both at synaptic and extrasynaptic sites and contribute to synaptic transmission and 
synaptic plasticity.
Blahos and Wenthold (1996) reported the presence of NR1/NR2A/NR2B subunit 
associations in adult rat forebrain, but in much lower proportion than NR1/NR2A or 
NR1/NR2B subunit associations. They suggested that the fraction of NR2A and NR2B 
subunits present in a single receptor complex is probably very small and that most NMDA 
receptors in the adult rat forebrain contain only one type of NR2 subunit. In agreement 
with this report, (Chazot & Stephenson 1997) identified NR1/NR2A/NR2B NMDA 
receptors as a minor subpopulation compared with NR1/NR2A and NR1/NR2B receptors. 
In contrast with these reports, Luo et al. (1997) have suggested that the majority of native 
NMDA receptors in adult rat cerebral cortex are the result of a combination of at least three 
different subunits (NR1/NR2A/NR2B) while native NMDA receptors composed of two 
different subunits (NR1/NR2B or NR1/NR2A) are present in a much lower proportion. In 
summary, triheteromeric NMDA receptors are present in rat brain and the expression level
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of triheteromers depends on the brain region.
The exact number of subunits which are present in one single NMDA receptor has been 
debated. Some previous studies suggested that the NMDA receptor is a pentameric 
structure based on the size of the receptor, the receptor potency to different receptor 
antagonists when native subunits and mutant subunits were coexpressed and the 
interpretation of single-channel conductance when native subunits and mutant subunits 
were coexpressed. For example, Premkumar & Auerbach (1997) suggested that three NR1 
subunits and two NR2 subunits are present in one single recombinant NMDA receptor. 
However, Behe et a l (1995) used similar methods and suggested that only two NR1 
subunits and probably three NR2 subunits are expressed by a single recombinant NMDA 
receptor.
Several groups, however, suggested a tetrameric structure with two NR1 subunits and two 
NR2 subunits for native NMDA receptors based on pharmacological evidence (Laube et al., 
1998; Mano & Teichberg, 1998). In addition, more recently data from expression studies 
showed that when truncated subunits obtained from truncation of NMDA receptor subunits 
before the third transmembrane domains were joined to full-length subunits to generate 
tandems, the functional expression of these tandems confirmed the tetrameric structure of 
NMDA receptors and also suggested that the subunits making up NMDA receptors are 
arranged as two NR1 and two NR2 subunits (Schorge & Colquhoun 2003). Furthermore, 
Furukawa et al. (2005) reported crystal structures of the ligand-binding core of NR2A with 
glutamate and that of NR1-NR2A heterodimer with glutamate and glycine. The 
NR1-NR2A heterodimer suggests a mechanism for ligand-induced ion channel opening. 
Also, the analysis of the heterodimer interface, together with biochemical and 
electrophysiological experiments, confirms that the NR1-NR2A heterodimer is the
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functional unit in tetrameric NMDA receptors.
1.2.3 Molecular properties and expression of the NR1 subunit
NRl is the most highly expressed gene of all ionotropic glutamate subunits and its 
expression can be detected in nearly every neuron in the brain (Moriyoshi et al. 1991), 
where its product, the NRl subunit seems to be indispensable for the assembly, expression 
and functioning of NMDA receptors. The NRl gene (GR1N1) has been mapped to 
chromosome 3 in rat (Location 3pl3) (Kuramoto et al. 1994) and 9q34-3 in human 
(Takano et al. 1993). The NRl subunit gene contains 22 exons with the possibility of 
alternative splicing of exons 5 (the N 1 cassette), 21 and 22 (the C 1 and C2 cassettes) where 
N1 and Cl can be present or absent and C2 can alternate with C2’, resulting in 8 different 
splice variants (Figure 1.3 and Table 1). The NRl splice variants are widely distributed in 
the central nervous system (CNS) and expression is developmentally regulated. In brief, 
NRl mRNA is barely detectable at embryonic day 14, increases gradually during 
development until the third postnatal week, after which it declines slightly to adults levels 
(Watanabe et al. 1993; Laurie & Seeburg 1994; Watanabe et al. 1994; Laurie et al. 1995). 
The individual regional distributions of splice forms appear to be established around birth, 
with little change thereafter. The NR1-2 and NRl-a splice forms occur extensively and 
approximately homogeneously throughout brain gray matter. The NRl-b variant are found 
primarily in the sensorimotor cortex, neonatal lateral caudate, thalamus, hippocampal CA3 
field, and cerebellar granule cells, but are absent from adult caudate. The NR1-1 and -4 
splice forms are detected in almost complementary patterns; the former are concentrated in 
more rostral structures such as cortex, caudate, and hippocampus, while the latter are 
principally in more caudal regions such as thalamus, colliculi, and cerebellum. These two 
splice forms account for a greater proportion of the adult NRl mRNA than that of the
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neonate. The NR1-3 mRNA variant is scarce, being detected only at very low levels in 
postnatal cortex and hippocampus. The different splice forms generate regional differences 
in NMD A receptor properties during development and in the adult CNS (Sugihara et al., 
1992; Durand et al., 1993; Laurie & Seeburg, 1994; Laurie et al., 1995; Zukin & Bennett, 
1995; Dingledine et al., 1999).
23
Figure 1.3 Splice variants of the NR1 subunit (Winkler et al. 1999)
Table 1.1 Nomenclature of NR1 subunit splice variants. The eight splice variants of 
the NR1 subunit have been named differently by several laboratories.
Sugihara 1992 000 001 010 011 100 101 110 111
Hollmann's
nomenclature NRl-4a NRl-2a N R l-3a N R l-la NRl-4b NRl-2b NRl-3b N R l-lb
Durand 1993 NR1E NR1C NR1D NR1A NR1G NR1F NR1H NR1B
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1.2.4 Molecular properties and expression of the NR2 subunits
To date, four NR2 subunits have been identified for the NR2 family and termed NR2A, 
NR2B, NR2C and NR2D (Monyer et al., 1992; Ishii et al., 1993). It has been demonstrated 
that they do not form functional NMDA receptors when expressed alone but only when 
coexpressd with NR1 subunits (Ishii et al. 1993). Although NR1 subunits are essential for 
forming functional NMDA receptors, NR2 subunits confer diversity to functional and 
pharmacological properties of NMDA receptors (Monyer et al. 1994). They modulate 
voltage-dependent Mg2+ block, ifenprodil sensitivity, Zn2+ block, receptor kinetics and 
single-channel properties (Dingledine et al. 1999).
The NR2A, NR2B, NR2C, NR2D subunits are composed of 1445, 1456, 1218 and 1333 
amino acids, respectively. The predicted molecular weights for NR2A to NR2D are 163, 
163, 133 and 143 kDa, respectively (Monyer et al., 1992). Similar to NR1 subunits, the 
protein and mRNA expression of NR2 subunits are developmentally and regionally 
regulated (Watanabe et al. 1993; Monyer et al. 1994; Watanabe et al. 1994). In the 
embryonic brain, NR2B and NR2D subunit mRNA predominate, the NR2A and NR2C 
mRNA first detected after birth. After birth, the expression pattern of NR2 subunits mRNA 
changes during development. At birth, weak expression of NR2A protein is restricted to the 
hippocampus, cerebral cortex and striatum (Wenzel et al., 1997; Okabe et al., 1998) 
thereafter the NR2A expression increases gradually and peaks in the third postnatal week 
and remains high in the adult brain (Wenzel et al. 1997). In adult rat, the NR2A subunit 
mRNA is highly expressed in cereberal cortex, hippocampus and cerebellum while NR2C 
mRNA is restricted to the granule cell layer of the cerebellum (Monyer et al., 1994; 
Watanabe et al., 1994a; Watanabe et al., 1994b). As with the NR2A protein expression, the
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protein expression for NR2B subunits increases during first three postnatal weeks then 
decreases to adults level (Wenzel et al., 1997; Paarmann et al., 2000). NR2D protein 
reaches peak around first postnatal week and decrease gradually and remain a low level in 
adult brain (Wenzel et al. 1997). In adult rat, the NR2D immonoactivity is mainly 
restricted to diencephalic, mesencephalic, and brainstem structure, being more prominent 
early development (Ishii et al. 1993; Monyer et al. 1994).
1.2.5 Molecular properties and expression of the NR3 subunits
In the NR3 family, there are two NR3 subunits, NR3A and NR3B. The NR3 subunits do 
not form functional NMDA receptors when expressed with NR2 subunits (Das et al. 1998; 
Chatterton et al. 2002). Interestingly, when NR3A or NR3B is coexpressed with NR1 
subunits, it can form an excitatory glycine receptor that is permeable to Ca2+, resistant to 
Mg2+ block, and unaffected by glutamate, NMDA, or NMDA antagonists (Chatterton et al.
2002). When NR3 subunits are coexpressed with both NR1 and NR2 subunits, functional 
triheteromeric NMDA receptors (NR1/NR2/NR3) are formed and NR3 subunits decrease 
single-channel conductance and Ca2+ permeability, compared with diheteromeric NMDA 
receptors (NR1-NR2) (Das et al. 1998; Perez-Otano et al. 2001; Chatterton et al. 2002). 
This finding is consistent with coimmunoprecipitation experiments, suggesting NR1, NR2, 
and NR3 can coexist together and form functional native NMDA receptors (Perez-Otano et 
al. 2001).
NR3 subunits are not essential NMDA subunits to form functional NMDA receptors, but it 
has been suggested the NR3 subunits may play a very important role in early development. 
For example, when coexpressed with NR1 and NR2 subunits, NR3 subunits influence
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surface expression of NMDA receptors (Perez-Otano et a l 2001). Also the expression of 
NR3 protein and mRNA is developmentally and regionally regulated. In rat, NR3A 
expression peaks between postnatal days 7 and 10 in the cortex, midbrain, and 
hippocampus and the expression level of these regions is higher than the levels in the 
olfactory bulb and cerebellum. Thereafter, the protein expression level of NR3A subunit 
decreases gradually and remain low expression level in rat brain (Andersson et a l 2001).
In situ hybridization and immunohistochemical experiments reveal that expression of 
NR3B subunits is very restricted in somatic motoneurons of the brainstem and spinal cord. 
Its expression in other types of motoneurons is significantly weaker. In the adult rat NR3B 
expression is predominant in the ventral horn of spinal cord and ficial, trigeminal, 
vestibular and reticular nuclei of the brainstem. All evidence taken together suggests that 
NR3B is important as a regulatory subunit that controls NMDA receptor transmission in 
motoneurons. It may be involved in the pathogenesis of neurodegenerative diseases 
involving motoneurons as well (Andersson et al., 2001; Nishi et a l , 2001; Chatterton et al., 
2002).
1.2.6 Expression of NMDAR subunits in the basal ganglia
1.2.6.1 NMDA receptors in substantia nigra pars compacta
Excitatory afferents to dopaminergic neurons of SNc originate from various structures; 
medial prefrontal cortex, subthalamic nucleus (STN) and pedunculopontine tegmental 
nucleus. It has been suggested that during Parkinson’s disease, these excitatory inputs 
might contribute excitotoxic cell death to the remaining dopaminergic neurons (Blandini et 
a l 2000). In adult rats, in situ hybridization studies have demonstrated that the most
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abundant NR1 isoform in SNc is NRl-2a, which lacks N1 and Cl segments and contains 
the C2 segment (Standaert et a l 1994; Albers et a l 1999). Therefore, the N1 segment does 
not affect the kinetics of NMDA receptor in dopaminergic neurons.
Although in both P7 and adult rat, high levels of NR2D protein and mRNA and low levels 
of NR2B protein and mRNA are expressed in the midbrain (Standaert et a l 1994; Dunah et 
a l 1996; Dunah et a l 1998), the composition of functional NMDA receptors in 
dopaminergic neurons is still not known. It has been suggested that the binary NR1-NR2D 
NMDA receptor was not detected in the midbrain, because all NR2D subunits were 
coimmunoprecipitated with NR1 and NR2B subunits (Dunah et a l 1998). This evidence 
taken together suggests that triheteromeric NMDA receptors are present on dopaminergic 
neurons. Similar conclusions were supported by single-channel recording data (Jones & 
Gibb 2005).
1.2.6.2 NMDA receptors in the subthalamic nucleus (STN)
The subthalamic nucleus receives excitatory input (glutamatergic input) from the cerebral 
cortex and the pars parafascicularis of the central complex. Adult rat STN neurons express 
the NRl-2b NR1-isoform. High levels of NR2D protein and mRNA were detected in STN 
while a low level of NR2B mRNA was found (Standaert et al., 1994; Wenzel et a l , 1996).
1.2.6.3 NMDA receptors in globus pallidus and substantia nigra pars 
reticulata
NMDA receptors are present in the striatal output structures, the GPi and SNpr. Both 
structures express NR1 (principally the NRl-4b isoform) and have prominent expression 
of the NR2D subunit, which can be detected both at the mRNA and at a protein level
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(Standaert et al., 1994; Wenzel et al., 1996).
1.2.6.4 NMDA receptors in striatum
The protein expression of NR1 isoforms in adult rat striatum was reported by 
(Kuppenbender et a l 1999). It has been suggested that projection neurons (medium spiny 
neurons) in striatum express high levels of N R l-la  isoform and low levels of NR 1-2a 
isoform while high levels of NRl-4a and NRl-2a isoforms are expressed by striatal 
intemeurons.
In P7 young animals, the NR1 and NR2B mRNA is highly expressed by striatal medium 
spiny neurons while low NR2D mRNA expression is found (Monyer et a l 1994). In adult 
rat striatum, NR2A expression is moderate in all striatal neurons except cholinergic 
intemeurons, and NR2B shows strong labeling in the medium spiny neurons and 
cholinergic intemeurons. No NR2C mRNA or protein was found in adult striatum and only 
some intemeurons such as somatostatin- or acetylcholine- containing neurons express 
NR2D subunits (Hallett & Standaert 2004). In addition, diheteromeric NMDA receptors 
containing NR1 either NR2A or NR2B are widely expressed in striatum, but triheteromeric 
receptors composed of NR1-NR2A-NR2B also are found in striatum (Dunah & Standaert 
2003).
1.3 Functional and pharmacological properties of 
recombinant NMDA receptors
The functional and pharmacological properties of NMDA receptors are largely determined 
by their subunit compositions (Cull-Candy et a l , 2001). The studies using recombinant
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NMDA receptors allow us to understand the functional and pharmacological properties 
converted by specific subunits. In other words, the diversity of NMDA subunits might be a 
basis of regulation of synaptic transmission and functional plasticity of native NMDA 
receptors. In the brain, native NMDA receptors are expressed regionally and 
developmentally. The expression of different NMDA subunits may determine 
physiologically functional differences of native NMDA receptors in the different regions 
during development. Understanding the functional and pharmacological properties 
exhibited by different recombinant NMDA receptors also give us the information about 
native NMDA receptor composition in different brain regions during development, 
provided we can make appropriate measurement from identified neurons.
1.3.1 Single-channel properties
The single-channel properties of recombinant NR1/NR2 NMDA receptors that have been 
reported include single-channel conductance, open times, shut times, direct transitions 
from main conductance level to sub-conductance level. (Stem et al., 1992; Stem et al., 
1994; Wyllie et al., 1996; Cull-Candy et al., 2001). These properties of native and 
recombinant NMDA-receptor channels have been shown to be partly determined by the 
identity of NR2  subunits while the effects of NR1 splice variants on single-channel 
properties have not been studied.
1.3.1.1 Single-channel conductance
The recombinant NMDA receptors composed of NR1-NR2A and NR1-NR2B show large 
single-channel conductances, which are 50 pS for the main conductance level and 40 pS for 
the not common sub-conductance level while the recombinant NMDA receptors formed by 
NR1-NR2C and NR1-NR2D have lower single-channel conductances of 38 pS for the main
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conductance level and 19 pS for the sub-conductance level (Stem et a l 1992; Stem et al., 
1994; Wyllie et al., 1996; Cull-Candy et al., 2001). In addition, the triheteromeric NMDA 
receptors formed by NR1-NR2A-NR2D show both high and low single-channel 
conductances of 50 pS, 40 pS 30 pS and 18pS (Cheffings & Colquhoun 2000).
1.3.1.2 Direct transitions between main conductance and
sub-conductance levels
There are some highly selective antagonists to identify NR2A-containing and NR2B- 
containing NMDA receptors such as Zn for NR2A-containing NMDA receptors (Paoletti 
et a l 1997) and ifenprodil for NR2B-containing NMDA receptors (Williams, 1993; 
Cull-Candy et al., 2001). These highly selective antagonists allow us to distinguish native 
NR2A- or NR2B- containing NMDA receptors. However, the shortage of selective 
antagonists for NR2C- and NR2D- containing NMDA receptors imposes a difficulty in 
distinguishing native NR2C- and NR2D- containing NMDA receptors using 
electrophysiological methods.
However, the single-channel properties of recombinant NR1-NR2C and NR1-NR2D 
receptors provide us with the possibility of identifying them based on open times and 
temporal asymmetry of direct transition between conductance levels. First, the steady state 
single-channel recordings from NR la/ NR2C show that main and sub-conductance levels 
of NRla/NR2C channels have similar opening durations (Stem et a l 1992) while for 
NRla/NR2D channels, the duration of sub-conductance levels is longer than the main 
conductance level (Wyllie et al. 1996). Second, the NRla/NR2D channels show temporal 
asymmetry, which is absent in any of the other three diheteromeric recombinant NMDA 
receptors (Stem et a l 1992; Wyllie et a l 1996).
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Single-channel properties of most of the likely triheteromeric NMDA receptors have not 
been reported.
1.3.2 Kinetics
The NMDA receptor channel opening peaks about 1 Oms after glutamate binds to NMDA 
receptors and it activates not just one channel opening, but the channel may re-open many 
times before the agonist dissociates. In other words, the event that underlies the synaptic 
current and macroscopic current is actually a burst that consists of many openings 
separated by brief shuttings (Gibb & Colquhoun 1992; Wyllie et a l 1998; Colquhoun 
2007).
The decay time course and desensitization time course of NMDA currents have been well 
studied and they are largely determined by the identity of NR2 subunits but the decay time 
course of NMDA receptors is also influenced by the identity of the NR1 isoforms (Monyer 
et al., 1992; Monyer et al., 1994; Vicini et al., 1998; Wyllie et al., 1998; Rumbaugh et a l , 
2000).
1.3.2.1 Recombinant NR1/NR2A NMDA receptors
NR1-NR2A NMDA receptors in outside-out patches show significant desensitisation when 
activated by glutamate or NMDA for 4 seconds (Wyllie et a l 1998). Compared with other 
NR2- containing NMDA receptors, the recombinant NR1-NR2A NMDA receptors show 
the fastest decay time course. Deactivation time constants from one or two exponential 
components have been reported: 120 ms (Monyer et al. 1994), 32 ms and 202 ms (Erreger 
et a l 2005), 33 and 247 ms (Vicini et a l 1998), 65 and 312 ms (Wyllie et a l 1996) (see
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Table 1.2).
1.3.2.2 Recombinant NR1/NR2B NMDA receptors
As with the NR1/NR2A NMDA receptors, NR1/NR2B receptor-mediated currents from 
outside-out patches show a significant desensitization when activated by glutamate or 
NMDA for 4 seconds. The NMDA receptors formed by NR1-NR2B and NR1-NR2C have 
similar decay time course. Deactivation time constants from one or two exponential 
components have also been reported: 400 ms (Monyer et a l 1994), 71 and 538 ms (Vicini 
et al., 1998), 93 ms and 569 ms (Banke & Traynelis 2003) and 128 and 799 ms (see Table 
1.2 ).
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Table 1.2 Summary of deactivation time course of NMDA receptors from previous
studies
Paper Receptor Applicationduration
T „
(ms)
*
(mb)
t d .
(MB)
% fast
(Rumbaugh et al 2000)
NRIa-NR2B (cell) 745 261
1239
49%
NRla-NR2B (patch) 603 250
1281
59%
NRlb-NR2B (cell) 194 182
480
97%
NR lb-NR2B (patch) 144 61
308
60%
NRle-NR2B (cell) 583 215
810
39%
NRlg-NR2B (cell) 167 167 100%
(Banke et al 2005) NR1-Ia/NR2B l-4ms (ImM glutamate) — 93-102 569-595
---
(Horak et a l 2004) NR1-Ia/NR2B 6ms (ImM glutamate) 498 208 839 54%
(Banke & Traynelis 2003) NR1-Ia/NR2B l-4ms (ImM glutamate) 184 95 617 83%
(Erreger et al. 2005)
NRl-la/NR2A lm s(lm Mglutamate) 32 202 94% (Area)
NRl-la/NR2B lm s(lm Mglutamate) 128 799 82% (Area)
(Wyllie et al 1998)
NR1-Ia/NR2A 1 ms (1 mM glutamate) 65 312 33%
NR1-Ia/NR2D 1 ms (1 mM glutamate) 5162 0%
(Vicini et al 1998)
NR 1 a/NR2 A (lifted 
HEK) 54 33 247 90%
NR la/NR2B( lifted 
HEK) 342 71 538 42%
NR 1 a/NR2C(lifted 
HEK) 260
NRla/NR2D(lifted
HEK) 1700
(Gotz et al 1997)
Dopamine cell on 
SNc 
P10-P15 rat
10ms
(lOOpM
glutamate)
456 150 1049 66%
Striatal principal 
neuom 
PI0-PI5 rat
401 147 1088 73%
Striatal Cholinergic 
neurons 
PI0-PI5 rat
347 130 687 61%
Nigra G ABA cells 
P10-P15 rat 339 142 797 70%
Globus pallidus 
neurons 
P10-P15 rat
196 67 382 59%
Subthalamic nucleus 
P10-P15 rat 292 137 833 73%
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1.3.2.3 Recombinant NR1/NR2C NMDA receptors
The NMDA receptors composed of NR1/NR2C have a fast rise time (Chen et al. 2006) and 
do not show any desensitization during 4 second exposure to glutamate or NMDA (Monyer 
et a l 1992; Chen et al. 2006) and have a similar deactivation time constant to NR1-NR2B 
NMDA receptors (Cull-Candy et al. 2001).
1.3.2.4 Recombinant NR1/NR2D NMDA receptors
Recombinant NR1/NR2D NMDA receptors also show no desensitization during long 
glutamate or NMDA applications (several seconds) (Monyer et al. 1992; Wyllie et al. 
1998). Intriguingly, recombinant NR1/NR2D NMDA receptor-mediated currents show the 
slowest rise time of 45 ms (Wyllie et al. 1998) and deactivation time constants of all 
NR1/NR2 subunit combinations: 4800 ms (Monyer et al. 1994) and 4469 ms (Wyllie et al. 
1998).
1.3.2.5 Decay time course of NMDA responses is influenced by NR1 
isoform
As mentioned before, all NR1 isoforms are produced by a single gene. Three regions on 
the NR1 gene (exons 5, 20 and 21) are alternatively spliced, giving rise to eight distinct 
isoforms. It has been demonstrated that the N 1 segment encoded by exon 5 influences the 
deactivation time constant of recombinant NMDA receptors (Prybylowski et al. 2000; 
Rumbaugh et al. 2000). NMDA receptors containing NR1 subunits with the N1 sequence 
present (NRl-lb, NRl-2b, NRl-3b, NRl-4b) show about 4 times faster decay time course
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than receptors without the N 1 segment.
1.3.3 Multiple effects of Mg2+ on recombinant NMDA receptors
1.3.3.1 Extracellular Mg2+ block of NMDA receptors
One unique feature of NMDARs compared with other ligand-gated ion channels is the dual 
dependence on agonist binding and membrane potential. In external medium containing 
physiological concentrations of Mg (about ImM), the inward current induced by NMDA 
is significantly blocked by extracellular Mg2+ at negative voltages while the block is 
relieved at positive voltages (Figure 1.4). This voltage-dependence dominates the 
physiological role of NMDA receptors. At resting membrane potential, NMDA receptors 
undergo rapid channel block by extracellular Mg2+, which significantly reduces the 
NMDAR component of the synaptic current. However, when neurons are depolarized, for 
example, by activation of colocalized AMPA receptors, the voltage-dependent block by 
extracellular Mg2+ is rapidly reduced, allowing ion influx though activated NMDA 
receptors. The voltage-dependence of the block has been interpreted by assuming the Mg2+ 
binding site is situated in the NMDA channel, and the magnitude of the voltage 
dependence has been used to localize the Mg2+ site by estimating the fraction (8) of the 
transmembrane field sensed by Mg2+. The affinity of external Mg2+ for NMDA receptors 
was represented by the Mg2+ affinity at 0 mV (Kvig2+(0mV)).
Single-channel recording from outside-out patches demonstrated that the mean open time 
of NMDARs decreases with increasing extracellular Mg2+ concentrations, while mean 
closure time is independent of the Mg2+ concentrations (Nowak et a l 1984; Ascher &
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Nowak 1988). Meanwhile, the values of 8 and (OmV) were calculated to be 1 and 8.8 
mM, respectively. These results suggested that the binding site for Mg is on the 
cytoplasmic side of the channel. However, electrophysiological and mutagenesis studies 
with recombinant receptors suggested that the blocking site can not be deep enough to 
account for the voltage dependence of external Mg block (Wollmuth et al. 1998). 
Subsequently, (Antonov & Johnson 1999) demonstrated that occupation of the NMDAR 
channels by permeant ions, such as Na+, K+, can affect Mg2+ block and taking ion 
permeation into account, the Mg binding site was placed at a much shallower position (8 
= 0.47).
I
In NMDA receptor channels, the subtype-specific differences in Mg block are determined 
by NR2 subunits (Kuner & Schoepfer 1996). Receptors assembled from NR1-NR2A and 
NR1-NR2B are blocked more strongly than those formed by NR1-NR2C and 
NR1-NR2D, reflecting a difference in voltage-dependence. Kuner and Schoepfer (1996) 
measured the subtype-specific differences of Mg block. The 8 and KMg(0mV) were 
obtained by fitting the current-voltage relation and gave, Kb (OmV) and 8 to be 4.8mM and 
1.05 for NR1-NR2A, and 3.7mM and 1.07 for NR1-NR2B. The receptors assembled from
94-NR2C or NR2D subunits have lower sensitivity to extracellular Mg block, with Kb (OmV) 
3.5mM, 3.6mM and 8 of 0.73, 0.75, respectively. Qian and Johnson (2005), using 
single-channel recording, explained the subunit-specific differences. They suggested that 
for recombinant NMDAR NR1-NR2D, the binding rate of Mg2+ block is similar to 
NMDAR assembled with NR1-NR2A or NR1-NR2B, while the unbinding rate was much 
faster than that for NR1-NR2A or NR1-NR2B.
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Figure 1.4 Multiple effects of Mg2* on NMDA receptors
The figure shows that NMDA receptors can be blocked by intracellular and extracellular 
Mg2+. Meanwhile, there is a Mg2* potentiation binding site that exists on the NR2B subunit
(http://www.securitylab.ru/_Article_Images/2005/10/nmda_receptor.gif).
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1.3.3.2 Intracellular Mg2+ block of NMDA receptors
•y i
The intracellular free concentration of Mgi is regulated at approximately 5-10 % o f the 
total concentration of Mgj2+ through buffering, ion exchange and pumping. M g2+ 
modulates diverse types of ionic channels, including NMDA receptors (Johnson & Ascher 
1990). NMDA receptors are blocked by intracellular Mg in a voltage dependent manner. 
The NMDA receptors are significantly blocked by millimolar internal Mg2+ at positive 
voltage and the effect is relieved at negative voltage. However, in normal physiological 
conditions, there is about 3mM of intracellular ATP that binds to intracellular Mg2+ and the 
free concentration of intracellular Mg2+ is evaluated at about 50 pM. Extracellular Mg2+ 
gives an apparent site of interaction between 0.8 and 1 across the transmembrane electric 
field whereas from the inside it is around 0.35. As pointed out by (Johnson & Ascher 1990), 
the overlap in the positioning of apparent blocking sites for intracellular and extracellular
i
Mg complicates definition of the mechanism of the block.
1.3.3.3 Glycine-independent and subunit-specific potentiation by 
extracellular Mg2+
Extracellular Mg2+ potentiates the NMDA receptor response in a voltage-independent and 
subunit-specific manner at saturating glycine concentration (Paoletti et al. 1995). Wang & 
MacDonald (1995) suggested using whole-cell recording techniques with tissue-cultured 
neurons that the potentiation was due to a marked increase in glycine affinity on NMDA 
receptors. (Paoletti et a l 1995) compared the NMDAR currents recorded in the absence of 
Mg2+ and after addition of Mg2+ at a physiological concentration (2mM) and suggested that 
only oocytes expressing NR1/NR2B displayed a Mg2+ potentiation over the voltage range 
tested (from -50 mV to +50 mV). The mean value of potentiation (Img/I0) was 2.55 ±0.13
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at negative voltages and 2.46 ± 0.07 at positive voltages. Outside-out patch-clamp 
experiments with recombinant NR1-NR2B receptors showed that the potentiation
produced by extracellular Mg2+ was due to an increase in open probability, from 0.03 to 0.1.
1
In addition, it has been found that extracellular Mg , like spermine, partly relieves the 
inhibitory effect of protons observed at physiological pH and the potentiation produced by 
Mg2+ and spermine are not additive.
1.3.4 Ifenprodil block of NMDA receptors
Ifenprodil is an allosteric NMDA receptor antagonist with chemical structure unlike any of 
the common competitive or un-competitive antagonists. High affinity inhibition by 
ifenprodil depends critically on the presence of an NR2B subunit. It has significant affinity 
for NR1-NR2B receptors (IC50 = 0.29 pM), that is about 300-fold higher than NR1-2A, 
NR1-NR2C or NR1-NR2D receptors (Williams 1993; Williams 1995). Ifenprodil inhibits 
NR1-NR2B recombinant NMDAR currents, with a maximal inhibition of 91% (Williams 
1993; Mott et a l 1998).
The major effect of ifenprodil on NMDA receptors is a high affinity, non-competitive, 
voltage-independent inhibition of receptors containing the NR2B subunit. It decreases the 
apparent association and dissociation rates of glutamate for NMDARs (Kew et a l 1996). 
Because the rate of agonist dissociation is decreased more than that of association, the 
apparent affinity of NMDA receptors for glutamate is increased ( E C 5 0  becomes smaller by 
approximately 3-6 fold). Thus, currents evoked by 0.3-1 pM NMDA were potentiated by 
3pM ifenprodil to about 200% of control current level (Kew et al. 1996). With increasing 
concentration of NMDA the effect of ifenprodil on NMDA-evoked current changes from 
one of potentiation to one of increasing inhibition. When the NMDA binding sites are
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saturated with a high concentration of NMDA, the ifenprodil-dependent increase in 
receptor affinity has no effect on the level of NMDA binding (Zhang et al. 2000). It has 
been suggested that ifenprodil inhibits NMDA receptor through shifting the pKa of the 
proton sensor to a more alkaline level, which would enhance tonic inhibition at 
physiological pH (Mott et a l 1998).
In diheteromeric NR1-NR2B receptors, by combining functional studies on recombinant 
NMDA receptors and biochemical studies on isolated domains, it has been shown that 
ifenprodil binds to the N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like 
domain of NR2B. In this domain, several residues, both hydrophilic and hydrophobic, were 
found to control ifenprodil inhibition (Perin-Dureau et al. 2002).
1.2 Parkinson’s disease
1.2.1 Background of Parkinson’s disease
Parkinson’s disease (PD) is a common, disabling and degenerative disorder o f central 
nervous system (CNS). It affects more than 1% of people aged over 65 in the world 
(Tanner 1992). In China, about 1,700,000 people have PD which is approximate half the 
number of PD patients in the world (4,000,000). Therefore, PD imposes a large economic 
cost on families and government. In addition, PD also decreases the quality of life of 
patients because the PD symptoms include tremor, muscle rigidity, slowness of movement 
and loss of postural balance leading to falls.
Thus, more attention needs to be put on PD. The primary pathology of PD is the loss of 
dopaminergic neurons in substantia nigra pars compacta (SNc), which project 
dopaminergic axons to the striatum. Since PD is both chronic and progressive, there are
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two main therapeutic areas for this disease, symptomatic therapy and neuroprotective 
therapy. Currently, the symptomatic therapy is based primarily on replacing the 
dopaminergic deficit by use of levodopa, dopamine agonists or MAO-B inhibitors. L-Dopa 
is the most widely used PD treatment. It is transformed into dopamine in dopaminergic 
neurons by L-aromatic amino acid decayboxylase. However, only 1-5 % of L-DOPA enters 
into the dopaminergic neurons (http://viartis.net/parkinsons.disease/treatments.htm). The 
remaining L-Dopa is often metabolized to dopamine elsewhere, causing side effects. Due 
to feedback inhibition, L-DOPA reduces the formation of endogenous L-Dopa, and so 
eventually becomes counterproductive. The dopamine-agonists such as bromocriptine and 
pergolide are moderately effective. Dopamine agonists initially act by stimulating some 
dopamine receptors. However, they cause dopamine receptors to become progressively less 
sensitive, eventually increasing the symptoms (Radad et a l 2005). MAO-B inhibitors such 
as selegiline and rasagiline reduce the symptoms by inhibiting monoamine oxidase-B 
(MAO-B), which inhibits the breakdown of dopamine by the dopaminergic neurons. The 
metabolites of selegiline might result in side effects such as insomnia. In addition, to drug 
treatments deep brain stimulation is presently the most used surgical means of treatment in 
people with advanced PD for whom drug therapy is no longer sufficient (Kern & Kumar 
2007). So far, there are no treatments that have been established to alter the progression of 
the underlying neurodegenerative process. However, NMDA receptor antagonists may 
contribute to this task. Next, the rationale for the use of NMDA receptor antagonists in 
Parkinson’s disease will be described.
1.2.2 Neural basis of Parkinson’s disease
Parkinson’s disease was the first disease of the nervous system to be identified as a 
molecular disease. The pathological mechanism underlying this disease is that the 
dopaminergic neurons in substantia nigra pars compacta progressively degenerated and the
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loss of dopaminergic neurons results in a profound loss of dopaminergic innervation of the 
striatum. The striatum and substantia nigra pars compacta are both part of basal ganglia 
which plays important roles in controlling voluntary movement. Next, the definition of 
basal ganglia and the function and role of basal ganglia in the normal conditions and in 
Parkinson’s disease will be described.
1.2.2.1 What are the basal ganglia?
The basal ganglia are a group of nuclei in the basal telencephalon interconnected by 
multiple feedback loops with the cerebral cortex, thalamus and brainstem, associating with 
a variety of functions: motor control, cognition, emotions and learning. Unlike other 
components of the motor system, the basal ganglia do not make either direct input or 
indirect input connections with the spinal cord. The primary input for basal ganglia is from 
cerebral cortex and output is directed to prefrontal, premotor and motor cortices through 
the thalamus. The non-motor functions of the basal ganglia are achieved by the frontal 
cortex (See figure 1.5).
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Figure 1.5 The basal ganglia consist of five nuclei: caudate nucleus, putamen, globus 
pallidus, subthalamic nucleus, substantia nigra
The basal ganglia comprise several interconnected brain areas deep in the brain, as shown 
here. First believed to be mainly involved in movement, the basal ganglia are now known 
to be also active in learning, habit formation, and certain psychiatric disorders. Image 
Credit: Ellen Davey (http://www.dana.org/news/brainwork/detail.aspx?id=6028)
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1.2.2.2 The basal ganglia consist of five nuclei
There are two sets of basal ganglia in the mammalian brain, mirrored in the left and right 
hemispheres. Each of them consists of five nuclei: the caudate nucleus, putamen, globus 
pallidus (external segment and internal segment), subthalamic nucleus, and substantia nigra 
(pars compacta and pars reticulata). The two structures, the caudate and the putaman, 
together are generally referred to as striatum (see Figure 1.5).
1.2.2.2.1 Striatum
The striatum is a primary input structure of the basal ganglia circuit. It receives excitatory 
projections from almost all cortical areas (McGeorge & Faull 1989), midline and 
intralaminar nuclei of the thalamus (Berendse & Groenewegen 1990) and from limbic 
structures, particularly the amygdala (Kelley et al. 1982). Another important input to the 
striatum is from dopaminergic neurons in substantia nigra pars compacta and in ventral 
tegmental area, which is mediated by the monoamine transmitter dopamine.
The primary output targets of striatum projection neurons are the external segment of 
globus pallidus (GPe) and the internal segment of globus pallidus and substantia nigra pars 
reticulata (Gpi/SNr). These two striated outputs conceptually form the beginning of the 
direct and indirect pathways (Penney & Young 1986). The functional segmentation of basal 
ganglia output is mainly based on these direct and indirect pathways which are described 
later in more detail. It has been shown that neurons containing enkephalin project to Gpe, 
while the neurons containing substance P project to Gpi/SNr (Blandini et al. 2000). A large 
number of dopamine D1 and D2 receptors are expressed by the projection neurons and it 
has been suggested that D1 and D2 class receptors have a differential effect on the direct 
and indirect pathways.
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The cellular composition of the striatum has been well studied. It has been shown that 
about 90% of striatum neurons are medium spinal neurons (medium-size 15-20 pm), 
containing GABA as transmitter while the remaining neurons are intemeurons (Difiglia et 
al 1980; Kawaguchi et a l 1995; Parent & Hazrati 1995; Holt et a l 1997).
1.2.2.2.2 Globus pallidus (GP)
The globus pallidus is divided into the GPe and the GPi. They all have similar main 
afferents from striatum, but the efferents for these two segments are different. The main 
output target of the external segment of globus pallidus is subthalamic nucleus, using 
GABA as a transmitter, while the GPi and SNr made up of the main output structure of 
basal ganglia and project GABAergic efferent back to frontal cortex thought thalamus. In 
addition, GPe and GPi also receive strong glutamatergic projection from the subthalamic 
neucleus.
1.2.2.2.3 Subthalamic nucleus (STN)
The subthalamic nucleus is a small lens-shaped nucleus in the brain where it is a part of the 
basal ganglia system. As suggested by its name, the subthalamic nucleus is located ventral 
to the thalamus and also is dorsal to the substantia nigra.
The subthalamic nucleus receives its main input from the external segment of the globus 
pallidus. This afferent is GABAergic, inhibiting the neurons of the subthalamic nucleus. 
Excitatory, glutamatergic inputs come from the cerebral cortex (particularly the motor 
cortex), and from the pars parafascicularis of the central complex. The subthalamic nucleus 
also receives neuromodulatory inputs, notably dopaminergic axons from the substantia
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nigra pars compacta (Nakanishi et al. 1988; Parent & Hazrati 1995).
The efferent axons are glutamatergic. Except for the connection to the striatum (17.3% in 
macaques), most of the subthalamic neurons are multitargets and directed to the other 
elements of the basal ganglia. Some send axons to the substantia nigra. Some are di-target 
with the lateral pallidum and the substantia nigra (2.7%) (Nakanishi et al. 1988; Gotz et al. 
1997) or the lateral pallidum and the medial (48%). Less are single target for the lateral 
pallidum (Parent & Hazrati 1995).
1.2.2.2.4 Substantia nigra compacta (SNc) and reticulata (SNr)
The substantia nigra is a major element of the basal ganglia and is subdivided into two 
segments, substantia nigra pars compacta and substantia nigra pars reticulata.
As mentioned before, the substantia nigra pars reticulata is part of the output nuclei of 
basal ganglia and it receives GABAergic afferents from the striatum and projects 
GABAergic efferents back to the thalamus (Parent & Hazrati 1995).
Neurons in the substantia nigra pars compacta contain neuromelanin and use dopamine as 
neurotransmitter (Parent & Hazrati 1995). The primary output targets are the striatum, 
subthalamic nucleus and globus pallidus. The afferents to these dopaminergic neurons in 
SNc originate from various structures. Both striatum and globus pallidus send GABAergic 
projections to nigra dopaminergic neurons while these neurons receive glutamatergic 
projections from the medial prefrontal cortex, subthalamic nucleus and pedunculopontine 
tegmental nucleus (Parent & Hazrati 1995).
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1.2.2.3 Functional organization of the basal ganglia
The basal ganglia circuitry is a very popular model. This exciting model is proposed based 
on two central concepts. First, there are two parallel circuits converting information from 
different regions of the cortex though the basal ganglia and back to the cortex via the 
thalamus. Second, each circuit allows the information flow and can process information 
individually and the balance of activities from these two parallel circuits controls voluntary 
movement (Alexander & Crutcher 1990; Haber 2003). The two pathways in the basal 
ganglia circuit model are the direct and indirect pathways (Figure 1.6). According to this 
model, the striatum is the primary input nucleus receiving information from the cortex to 
the basal ganglia output nucleus (GPi/SNr) though the direct and indirect pathways. The 
two pathways originate from different neurons in the striatum. In the direct pathway, the 
striatal GABAergic neurons containing dynorphin and expressing D1 dopamine receptors, 
project to the output nucleus, GPi/SNr while the striatal GABAergic neurons containing 
substance P and expressing D2 dopamine receptor projects to GPe. The GPe sends an 
inhibitory projection to the STN. The STN, in turn, sends its excitatory glutamatergic 
efferents to the output nuclei, GPi/SNr.
The functional activity of this organization is that activation of the direct and indirect 
pathways give rise to opposite changes in the net output of the basal ganglia circuitry. In 
fact, in the direct pathway, activation of the striatal GABAergic neurons causes inhibition 
of the output nuclei of the basal ganglia, GPi/SNr and hence disinhibition of the thalamus. 
In contrast, in the indirect pathway, activation of striatal GABAergic neurons inhibits the 
GPe. This leads to disinhibition of the STN neurons. In turn, increased activity of STN 
neurons increases the activity of the output nuclei (Figure 1.6).
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Figure 1.6 The functional organization of the basal ganglia (Figure is taken from 
Blandini et aL 2000)
There are two pathways in this basal ganglia circuit to process the information from the 
cortex; direct pathway and indirect pathway. Th striatum is the main input nuclei of the 
basal ganglia, which receives excitatory glutamatergic input from almost the entire cortex. 
In the direct pathway, the striatum projects GABAergic axons to the internal segment of 
the globus pallidus or substantia nigra pars reticulata (GPi/SNr) then output information is 
sent back to the cortex through the thalamus. In the indirect pathway, the information is 
projected to STN, then STN sends excitatory glutamatergic input to the output nuclei of 
basal ganglia (GPi/SNr). Therefore, the direct and indirect pathways have opposite effects 
on information from the cortex and the balance of activities of the two pathways 
determines the output of information from the basal ganglia.
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1.2.2.4 Basal ganglia circuits in Parkinson’s disease
In patients with Parkinson’s Disease (PD), dopaminergic innervation of the caudate 
putamen is lost due to the progressive death of dopamine neurones in the SNc. As 
mentioned before, STN neurons project excitatory glutamatergic input to dopaminergic 
neurons of SNc (Nakanishi et al. 1988; Gotz et al. 1997). One result of the loss of 
dopamine is an increased excitatory drive from the subthalamic nucleus to the remaining 
dopamine neurones of the substantia nigra (Hamani et a l 2004). In effect, the basal ganglia 
neural circuit attempts to compensate for the loss of some dopamine neurones by driving 
the remaining neurones much harder. It has been hypothesised (Blandini et al. 2000; 
Hallett & Standaert 2004) that an increased excitatory drive may generate oxidative stress 
and excitotoxic cell death of dopamine neurones via excessive activation of NMDA 
receptors. This may contribute to the disease progression in PD (Blandini et al. 2000).
1.2.3 Excitotoxic cell death and the projects described in this 
thesis
Glutamate is an excitatory neurotransmitter that plays a very important role in the central 
nervous system, rapidly signalling sensory information and complex motor commands 
from one part of the body to another, contributing to maintaining homestasis in the body 
and contributing to consioursness and decision-making processes in the brain. 
Glutamatergic terminals in the brain contain high concentrations of glutamate, about 
lOmM. During synaptic transmission, the glutamate concentration in the synaptic cleft may 
be greater than ImM for 1ms (Clements et al. 1992) to convey information to postsynaptic 
neurons. However, because glutamate has such profound postsynaptic effects, its presence 
in excessive amounts or for excessive periods of time can course excitotoxic cell death
50
(Choi 1992). Two different mechanisms may contribute to excitotoxic cell death, acute 
excitotoxic cell death and chronic excitotoxic cell death. For acute exitotoxic cell death, for 
example, in head or spinal cord injury, large amounts of glutamate are released from 
injured cells. This excessive amount of glutamate can cause prolonged activation of 
postsynaptic glutamate receptors, especially NMDA receptors. The excessive activation of
9+NMDA receptors induces large amounts of Ca influx into cells, causing cell death. In 
addition, a slow, subtle form of excitotoxic cell death also may contribute in a variety of 
slow neurodegenerative diseases, such as Parkinson’s disease, Alzheimer’s disease, 
multiple sclerosis, HIV-associated dementia and amylotrophic lateral sclerosis (Lipton 
2006). In these diseases, excessive periods of exposure to glutamate may contribute to 
chronic excitotoxic cell death.
As mentioned before, in Parkinson’s disease patients, the loss of dopaminergic neurons of 
SNc decreases the release of dopamine in the striatum. In order to compensate for the 
reduced level of dopamine in the striatum, the STN drives the remaining dopaminergic 
neurons much harder to increase dopamine release in the striatum (Blandini et al. 2000). 
This process uses glutamate as a transmitter and is partially mediated by NMDA receptors 
on dopaminergic neurons of SNc. The increased synaptic transmission may increase the 
probability of excitotoxic cell death thereafter accelerating the death of the remaining 
dopaminergic neurons. Therefore, it has been suggested that NMDA receptor antagonist 
might have therapeutic value in Parkinson’s disease as neuroprotective drug (Hallett & 
Standaert 2004). From a drug discovery perspective it is clearly disable to know both the 
subunit composition of native NMDA receptor subtypes and their distribution in the brain. 
Such information is crucial to the development of new subtype-selective therapeutic 
compounds with improved pharmacological profiles.
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1.3 Experiments conducted in this study
For my project, I focused on the subunit composition of NMDA receptors in P7 rat 
dopaminergc neurons. The functional and pharmacological characterization of NMDA 
receptors are applied as a basis of identification of NMDAR subunit composition. Through 
the identification and localization of NMDA receptor subtypes to specific neuronal 
populations it should be possible to improve our understanding of how NMDA 
receptor-mediated signalling is regulated in dopaminergic neurons of SNc and how 
subtype-selective drugs could be more efficiently used to target specific brain areas 
affected by particular neuropathological conditions such as Parkinson’s disease, increasing 
therapeutic efficacy and reducing at the same time the potential side effects of drugs.
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Chapter 2: Materials and Methods
2.1 Solutions
2.1.1 Slicing solution
A modified Krebs solution (Edwards et a l 1989) with the following composition was used 
for slicing (in mM): sucrose, 206; KC1, 2.5; CaCh, 1.0; MgCU, 4.0; Naf^PC^, 1.25; 
NaHCC>3, 26; glucose, 25; at pH 7.4 when bubbled with 95% O2 and 5% CO2.
2.1.2 External solution
A magnesium-free Krebs solution with the following composition was used for the external 
recording solution (in mM): NaCl, 125; KC1, 2.5; CaCh, 1.0; NaH2PC>4, 1.25; NaHCC>3, 26; 
glucose, 25; pH 7.4. The external solution for recording was continuously gassed with a 
mixture of O2 (95%) and CO2 (5%) (BOC Gases, Manchester, UK). In my whole-cell 
experiments 200nM of TTX was added to the external recording solution to block action 
potentials in the slice and avoid excitotoxic effects.
2.1.3 Pipette solution
In order to minimize potassium currents, patch pipettes were filled with cesium chloride 
(CsCl) internal solution (Gibb & Colquhoun 1991). The composition of the internal 
solution was (in mM): CsCh, 140; EGTA, 10; HEPES, 10; NaCl, 10; adjusted to pH 7.4 
with NaOH (1M). This solution was filtered and stored frozen in 1 ml aliquots.
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For whole-cell recordings, ATP ImM, GTP 0.5 mM and MgCh 0.5mM were added to the 
pipette solution to avoid run-down of the whole-cell current and TEA lOmM was added to 
each 1ml aliquot to block potassium channels.
2.2 Drugs and chemicals
NaH2PC>4 (500g, Prod. 301324Q), CaCh (calcium chloride solution, 1.0M, 1L, 
Prod. 190464k), MgCh (magnesium chloride standard solution, 1.0M, 1L, EC No. 
2320946), sucrose (1 Kg, Prod. 102745C), and CsCl (lOOg, Prod. 100675U) were 
purchased from BDH (Poole, England). NaCl (lKg, SigmaUltra, minimum 99.5%, EC 
231-589-3), NaHCC>3 (250 g, SigmaUltra,minimum 99.5% EC 205-633-8), KC1 (250G, EC 
No. 2312118), glucose (250g, SigmaUltra, minimum 99.5% GC, EC 200-075-1), NMDA 
(N-methyl-D-aspartic acid, 250 mg, minimum 98% titration, 099F5805), HEPES 
(N-[2-hydroxyethyl] piperazine-N’-[2-ethanesulfonic acid], lOOg, minimum 99.5%, Lot 
48H5449), bicuculline methiodide (250 mg, Lot 36H3897), strychnine (25G, Lot 18H1178), 
EGTA (ethylene glycol tetraacetic acid, 100 g, 97%, Lot 17H5714), ATP (adenosine 
5 -triphosphate disodium salt, lOg, 99%, Lot 17h7816), GTP (guanosine 5 -triphosphate 
sodium salt, 250 mg, 95%, CAS. 36051-31-7), nimodipine (100 mg, CAS 66085-59-4), 
ifenprodil tartrate salt (25mg, CAS. 23210-58-4), TEA (tetraethylammonium chloride, 25g, 
Lot 61K1464) and L-glutamic acid monosodium salt hydrate, glycine (lOOg, 99%, Lot 
77H2512), cesium hydroxide (99%, lOOg in water, CAS 21351-79-1), sodium hypochlorite 
(250ml, Batch U20738) and memantine hydrochloride (25mg, 98% GC, CAS 41100-52-1) 
were purchased from Sigma (St. Louis, MO, USA) were purchased from Tocris (Bristol, 
UK). TTX (tetrodoxin, lmg, Batch APN06092-1-1), NBQX (lOmg, Batch APN 06093-1-1) 
was purchased from Ascent Scientific.
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2.3 Brain slice preparation
Coronal brain slices were prepared as previously described (Jones & Gibb, 2005). 7 
day-old Sprague-Dawley rats were decapitated using a pair of surgical scissors (RS6930, 
Roboz, Germany) in accordance with the Animals Scientific Procedures Act, UK (1986). 
The skin was cut along the midline with a pair of small scissors. The skull was cut along 
the midline with a pair of fine scissors and the skull bones were removed using fine curved 
forceps. Within 60 seconds of decapitation the exposed brain was submerged in a 100 ml 
plastic weighting boat (Fisher Scientific, Loughborough, UK) containing ice-cold slicing 
solution continuously bubbled with a mixture of O2 (95%) and CO2 (5%).
The brain containing telencephalon, diencephalon and mesencephalon was isolated from 
the rostral part of the cerebellum and caudal part of the olfactory bulb. Then the brain was 
removed from the skull using a fine spatula. The brain was removed into ice-cold 
oxygenated slicing solution and allowed to cool down for 3-5 minutes.
For coronal brain slices, the rostral part of the telencephalon was glued, using 
cyanoacrylate instant adhesive (Loctite UK Ltd, Watchmead, Welwyn Garden City, Cat No. 
40637), to the specimen bath of a vibroslicer (DTK 1000, Dosaka, Kyoto, Japan) with the 
dorsal side of the brain facing the cutting blade. Immediately, the specimen bath was filled 
with oxygenated ice-cold slicing solution until the tissue was completely covered. Slices 
were cut using carbon steel blades or ceramic blades (Campden Instruments Ltd, UK) at a 
thickness of 250- 300 pm. Hypodermic needles (Monoject, Ballymoney, UK) were used to 
dissect out the slices containing substantia nigra pars compacta from the adjacent cerebral 
cortex. Slices were transferred into an incubation chamber using a plastic disposable 
Pasteur pipette (Scientific Laboratory Supplies Ltd, Nottingham) cut to a tip opening of 3-5
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mm across. The incubation chamber contained 100 ml external recording solution with 
additional 1 mM MgCh added and was continuously bubbled with a mixture of O2 (95%) 
and CO2 (5%). Slices were incubated at room temperature (20 -  24 °C) for a period that 
ranged from 1 to 8 hours before experimenting.
2.4 Cell visualisation and identification of dopaminergic 
neurons in SNc (substantia nigra compacta)
The cell bodies of individual neurons in brain slices were visualised under Normaski 
differential interference contrast optics (Edwards et a l 1989) using an upright microscope 
(Axioskop FS, Zeiss, Oberkochen, Germany) with an achromat 40X water immersion 
objective with a numerical aperture of 0.75 and a working distance of 1.6 mm at a total 
magnification of 600X. Visualisation was carried out on a monochrome video monitor 
(VM-902K, Hitachi-Denshi, Tokyo, Japan) connected to CCD monochrome camera (RS 
Components, Corby, UK) mounted on top of the microscope trinocular head. Slice health 
was visually checked before patching and the presence of a considerable proportion of 
neurons with a smooth surface readily evident on the surface of the slice was used as an 
indicator of a good healthy slice. Individual healthy cells were identified by the smooth 
appearance of their surface.
Dopaminergic neurons were identified using a combination of morphological and
electrophysiological criteria. Initially they were distinguished from intemeurons in SNc by
their large cell bodies, which were readily apparent under DIC optics. Dopaminergic
neurons had ovoid, polygonal, or fusiform cell bodies that emitted 3-6 primary dendrites
(Figure 2.1). In coronal sections, the dendrites of ovoid- or polygonal- shaped neurons in
SNc are oriented mainly along the dorsoventral axis, whereas fusiform-shaped neurons
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have dendrites that are oriented primarily mediolaterally (Tepper et a l 1987). In my 
experiments, the averaged cell capacitance of dopamine cells in P7 SNc was 53.2±2.5pF 
(mean ± S.E.; n=21) which is consistent with previous studies, 59.7±6.7pF from P5 rat 
(Washioe/a/. 1999).
Various electrophysiological characteristics of dopaminergic neurons were also used to 
identify dopamine cells in SNc. It is observed that dopaminergic neurons very often 
displayed spontaneous activity at a constant rate of 0.5-3.0 Hz. This activity is apparent 
upon suction to obtain the cell-attached gigaseal (>10GQ) configuration. In the whole-cell 
configuration, dopaminergic cells possess a hyperpolarization-activated inward current 
(Counihan et al.) with characteristically slow kinetics. In our experiments, a voltage step 
from -60mV to -120mV was applied for 1.5s to activate a clear slow time-dependent 
inward current to identify dopaminergic neurons in SNc (see Figure 2.2). These 
observations are in good general agreement with previous descriptions of dopaminergic 
neurons in rat SNc (Yung et a l 1991; Hajos & Greenfield 1993).
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Figure 2.1 DIC images of dopaminergic neurons from P7 rat SNc.
A  a n d  B .  t w o  m i c r o s c o p e  i m a g e s  o f  d o p a m i n e r g i c  n e u r o n s  i n  P 7  r a t  S N c .  T h e y  a r e  
t y p i c a l  o f  S N c  d o p a m i n e r g i c  n e u r o n s  i n  t h i s  s t u d y .  A .  T h e  n e u r o n  h a d  a  p o l y g o n a l  c e l l  
b o d y  w i t h  t h r e e  p r i m a r y  d e n d r i t e s  w h e r e a s  B  h a s  a n  o v o i d  c e l l  b o d y
AOpA
200pA
500m s
i-60mV -120 mV (1.5 seconds)
Figure 2.2 Identification of dopaminergic neurons in P7 rat SNc
F i g u r e  2 . 2 A  i s  a  d e t a i l e d  c o r o n a l  s l i c e  m a p  o f  r a t  b r a i n  f r o m  T h e  R a t  B r a i n  A t l a s  ( P a x i n o s  
a n d  W a t s o n ,  1 9 9 8 ,  f o u r t h  e d i t i o n ) ,  s h o w i n g  w h e r e  t h e  s u b s t a n t i a  n i g r a  c o m p a c t a  ( S N c )  i s  
i n  t h e  c o r o n a l  s l i c e s .  T h i s  m a p  w a s  u s e d  a s  a  g u i d e  t o  f i n d  d o p a m i n e r g i c  n e u r o n s  i n  S N c .  
F i g u r e  2 . 2 B  s h o w s  a  t y p i c a l  I h  c u r r e n t  f r o m  a n  S N c  d o p a m i n e  c e l l .  M o r e  t h a n  8 5 %  o f  
t e s t e d  n e u r o n s  i n  S N c  p o s s e s s e d  a n  I h  c u r r e n t ,  w h i c h  w a s  a c t i v a t e d  b y  a  v o l t a g e - s t e p  f r o m  
- 6 0 m V  t o  - 1 2 0 m  V  f o r  1 . 5 s .  I n  t h i s  w a y ,  d o p a m i n e r g i c  n e u r o n s  i n  r a t  S N c  c o u l d  b e  
d i s t i n g u i s h e d  f r o m  i n t e r n e u r o n s  i n  S N c .
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2.5 Patch-pipette making
2.5.1 Patch-pipette fabrication
Patch pipettes were made before patching cells in a vertical pipette puller (MF-83, 
Narishige, Tokyo, Japan) from thick-walled borosilicate glass capillaries containing an 
internal filament (GC150F-7.5, outer diameter 1.5 mm, inner diameter 0.86 mm, Harvard 
Apparatus Ltd). The pipettes were pulled in two stages. The first stage is to thin the glass to 
200- 400 pm at the narrowest point over a 7- to 10-mm region. The second pull is to pull 
the two halves apart, leaving clean, symmetrical breaks. Both halves were used. The length 
of the first pull and the heat of the last pull are the main determinants of the tip diameter of 
the final pipette.
2.5.2 Patch pipette coating and storage
For single-channel recordings, pipettes were coated with an insulating silicone resin 
(Sylgard 184® Dow Coming, USA) from the pipette shoulder to near the pipette tip and 
then heated with a heated coil connected to a variable voltage source in order to cure the 
Sylgard. Then the tip of the pipette was cleaned and smoothed by fire polishing on a 
microforge (MF-83, Narishige, Tokyo, Japan) to a final resistance of 5-15 MQ. Patch 
pipettes were stored horizontally mounted on a strip of Blu-Tack (Bostik, Leicester, UK) 
fixed to the base of a 90mm Petri dish (Sterilin, Staffs, UK).
2.6 Patching procedure
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2.6.1 Whole-cell recordings
2.6.1.1 Procedure
Pipettes were back-filled with pipette solution and the level in the pipette was kept to a 
minimum to reduce electrical interference produced by solution creeping up the electrode 
or going into the suction line. Any bubbles left in the pipette can be removed by tapping 
the side of the pipette. Patch pipettes were positioned in an electrode holder connected to 
the head-stage of a patch-clamp amplifier (Axopatch 200A, Axon Instruments, Foster City, 
CA, USA) and some positive pressure was applied to the inside of the pipette to generate a 
tiny stream of solution at the tip of the pipette that prevented the accumulation of debris at 
the tip and the mixing of the pipette solution inside the pipette with the external solution in 
the recording chamber. The patch pipette was then lowered into the recording chamber. 
Once in solution, the pipette resistance was measured by passing a 5 mV rectangular pulse 
through the input using the patch-clamp amplifier. Patch pipettes usually had a final 
resistance of 10 - 15 MQ for single-channel recordings and 5 - 1 0  MQ for whole-cell 
recordings. Positioning of the patch pipette was carried out under the optical field of the 
microscope using a micromanipulator (Sutter Instrument, MP-225, England, UK) and 
under visual control the patch pipette was lowered further down until visual contact with 
the slice. Contact between the patch pipette and the cell was visually confirmed by the 
formation of a characteristic dimple on the cell surface caused by flow of solution from the 
pipette tip. Immediately, the positive pressure was released and a small amount of suction 
was applied to the back of the electrode. Then the cell membrane and the tip of the 
electrode begin to form a high resistance gigaohm seal. The membrane under the patch 
pipette was held at -60 mV and suction was applied through the tubing connected to the 
back of the electrode holder to break the membrane and gain electrical access to the cell
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interior and then a whole-cell current can be recorded.
2.6.1.2 Compensation of series resistance
In whole-cell voltage-clamp recordings, the membrane potential of the cell was controlled 
by the potential applied to the pipette. The control of potential is not complete but depends 
on the access resistance between the pipette and the cell interior and on the size of the 
currents that must flow though this resistance.This access resistance is called series 
resistance (Rs). Series resistance arises from the pipette itself, but normally the major part 
arises from the residual resistance of the broken patch membrane. Series resistance not 
only slows the charging of the cell membrane capacitance because it impedes the flow of 
the capacitive charging current when a voltage step is applied to the pipette electrode, but 
also gives errors in membrane potential when large membrane currents flow.
In order to reduce the voltage error due to the series resistance existing in whole-cell 
experiments, more than 70% of the series resistance was compensated by the Axopatch 
-200 A before starting recordings. The voltage error can be calculated by Ohm’s law ( V error 
= IX R S). The average series resistance (Rs) before compensation from my experiments 
was 20 MO (n = 150). The holding current ( I membrane) was usually less than 50 pA. 
Therefore, originally the voltage error (Ve= Imembrane Rs) was less than lmV and reduced to 
-0.2 mV after 80% compensation. Although during the response evoked by lOpM NMDA 
application, the currents increased to 700.5 ±  64.6 (Mean ±  S.E., n= 17) pA, the 
voltage error would be -2.8 mV after compensation. For experiments where ifenprodil 
inhibition of NMDAR, only dopamine cells with series resistance less than 10MQ were 
used. In the presence of 250 pM of NMDA and lOpM of glycine, the whole-cell NMDA 
current increased to about 1500 pA and the voltage error is less than 4mV after 85%
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compensation. Therefore in these experiments series resistance errors had little impact on 
the whole-cell recordings.
2.6.2 Single-channel recording
For single-channel recording, high resistance gigaohm seals with more than 40GQ were 
required for low noise recording. After gaining a whole-cell configuration, the patch 
electrode was very slowly withdrawn away from the cell using the manipulator until an 
outside out patch was obtained. Electrical noise was reduced by bringing the patch 
pipette towards the surface of the bath leaving only its tip in the solution. The patch pipette 
was also brought toward the inlet of the recording chamber to improve contact between the 
patch and the incoming solutions. Before recording was attempted, the noise level was 
checked and an RMS noise level below 0.300 pA at a bandwidth of 5 kHz was considered 
acceptable for recording.
2.6.3 Concentration jump experiment
2.6.3.1 Theta glass tubing
Dual-channel theta glass tubing is provided by several different suppliers. The borosilicate 
theta glass from Hilgenberg (Malsfeld, Germany, outer diameter 2.0 mm, inner diameter 
1.4mm, and septum thickness 0.1167 mm) and aluminosilicate theta glass tubing (Sutter 
Instrument, O.D. 1.5 mm, I.D. 1.0 mm, 10 cm length, catalog: AF150-100-10) were used in 
my experiments. The use of thick-walled glass tubing is advantageous because the 
application pipette is mechanically more stable, minimizing oscillations in the solution 
exchange. Thin septa are preferable because the interface between the solutions flowing 
down the two barrels of the application pipette is sharper.
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2.6.3.2 Pulling and breaking
The theta glass tube was pulled to an outer diameter of about 300 pm in one step. Then the 
raw piece was cut into two parts under visual control of a 10 X binocular microscope using 
a diamond pencil. This step was critical, because tip irregularities could cause turbulence 
of flow. Sometimes, it was just necessary to touch the glass, in other case the tubing had 
to be rotated and scratched again until the two parts separate. A typical theta glass pipette 
shows a tip outer diameter of 300 pm and a shank length of about 5 mm.
2.6.3.3 Tubing connection
To connect the two barrels of the application pipette with the solution reservoirs, 
polyethylene (PE) microtubing (Portex, England, O.D. 0.61 mm, I.D. 0.28 mm) was 
inserted into the back end of the application pipette barrels and moved as far as possible 
toward the tip. The space between the pipette wall and the PE tubing was filled with glue 
(Loctite UK Ltd, Watchmead, Welwyn Garden City, Cat No. 40637) by putting a drop of 
glue on the back end of the application pipette and allow the glue to flow as far as possible 
to the end of the PE tubing. The space between PE tubing and glass wall was filled almost 
entirely to minimize the dead volume in the pipette.
2.6.3.4 Mounting the application pipette to the Piezo translator
To fix the application pipette to the Piezo translator (EXFO Burleigh products Group Inc, 
LSS-3100 Ultrafast Solution-Switching System, Canada) and minimize the possibility of 
application pipette vibration, we use the following design. A trapeziform hard plastic piece
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was mounted on the bottom of the Piezo translator using four screws. A 2.5 cm length 
groove was made on the one side of the trapezoform piece for mounting the application 
pipette.
2.6.3.5 Perfusion of application pipette
Two 1 Oml-syringes were loaded after slight modification of the original design and were 
connected to the back end of the application pipette with PE tubing (Potex Fine Bore 
Polythene Tubing, I.D. 0.38 mm, O.D. 1.09 mm, REF 800/100/120). One syringe contains 
control solution (external solution 20 pM glycine and 20 pM DNQX) and the other syringe 
contains glutamate solution (external solution with ImM glutamate, 20 pM glycine and 20 
pM DNQX). Both solutions were perfused into the application pipette by gravity. A flow 
velocity of about 100 pm / ms at the application pipette tip was used and flow rate was 
adjusted by moving the vertical position of the syringes and hence changing the level of 
the solution surface. For an application pipette with 120 pm barrel width, a perfusion rate 
of about 10 ml/hr was used. Bath perfusion was at 2-3 ml/min and roughly parallel to the 
direction of solution flow out of application pipette to avoid turbulence and to remove the 
agonist quickly from the recording bath.
Only filtered solutions were used for pipette perfusion using 0.22 pm syringe filters 
(Millipore Corporation, U.S.A, Cat No. SLGS033SS) to minimize the risk of destroying 
patches due to small particles in the perfusion solution. The perfusion solutions were held 
at room temperature for at least half an hour before use to avoid bubble formation.
2.6.3.6 Cleaning and storage of application pipettes
To avoid contamination with dirt and bacteria, application pipettes were rinsed with
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distilled and deionised water containing 0.5% of sodium hypochlorite for at least 20 
minutes after each experiment. The application pipettes were stuck inside a 60-ml plastic 
test tube using Blu-Tack (Bostic, Leicester, UK) and the tips of the application pipettes 
were submerged in distilled water to avoid contamination.
2.6.3.7 Open-tip response
In order to map out the optimal position of the recording pipette, open-tip experiments 
were performed every day before experiment. Theta glass application pipettes were 
perfused with lOmM NaCl solution and ImM NaCl solution, respectively. To begin with, 
an open-tip recording pipette was positioned in the 1 mM NaCl solution, 100 pm away 
from application pipette tip and 20 pm away from the interface. The position of the 
recording pipettes was slightly below the center of the application pipette tip and the angle 
between the application pipette and the horizontal plane was about 20°. Then 5 volt 
electrical pulses for 1 -4 ms which were generated by WinWCP (written by John Dempster, 
University of Strachclycle, 1991-2005) were filtered with a low-pass bessel filter at 
frequency of 0.5 kHz (Warner Instrument Corp.) to smooth the rising and falling phase of 
the voltage pulses then the filtered pulses were repeatedly applied to the Piezo translator 
and the open-tip response was observed as a change in current recorded by the patch-clamp 
amplifier. Once the optimal position of the recording pipette was found, it was documented 
in order to be able to reproducibly find it when a good outside-out patch was made. An 
example of an open tip experiment is shown in figure 2.3 and the measurement of the 
change in liquid junction potential for this experiment indicated that the 20-80 % rise-time 
for the exchange of control and test solutions was < 200 ps (fitting of the rising phase is 
shown in figure 2.3).
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Figure 2.3 A example of open-tip experiments
Figure 2.3 shows the liquid junction potential between high and low concentrarion of NaCl 
which were purfused from a theta glass application pipettes. The 1-4 ms solution change 
between ImM NaCl to 10 mM NaCl was achived by fast moving recording pipette using a 
Piezo translator. The rise time phase of this junction potential is well fitted with one 
exponential component with 10-90% rise-time of 420 ps for the exchange of control and 
test solutions.
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2.63.8 Patching procedure and data analysis
To obtain good outside-out patchs, high resistance gigaohm seals of more than 40GQ 
resistance were required for low noise recording. After gaining a whole-cell configuration, 
the patch electrode was very slowly withdrawn away from the cell using the manipulator 
until an outside out patch was obtained. Then the outside-out patch was positioned in the 
place where the pipette was in the open tip recording. Then 5 volt electrical pulses for 1 ms 
or 4 seconds duration were repeatedly applied to the Piezo translator using the program 
WinWCP to make fast applications of glutamate. All 10-second sweeps evoked by fast 
application of ImM glutamate were recorded by WinWCP at a holding potential of -60 mV, 
filtered at 2 kHz and sampled at 10 kHz onto a computer hard disk via a CED 1401 plus 
interface (CED Instruments, Cambridge, UK).
During data analysis, all sweeps from one patch were averaged by WinWCP and the 
decaying phases of the averaged sweeps were well fitted with two exponential components 
(the equation for two exponential fitting is y(t) = Aiexp(-t/ii) + A2exp(-t/i2) ). Then all data 
from 6 individual patches were averaged by Mircsoft Excel and the decaying phase of the 
averaged curve was fitted with two exponential components.
2.7 Drug application and experimental design
All solutions were perfused into the recording chamber by gravity. The exchange between 
solutions was made by manually switching a two-way tap. Solution was removed from the 
recording chamber by suction supplied by a suction pump connected to a solution 
reservoir.
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2.7.1 Whole-cell recordings
All whole-cell currents recorded were filtered on-line at 2 kHz, digitized at a sample rate of 
10kHz and were recorded and analyzed using WinEDR-V2.5.9 and WinWCP-V3 5.9 (written 
by John Dempster, University of Strachclycle, 1991-2005)
2.7.1.1 Mg2+ block experiments
Slices were placed in a recording chamber on the stage of a Zeiss Axioskop microscope 
and were continuously bathed in the external solution at room temperature with 0.5pM of 
conotoxin MVIIC and 2//M of nimodipine to minimize the effect of voltage-gated calcium 
channels.
Following by a voltage-step from -60 mV to 0 mV for 1.5 seconds to inactivate voltage 
gated calcium channels and a voltage-ramp from -100 mV to +40 mV for 2 seconds 
(Figure 2.4), the NMDA-induced current and membrane current-voltage relationships were 
obtained for each cell at three different Mg concentrations (contaminating concentration 
of Mg2+, lOOpM Mg2+, and ImM Mg2+) using the following protocol.
As shown in figure 3.1 A, after obtaining the whole-cell configuration, the cell was held at
7 -4--60mV and the recording channels perfused with Mg - free external solution. A few
minutes later when the holding current reached steady state, four voltage changes were
made using the protocol above to evoked control current-voltage relationships (I-V
relations) which were stored on computer using the WinWCP program. Then application of
20pM NMDA and 1 OpM glycine evoked a whole-cell NMDA current, four voltage ramps
were applied when the NMDA whole-cell current reached a steady state and NMDA I-V
relations were recorded on computer. Afterwards, the NMDA response was washed out
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followed by application of control Mg2+- free external solution and four control I-V 
relations were recorded when the control current was stable. In order to the obtain NMDA
9 -4-I-V relation in the presence of a contaminating concentration of Mg , eight control I-V 
relations obtained before and after application of NMDA and four I-V relations obtained 
during application of NMDA were averaged, then the averaged control ramp was 
substracted from averaged ramp recorded in the presence of NMDA. Using the same
I
protocol, the NMDA I-V relations in the presence of lOOpM and ImM Mg were obtained
^ I
(Figure 2.4). For Mg ramp experiments in the presence of lOpM ifenprodil, a saturating 
concentration of NMDA (200 pM) and 1 OpM glycine were applied to avoid the change in 
NMDA receptor affinity that occurs on coapplication of 1 OpM ifenprodil.
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Figure 2.4 Experimental protocol for recording voltage-dependent Mg2+ block of 
NMDAR currents
A. Example currents recorded from whole-cell patch-clamp recordings from a P7 rat 
dopaminergic neuron in SNc. The cell was clamped and held at -60mV. Before voltage 
ramps from -lOOmV to +40mV, a voltage step to OmV was added for 1.5s to inactivate 
voltage-gated calcium channels. This protocol was repeated before and during a 
steady-state NMDA current. For each Mg + concentration, four voltage ramps were made 
and the average of these four ramps was used to estimate the voltage-dependence of Mg2+ 
block. B. The control current trace was substracted from the traces recorded in the presence 
of NMDA. The resultant Inm da values were plotted versus membrane potential.
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2.7.1.2 Ifenprodil inhibition experiments
Slices were placed in a recording chamber on the stage of a Zeiss Axioskop microscope 
and were continuously bathed in the external solution with 100 nM of TTX at a flow rate 
about 3-5 ml / min to reduce excitotoxic effects during application of 250 pM of NMDA.
As shown in figure 5.1, the dopamine cells were held at -60 mV during whole experiments 
and the application of 250 pM NMDA and 10 pM glycine produced an inward whole-cell 
NMDA current that was inhibited by coapplication of 1 pM and 10 pM of ifenprodil.
2.7.1.3 Memantine ramp experiment
^ I
The protocol for memantine ramp experiments is similar to the Mg block experiment. 
Three concentrations of NMDA (lOOpM, 50 pM and 10 pM) and 10 pM glycine were
^ I
used respectively to produce NMDA whole-cell currents and ImM Mg was coapplied
^ I
during the whole experiment to study the effect of Mg block on memantine. Taking the 
100 pM NMDA experiment as an example, after obtained the whole-cell configuration, 
dopamine cells were held at -60 mV, then four voltage ramps as shown in figure 6.1 were 
applied to evoke I-V relations when the holding current reached a steady state. Then 
application of lOOpM NMDA and lOpM glycine evoked a whole-cell NMDA current, four 
voltage ramps were applied when the NMDA whole-cell current reached a steady state and 
NMDA I-V relations were recorded on computer. Afterwards the NMDA response was
74-washed out followed by application of control external solution with ImM of Mg and 
four control I-V relations were recorded when the current was stable. In order to obtain the 
NMDA I-V relation in the absence of memantine, eight control I-V relations obtained
before and after application of NMDA and four I-V relations obtained during application of
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NMDA were averaged, then the averaged control ramp was subtracted from the averaged 
ramp in the presence of NMDA. Using the same protocol, the NMDA I-V relations in the 
presence of lpM, 5 pM and 50pM memantaine were obtained.
2.7.2 Single-channel recordings
2.7.2.1 Single-channel recording from subthalamic nucleus (STN)
In single-channel experiments each outside-out patch from P7 rat STN was firstly exposed 
to a constant concentration of NMDA (200pM) for 2-5 minutes in the presence of 
saturating concentrations of glycine (10 pM). Then ifenprodil (10 pM) was applied 
together with NMDA and glycine for 2-5 minutes.
2.7.2.2 Deactivation and desensitization experiment
Outside-out patches were obtained from P7 rat SNc dopaminergic neurons and each 
outside-out patch firstly was exposed to control solution which contained 20pM glycine 
and 20 pM DNQX ( DNQX was used to block AMPA and kainate receptors ). Then test 
solutions (ImM glutamate, 20pM glycine and 20 pM DNQX) were applied by Piezo 
translator for 1ms to measure the activation and deactivation time course and for 4 seconds 
to measure the desensitization time course.
2.7.2.3 Single-channel recording from P7 rat dopaminergic neurons
In single-channel recording experiments each outside-out patch from P7 rat dopamine cells 
was firstly exposed to a constant concentration of glutamate (lOOnM) for 2-5 minutes in
the presence of saturating concentrations of glycine (lOpM). During the
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whole-expriements, 20pM DNQX, lpM  of strychnine and lOpM of bicuculline were 
coapplied to inhibit AMPA and kainate receptors, glycine receptors, and GAB A receptors.
2.8 Whole-cell data acquisition and analysis
2.8.1 Whole-cell NMDA responses - WinEDR
Whole-cell currents evoked by NMDA and glycine application were recorded using an 
Axopatch 200A patch-clamp amplifier (Axon Instruments). Signals were amplified and 
filtered at 2 kHz (8 pole Bessel) and digitised at 20 kHz using an analogue-to-digital 
converter (CED micro 1401, Cambridge Electronics Design, UK). Whole-cell currents 
were stored on computer using the program WinEDR (V2.2.3) (available at 
http://spider. science, strath.ac .uk/Phy sPharm / showPage.php?page Name=software_ses).
After recording the whole-cell currents traces were printed out using the program WinEDR 
and then the mean maximum currents manually measured with a ruler. Excel was used to 
organize and analyze all the data obtained from manually measured current traces. An 
average current was calculated and a percentage change from different responses was 
calculated.
2.8.2 Whole-cell Mg2+ ramp experiment- WinWCP
Whole-cell currents evoked by NMDA and glycine were recorded using an Axopatch 200A 
patch-clamp amplifier (Axon Instruments). Signals were amplified and filtered at 2 kHz (8 
pole Bessel) and digitised at 20 kHz using an analogue-to-digital converter (CED micro 
1401, Cambridge Electronics Design, UK).
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The NMDA current ramps were evoked and recorded by WinWCP (available at 
http://spider.science.strath.ac.uk/sipbs/page.php?page=software_ses)
In order to measure the fractional block of NMDA whole-cell currents by external Mg2+ at 
-60 mV, NMDAR I-V relationships at positive voltages from 0 mV to +40 mV were 
extrapolated to -100 mV and the control current values at -60 mV, -80mV and -100 mV 
were calculated from the this line. The ratios of residual current in the presence of Mg2+ to 
control current were used to calculate external Mg IC$o at different voltages.
2.9 Single-channel data analysis
2.9.1 Steady-state single-channel recordings -  WinEDR
Steady state single-channel activity was produced by a constant concentration of glutamate 
lOOnM or NMDA (200pM) and a constant saturating concentration of glycine (10 pM), 
and recorded using an Axopatch 200A patch-clamp amplifier (Axon Instruments). Signals 
were amplified and filtered at 2 kHz (8 pole Bessel) and digitised at 20 kHz using an 
analogue-to-digital converter (CED micro 1401, Cambridge Electronics Design, UK). 
Single-channel currents were stored on the computer using a program WinEDR.
2.9.2 Jump experiment recording-W inW CP
1 ms or 4 second pulse of ImM of glutamate was applied by Piezo translator which was
driven by 5mV voltage pulse for 1ms added by WinWCP program (available at
http://spider.science.strath.ac.uk/sipbs/page.php?page=software ses). Each sweep of
NMDA current evoked by fast application was recorded using an Axopatch 200A
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patch-clamp amplifier (Axon Instruments) for 10 seconds to investigate whether there is 
any slow deactivation component in the response of NMDA receptors on dopaminergic 
neurons. Signals were amplified and filtered at 2 kHz (8 pole Bessel) and digitised at 20 
kHz using an analogue-to-digital converter (CED micro 1401, Cambridge Electronics 
Design, UK). Single-channel currents were stored on the computer using the program 
WinWCP. For each experiment all NMDA current sweeps were averaged to obtain an 
averaged deactivation time course and averaged desensitization time course.
2.9.3 Detection and fitting of single-channel data - SCAN
Each digitised single-channel record was scanned and opening and closing transitions were 
detected, measured and fitted using an interactive computer program (SCAN, available at 
http://www.ucl.ac.Uk/Pharmacology/dcpr95.html#scan) that carried out direct fitting of 
each event time-course based on the step response of the recording system (Colquhoun & 
Sigworth, 1995). Briefly, the digitised recording was displayed and scanned by scrolling it 
across the computer screen under visual inspection. Events were detected after crossing a 
threshold placed close to the baseline. Once it was decided that the event could be fitted, 
the program made initial guesses for the positions of all the transitions and amplitudes and 
performed a least-squares fit on the basis of these guesses; finally, it displayed the fitted 
curve superimposed on the digitised event. If the step-response function fitted poorly, the 
fit was adjusted to obtain the fit that best described the event. Fits were stored as a list of 
values with the amplitude and duration of each open period and the duration of each closed 
period. Incompletely resolved openings had their amplitude constrained to be the same as 
that of the closest opening longer than 2 filter rise-times if such an opening was present in 
the region of trace being fitted. If on the contrary, there were no openings with such 
characteristic in the section of trace being fitted, they were fitted as openings to the mean
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amplitude level. After the record was fitted, a data file containing all the values describing 
the lifetime and amplitude of all single-channel events present in the record was created 
and stored as a computer file which was later used during the analysis of the single-channel 
data.
2.9.4 Analysis of single-channel distributions - EKDIST
Display and analysis of single-channel data distributions was done using the program 
‘EKDIST’ (Available at http://www.ucl.ac.Uk/Pharmacology/dcpr95.html#scan) designed 
by D. Colquhoun (Department of Pharmacology, University College London). Before 
analysis, a fixed resolution for open times and closed times that gave a false event rate less 
than 10”11 events per second was imposed, and a ‘real’ difference between adjacent 
amplitude levels defined as > 0.25 pA.
2.9.4.1 Stability plots
Stability plots (Weiss & Magleby 1989) for amplitudes were built by plotting the 
individual single-channel current amplitude of each opening against the interval number in 
which the opening was detected. The amplitude of each single opening longer than 2 
rise-times (332 ps) was plotted. Each data point on the plot represented a single 
observation independently of its duration.
Before a patch was accepted for detailed analysis, the long term stability of the data 
records was checked by making stability plots for open times, shut times and / ’open- 
Stability plots for open and shut times were made by calculating a moving average of 50 
consecutive open or shut time intervals with an overlap of 25 events and plotting this
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average against the interval number at the center of the averaged values. Stability plots for 
open probability were made by calculating a Popen value for each set of 50 open and shut 
times. Once the stability of the record was confirmed, values were sorted into bins and 
used in the construction of frequency distribution histograms.
2.9.4.2 Distribution of fitted amplitudes
The amplitude of channel openings can be measured accurately only if the duration is at 
least twice the rise-time (Tr) of the recording system (Colquhoun & Sigworth, 1995). 
Frequency distribution histograms containing individual open-channel amplitudes longer 
than 2 filter rise-times were constructed and fitted with the sum of three Gaussian 
components with their standard deviations constrained to be the same. The relative area 
occupied by each Gaussian component represents the relative frequency of events to each 
particular amplitude level rather than the relative time spent at each level. Each 
single-channel opening longer than 2 filter rise-times represented one observation 
independently of its duration.
2.9.4.3 Distributions of open times and shut times
As the duration of closed and open time intervals can vary from tens of microseconds to 
tens of seconds, frequency distribution histograms were constructed using a logarithmic 
transformation of the abscissa (Sigworth & Sine 1987) and a square root transformation of 
the ordinate (Sigworth & Sine 1987). Distributions were fitted using the maximum 
likelihood method with probability density functions that were a mixture of three 
exponential components for open times and five exponential components for closed times 
(Gibb & Colquhoun 1992).
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2.9.4.4 Statistics (student t-test)
Statistical analysis (student’s paired or unpaired t-test) was performed in Microsoft Excel 
and Graphpad Prism software, with a significance level of p < 0.05.
During fitting of Mg2+ block and memantine block data, in order to test which model is 
able to well explain the Mg or memantine block data, we minimized the sum-of-squares 
values during the curve fitting then the model with minimal sum-of-squares value was 
considered as the best model to explain the block.
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Chapter 3: Mg2+ block of NMDA receptors in 
dopaminergic neurons of rat substantia nigra 
pars compacta
3.1 Summary
1. Whole-cell patch-clamp recording of bath application-induced NMDA 
receptor-mediated currents ( I n m d a )  in dopaminergic neurons of substantia nigra pars 
compacta in brain slices from P7 rats were used to characterize the voltage-dependence 
of Mg2+ block of NMDA receptors.
2. NMDA receptors on dopaminergic neurons undergo a significant voltage-dependent 
Mg2+ block. At resting potential (-60mV), the application of NMDA (lOpM) and 
glycine (lOpM) produced inward currents which were blocked by the physiological 
concentration of Mg2+ (ImM) by 85.2 ±0.1%  (±SE, n=16) and at lOOpM Mg2+ by 
60.3 ±0.1 % (±SE, n=9). The I C 5 0  value for Mg 2+ block at -60mV was 74.4pM.
3. Concentration-inhibition curves were constructed at each voltage selected. The IC50 of
 ^I
Mg at each voltage was obtained by curve fitting of lMg / Icontroi ratio at various 
concentrations of external Mg2+. The Mg2+ IC50 values at -lOOmV, -80mV and -60mV 
were 7.9 pM, 18.8 pM and 74.4 pM, respectively (n=12). Compared with previous 
studies, these IC50 values suggest that NR2A- or NR2B-containing NMDA receptors
are present on dopaminergic neurons.
4. The application of the NR2B subunit-specific NMDA antagonist ifenprodil (10 pM) 
reduces the NMDA induced whole-cell current (75.7 ±  1.9%). The residual 
ifenprodil-insensitive I n m d a  component had a lower Mg sensitivity than the total 
NMDA current. The Mg IC50 values for the ifenprodil-insensitive current at -lOOmV, 
-80mV and -60mV were 46.6 pM, 97.3 pM and 259.3 pM, respectively (n=9). These 
data suggest that NR2C- or NR2D-containing NMDA receptors are expressed by P7 rat 
dopaminergic neurons.
 ^I I
5. Four Mg block models were used to explain the voltage-dependent Mg block of 
NMDA receptors on dopaminergic neurons. Fitting NMDAR I-V relationships with 
different models shows that trapping block model, potentiation model and proton block 
model all give same voltage-dependent block parameters, 8 and KMg2+ (0 mV), being 
0.82 and 6 mM in the absence of ifenprodil and 0.64 and 4.87 mM in the presence of 
ifenprodil. The sequential block model stimates a higher Mg2+ affinity 432 pM in the 
absence of ifenprodil and 348 pM in the presence of ifenprodil.
6. The voltage-dependent Mg2+ block parameter for dopamienrgic neurons is 0.82, which 
is smaller than NR1-NR2A and NR1-NR2B NMDARs but higher than NR1-NR2C and 
NR1-NR2D NMDA receptors. This result suggests that a mixed population of NR2 
subuntis is present in doapminergic neurons. The decrease in 8 in the presence of
9-J-ifenprodil suggests that NR2 subunits with a low Mg sensitivity are expressed by 
dopamine cells.
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3.2 Introduction
NMDA receptors are unique glutamate-gated ion channels in displaying a 
voltage-dependent Mg2+ block, and requiring the binding of both the transmitter and the 
co-agonist, glycine, for their activation (Mayer et a l 1984; Nowak et a l 1984; Johnson & 
Ascher 1987). The functional and pharmacological properties of NMDARs are mainly 
determined by NR2 subunits (Cull-Candy & Leszkiewicz 2004). For example, recombinant 
receptor channels assembled from NR1-NR2A and NR1-NR2B subunits are blocked more 
strongly by external Mg2+ than the channels formed by the NR1-NR2C and NR1-NR2D 
subunits (Monyer et a l 1994).
The voltage-dependent Mg block of NMDARs has important physiological functions and 
pharmacological practical value. Firstly, at resting membrane potential, NMDARs undergo
y ,
rapid channel block by physiological concentrations of Mg , which significantly reduces 
the NMDAR component of the synaptic current (Herron et al. 1986; Forsythe & 
Westbrook 1988). However, when neurons are depolarized, for example, by activation of
y ,
colocalized AMPA receptors, the voltage-dependent block by external Mg is rapidly 
reduced, allowing Na+ and Ca2+ ion influx through activated NMDA receptors. It has been 
suggested that NMDA receptors in injured neurons decrease their sensitivity to 
voltage-dependent Mg2+ block (Furukawa et a l 2000). It is not clear yet that whether in 
PD the NMDARs in dopamine cells of SNc undergo a switch in sensitivity to Mg2+ block 
when the neurons are injured during disease progression. Secondly, the transition between 
membrane hyperpolarization and depolarization of dopamine cells in SNc is facilitated by 
voltage-dependent Mg2+ block (Hu & Bourque 1992). Finally, the subtypes of native 
NMDAR can be investigated by comparing voltage-dependent Mg2+ block in native cells
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with that of recombinant receptors (Kirson et al 1999).
The aim of this study is to characterize Mg block of NMDAR on dopamine cells of SNc 
to investigate NMDAR composition and to add to information concerning the physiology 
of NMDA receptors in substantia nigra. My results and those from other studies support 
the idea that NR2B-containing and NR2D-containing NMDARs are present in SNc 
dopamine cells and dopamine cells experience a reduced Mg block due to the presence of 
NR2D-containing NMDA receptors. In order to quantify the voltage dependent Mg2+ block, 
two Mg2+ block models are developed to accurately estimate the voltage dependent 
parameters for Mg2+ block.
3.3 Modelling and curve fitting
9+The blocking mechanism of NMDA channels by Mg has been extensively investigated. 
In the widely accepted mechanism, Mg2+ is considered as an open channel blocker and can 
bind to an open NMDA receptor channel at a discrete site situated in the membrane 
electrical field, obstructing current flow. As a result, the affinity of Mg for the binding 
site changes as a function of membrane voltage. There are three widely accepted models 
used to explain the interaction of Mg2+ with the NMDA channel. First is the sequential
 ^I
model (Scheme 3.1). It assumes that Mg can only bind to an open NMDA channel. When 
Mg is bound, ion flow is blocked and agonist cannot unbind from the receptor and so the
9+channel stays in open (blocked) state until Mg leaves the channel. This sequential 
blocking model is roughly consistent with single-channel data except that the burst length 
does not increase linearly with Mg2+ concentration (Nowak et al. 1984). Therefore, some 
modifications were made based on the sequential block model to produce the three-state
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model (Scheme 3.2) and a trapping block model (Scheme 3.3) to provide a satisfactory 
explanation for the data. The three-state model was first pointed out by Jahr and Stevens 
(1990) and the predictions of this model for the distribution of open times, closed times, 
and number of interruptions per burst are in approximate agreement with previous studies. 
This model is considered as an embryo of the trapping block model. In the three-state 
model (Scheme 3.2), Mg2+ can only bind to the open NMDA channel (B) and the channel 
can close and the agonist can unbind from the NMDA channel before Mg2+ leaves the 
NMDA channel (C). However, the model did not distinguish the two NMDAR closed 
states between AR (agonist bound closed state without Mg2+ bound) and ARB (agonist
^ I
bound closed state with Mg bound). Then another modified symmetrical trapping block 
model was proposed by Sobolevsky and Yelshansky in 2000 (Scheme 3.3). In this trapping
^ I
block model, Mg allows the channel gate to close during the block and it can be 
subsequently trapped in the channel when the agonist dissociates. These models mentioned
 ^I
above failed to predict a slow component of Mg unblock in response to a depolarizing 
voltage jump. In order to explain the observation of slow Mg2+ block, another two 
asymmetric trapping block models were proposed by Scheme 3.4 (Kampa et al. 2004) and 
Scheme 3.5 (Vargas-Caballero & Robinson 2004). Both models suggested that occupation 
of the channel by Mg2+ moderately accelerates only the rate of channel closure 
(Vargas-Caballero & Robinson 2004) or accelerates rates of channel closure and agonist 
unbinding, along with increasing the occupancy of desensitizated states (Kampa et al. 
2004). These models predict accurately the appearance of a slow component of Mg2+ 
unblock.
In addition to subunit specific external Mg2+ block of NMDA receptors, multiple Mg2+ 
effects on NMDA receptors have been reported. For example, NMDA receptor channels 
are blocked by intracellular Mg2+ in a voltage-dependent manner (Johnson & Ascher 1990).
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In the absence of extracellular Ca , the block of NMDA receptor channels composed of
9-4-NR1-NR2A by intracellular Mg showed a voltage-dependence (5) of around 0.38 and an 
affinity for the channel of 4mM at OmV membrane potential (Johnson & Ascher 1990; 
Wollmuth et a l  1998). This effect, however, in my experiments is a minor effect because 
the presence of 3mM ATP and lOmM EGTA and 0.5mM GTP chelates the 0.5mM Mg2+ in
9+the pipette solution. The free intracellular Mg concentration was calculated to be 22.8 
pM using the MaxChelator program (available from 
http://www.stanford.edu/~cpatton/maxc.htmn. In addition, external Mg2+ also potentiates 
NMDAR-mediated whole-cell currents in a subunit specific and voltage-independent 
manner. The effect has been reported both in oocytes and HEK cell expression systems 
(Paoletti et al  1995) and in native hippocampal neurons in CA1 region (Wang & 
MacDonald 1995). Wang and MacDonald (1995) discovered that at positive potentials,
9 -4-Mg potentiates NMDA responses recorded in low glycine concentration and they 
suggested that the potentiation is related to a significant increase in affinity of the NMDA 
receptor for glycine. However, in the meantime, Paoletti et al  (1995) suggested that the 
potentiation effect is still obvious in the presence of saturating concentrations of glycine
9 , 9-t-
and the effect is not mimicked by extracellular Ca and Ba and is dependent on the 
presence of NR2B subunits. In my experiments, the potentiation by Mg2+ might be 
considerable because of the presence of NR2B-containing NMDA receptors (see ifenprodil 
block, chapter 5 or Jones & Gibb, 2005). In order to accurately estimate Mg2+ block 
voltage-dependence (6) and affinity for the NMDA receptor, A^ Mg2+(0mV), and also to 
investigate if the NMDAR potentiation by Mg2+ influences the estimation of the voltage 
dependent Mg2+ block parameters, the potentiation model (Scheme 6) was developed based 
on the trapping block model to fit NMDA I-V relationships. In this model, there are two 
NMDA receptor open states, AR* and AR*M (Mg2+ potentiation state). As with the
9 -4-trapping block model, Mg allows the channel gate to close during the block and it can be
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subsequently trapped in the channel when the agonist is removed.
Allosteric regulators such as polyamines acting at NR1/NR2B NMDA receptors (Traynelis 
et a l  1995), ifenprodil acting at NR1/NR2B NMDA receptors (Mott et al 1998), and zinc 
acting at NR1/NR2A (Paoletti et a l  2000) have been suggested to exert their actions 
through modification of proton inhibition (Erreger & Traynelis, 1995, 1996). 
Proton-sensitive gating is therefore a feature of receptor activation that can be regulated by
9+exogenous molecular or therapeutic agents. In order to investigate whether Mg 
potentiation of NMDA receptors acts through modification of extracellular proton block, a 
proton block model (Scheme 3.7) was developed based on the trapping block (Scheme 3.3) 
and potentiation models (Scheme 3.6) and used to fit NMDA I-V relationships. In this 
proton block model (Scheme 3.7), we assume occupancy of the proton binding sites on the
94* 9+receptor is mutually exclusive with the Mg potentiation sites. Once Mg binds to the 
NR2B subunit potentiation site, protons can not bind and vice-versa. With the potentiation 
model, there are two NMDA receptor channel open states, AR* and AR*M (the Mg2+ 
potentiation state).
3.3.1 Scheme 3.1 Sequential block model
ARD
k-6
A + R AR AR*+B AR*B
k2 k4 ke
A sequential block mechanism used to describe channel block o f ligand-gated ion channel receptors. 
Mg2+ can only bind to the receptor in the open state. When Mg2+ binds to the open state, ion flow 
through the channel is blocked. The NMDA receptor channel can not close until Mg + unbinds from the 
NMDA receptor. Here k\ and k2 refer to agonist binding and unbinding rates, respectively, £ 3  and k4 are 
channel opening and closing rates and k5 and £ 6 are Mg + microscopic association and dissociation rates.
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A R d refers to the N M D A  receptor desensitized  state.
3.3.1.1 Equations for the sequential block model
The open probability equation for the sequential block model is shown below [1].
P „ I d £ I ________________!_______________[i]
~  [ * w l  ^ * t _ L + *! + 1 + *l iA  + k [M r* ]
k| *3 [A] k} k_j k, k6
Here, k\ and k2 are agonist binding and unbinding rate constants, £ 3  and £ 4  are channel opening and
closing rates, £ 5  and k6 are blocker microscopic association and dissociation rates and k d and refer to
desensitization rate constants. [A] indicates agonist concentration and [Mg2+] refers to concentrations 
o f extracellular Mg2+.
The voltage dependence of Mg2+ block is expressed by [2]:
k S  VFz
^  = K Ul!( 0 m V ) E x p ( ^ - )  [2]
Here £ 5  and £ 6 are antagonist microscopic association and dissociation rates. 8  indicates the fraction o f 
the membrane voltage at the blocking site and the sign o f 8  is determined by whether the blocking drug 
approaches the binding site from inside or outside o f the membrane. K Mg2+ (OmV) refers to the 
dissociation constant in the absence o f a transmembrane voltage, z refers to the valence o f the blocking 
drug and F, R and T have their usual meaning; Faraday constant (9.65><104 C mol'1), the gas constant 
(8.23J K' 1 mol'1) and the absolute temperature (293K at room temperature) respectively.
Thus, the current at any particular voltage is described by equation [3]:
I» = N (V h - V rev)yPopen
[3]
= ____________________r < y „ - v m ) N ____________________
* 2 _ * lJ _ + * « +1 + *±<L*t + _______ [Mg2*]_______
*, *3 Ml *3 *-* *3 K ^ J 0 m V )E x p ( V^ )
K1
Here, y  stands for NMDA single-channel conductance. Vh and Vrev refer to holding potential and NMDA 
reversal potential, respectively. N indicates number o f NMDA receptors on a tested neuron, k], k2, k3, /c4, 
k+d, k.d, [A] and [Mg2+] are defined on equation [1]. 8 , z, F, R  and T  are defined on equation [2].
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3.3.1.2 Curve fitting for the traditional sequential block model
There are several conditions which have been applied during the NMDA I-V curve fitting.
1. According to previous studies, we fixed the values of k^kx, k+Jk-d and k^fa at lOpM, 5 
and 2, respectively during curve fitting (Sobolevsky et a l  1998) (Benveniste & Mayer 
1991) (Lester & Jahr 1992) in order to give a control open probability consistent with 
previous estimates.
2. There is always contaminating Mg in rat brain slices which caused NMDA I-V curves 
obtained in zero-Mg2+ NMDA-containing solutions to bend at negative voltage. 
Therefore, the contaminating extracellular Mg2+ concentration is set to vary during 
curve fitting.
3. Since the different concentrations of external Mg2+ are assumed to not affect N (the 
total number of NMDAR on dopaminergic neurons), 5, A^Mg2+(0mV) and y 
(single-channel conductance), N, y, 5 and +(0mV) were constrained to be the same 
for all Mg2+ concentrations during curve fitting.
4. Here, we assume that the single-channel conductances for all the receptors on SNc are 
the same, which are set to be 50pS during the curve fitting.
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3.3.2 Scheme 3.2 The three-state model (Jahr & Stevens 1990)
3.3.3 Scheme 3.3 Symmetrical trapping block model
ARD
A + R AR , w AR*+B
k2 kA A
k& kb
A + RB ARB , 't3- w AR*B
/C2 J
k<
kA
k+a
ARBD
Mg2+ trapping block mechanism used to describe channel block o f ligand-gated ion channel receptors. 
Mg2+ allows the channel gate to close during the block and it can be subsequently trapped in the channel 
when the agonist dissociates. Here, k\, k2, £3 , £4 , k5, £6, k+d and k_d are defined on section 3.1.1.1.
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3.3.3.1 Equations for the traditional trapping block model
The open probability equation for the traditional trapping block model is shown below [4]. 
_ [AR*] _ __________________ 1__________________  [4]
[*7 •<«/] (^L^Lj_ + L^ + l+4 'iA ) (l + — [Mg2+ ])
k3 [A] fa kd_ fa k6
Here, fa, fa, fa, fa, fa, fa, fa+, fa., [A] and [Mg2+] are defined on section 3.1.1.1.
The voltage dependence of Mg block is expressed by relation [2]:
Thus, the current at any particular voltage is described by equation [5]:
IB = N (V h - V rev)yPopen [5]
= _________________________ N_________________
( ^ 1 ^ ± _ L h A  +  1 + ^ A )  (1 , [Mg2+] }
*, *, M  *,
Here, y, Vh, Vrev, N, fa, fa, fa, fa, k+d, k^, [A], [Mg2+], 8, z, F , R  and T are defined on section 3.1.1.1.
4.3.3.2 Curve fitting for the trapping block model
See the section 3.3.1.2
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3.3.4 Scheme 3.4 Asymmetric trapping block model (Kampa et
al 2004)
Mg block scheme shows two agonist molecules bind to an NMDA receptor (R) to form 
the A2R state. Then the A2R can open to open state (O) or goes to Df (fast desensitisation 
state) and Ds (slow desensitisation state). Mg2+ can bind to all five states, although binding 
is much more rapid to the open state than to other states (dashed line).
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3.3.5 Scheme 3.5 Asymmetric trapping block model
(Vargas-Caballero & Robinson 2004)
Asymmetric trapping block kinetic scheme for the NMDA receptor. This model suggests 
that Mg2+ binding affects the NMDA receptor channel gating. Therefore, in this model, KA 
t K ' * , K Ei : K ’E',KDt K ’v .
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3.3.6 Scheme 3.6 Potentiation model
a r d
k+d
A + /Ci
a r db
k+d
kb
k2
k*M k-M
/C1
k z  k s
= ±  AR*+ B ^ =
k&
ki
A R ^
/C+M /C-M
k z
A R*B^i
kA
k+M
k*>
kz
k*M k-M
kA
ARB
k-d
kz
ki
k*M  k-M
k2
^RB+ A
A
k*M
r
k-d
kA
ARm*+B^===^ARm*B ^  " ARMB.------ WRMB + A
k& kz
k+d
a r md
/(1
k+d
a r mdb
Mg2+ block and potentiation mechanism used to describe channel block o f ligand-gated ion channel 
receptors. There are two NMDA receptor open states in this model (AR* and AR*MB), in the trapping 
block model, NMDA receptors can close while Mg2+ blocked and Mg2+ can be subsequently trapped in 
the channel when the agonist dissociates. Here, £_m and k+M stand for microscopic association and 
dissociation rates for Mg + potentiation. k\, k2, £3 , £4 , k5, fa, k .d and k^  are defined on section 3.1.1.1.
3.3.6.1 Equations for the potentiation model
The open probability for the potentiation model is shown in equation [6].
k
P  =open
1 +
[AR*] + [A R * m ] = ____________________________k ^ _________________________ [6]
[R 1 dmh 1 + + (* ±  + k±  + ^ L + k1 _L )](! + [M g2+ ])
k } k _ „ A k_d k x [A] kb l
Here, k\ and k2, £3 , £4 , ks, *6 , £+d, £-d, [A] and [Mg2+] are defined on section 3.3.1.1. k.M and £+M are 
defined on section 3.3.6.
1
The voltage dependence of Mg block is expressed by relation [2]:
Thus, the current at any particular voltage is described by equation [7]:
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h  = N(vh-v„,)rP,w„
(1 +  ^ i L  ) y(Vh -  Vm  )N
=  ____________________________________
“ p + ^ + ^ + ^ x  }+k^ +k ± m +  L^g2:-L  )
*-a, *3 *-», *-./ *, Ml A’„K2, ( 0mI/ )exp( * , - )
K I
Here, £.m and k+M are defined on section 3.3.6. y, Vh, Vrev, N, k\, k2, £3, £4, [A], [Mg2+], 6 , z, F, R  and T 
are defined on section 3.1.1.1.
3.3.6.2 Curve fitting for the Mg2+ potentiation and block model
The fitting conditions are similar to the method which is described on section 3.3.1.2 apart 
from the k+m and k.m. In this curve fitting, the k+M and k.M are set to vary.
3.3.7 Scheme 3.7 Mg potentiation with proton block model
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Combined Mg2+ block and potentiation due to relief o f proton block mechanism, Mg2+ allows the 
channel gate to close during the block and it can be subsequently trapped in the channel when the 
agonist dissociates. Here k\, ki, £3, kA, ks, kb, k+& and k.& are defined on section 3.1.1.1. k+M and £_m stand 
for microscopic association and dissociation rates for Mg2+ potentiation, and k+u and k.H refer to 
microscopic association and dissociation rates for proton block.
3.3.7.1 Equations for Mg2+ potentiation with proton block model
The equation for traditional trapping block model is shown below [8].
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i + *+" [81
^  [(I + X*2 1 *J +1 + *4 + k*' *4) + (*4 *+" [W+]X1 + *"+ + *2 1 )K1 + k- [Mg2*])*,M1*’ a, *,*.,/ JA A, M] *6l *
Here *i, *2 > ks, k4, ks, h ,  k+d, k.d, [A] and [Mg2+] are defined on section 3.1.1.1. k+M, k.M, k.H and k.w are 
defined on section 3.3.7.
^ I
The voltage dependence of Mg block is expressed by relation [2]:
Thus, the current at any particular voltage is described by equation [9]:
[9]
IB = \  (Vh -  Vre)yPopen
(l + k-r~W,-r„)K
  *-,/______________________________________
\ ll + L » tk±k+l+k +L±L)+(L*^lH-w + L± + L ± w  +-----I^U—_ }
*-«  *i *-./ *1*-// *,/- l i M  K tl)/,JOml')F-xpi )
R T
Here k\, ki, ks, k4, ks, k<>, k+d, k^, [A], [Mg2+],8, z, F, R  and T  are defined on section 3.1.1.1. k.w and £.H 
are defined on section 3.3.7. k.M and £+M are defined on section 3.3.6.
3.3.7.2 Curve fitting for traditional trapping block model
1. During curve fitting, the k+M and k.m are set to vary.
2. Since all experiments were carried on at pH=7.4 condition, the proton concentration is 
0.0398 at room temperature and the A[hj=&+///£-h is set to be 0.1.
3. The values for other parameters are defined on the section 3.3.1.2.
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3.4 Results
All experiments were carried out upon dopaminergic neurons of substantia nigra pars 
compacta in coronal brain slices from P7 rats. Dopaminergic neurons were voltage 
clamped at -60mV in the presence of TTX (lOOnM), nimodipine (2pM) and conotoxin 
MVIIC (0.5pM) to minimize the effect of voltage-gated sodium and calcium channels.
3.4.1 External Mg2+ inhibition of NMDA-mediated whole-cell 
currents at resting potential
In order to characterize external Mg2+ block of NMDAR at resting potential, three 
concentrations of Mg2+ (contaminating Mg2+, lOOpM and ImM) were co-applied with 
lOpM NMDA and lOpM glycine.
Figure 3.1 shows that the application of external Mg (lOOpM and ImM) significantly 
decreased the NMDA-induced whole-cell currents. Figure 3.1 A illustrates a current trace 
from a whole-cell recording, where the first NMDA response was evoked by application of
*7 4 -NMDA (lOpM) and glycine (lOpM) in the presence of only contaminating Mg . Then the 
whole-cell NMDA response was washed off by application of external solution in the 
absence of NMDA and glycine. The second and third NMDA response were evoked by 
coapplication of NMDA (lOpM) and glycine (lOpM) together with lOOpM and ImM Mg2+, 
respectively. Details of whole-cell recordings are given in Table 3.1.
Figure 3.IB shows that external Mg2+ inhibits whole-cell NMDA currents in a
concentration dependent manner. The physiological concentration of Mg (ImM) blocked
the NMDA current by 85.2 ± 0.1% (Mean ± S.E., n=16) while lOOpM Mg2+ caused a 59.3
96
±0.1%  (Mean ± S.E., n=9) inhibition.
To further quantify Mg2+ inhibition of the NMDA-activated current at resting potential,
”7+concentration-inhibition curves were constructed at -60mV. The contaminating Mg 
concentration was estimated from simultaneous fitting of the I-V curves to be 23.4pM (The 
method to obtain this result was described in 3.4.2 section of this chapter). The I C 5 0  of 
Mg2+ at -60 mV was estimated to be 74.4 pM (Figure 3.1C ) .
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Figure 3.1 Mg2+ inhibition of NMDAR-mediated whole-cell currents at resting 
potential.
A. NMDA-mediated current trace evoked by application of lOpM NMDA and 10 pM 
glycine at -60mV. Bars above the current trace show the time of application of the 
indicated solutions. Upright lines on NMDA current trace are current traces evoked by 
voltage-ramps from -lOOmV to +40mV. In B, summary of results with Mg2+ inhibition at 
-60mV shows a significant inhibition of NMDA-evoked whole-cell current by different 
concentrations of Mg2+. In C, external Mg2+ concentration-inhibition curve at -60mV 
constructed according to the Hill-Langmuir equation. I C 5 0  value is estimated to be 74.4 pM.
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Control NMDA 
response (pA)
NMDA response with 
lOOpM Mg2* (pA)
Remaining curren t in 
the presence o f Mg2+ 
lOOpM
NMDA response with 
Im M  Mg2+ (pA)
Remaining cu rren t in 
the presence of Mg2* 
Im M
02032006-1 177 42 23.7%
02032006-2 339 45 13.3%
10032006-1 557 216 38.8% 75.5 13.6%
15032006-1 1070 591 55.2% 42.3 4.0%
15032006-2 868 350 40.3% 112.5 13.0%
16032006-4 544 193 35.5% 56.1 10.3%
16032006-5 619 248 40.1% 67 10.8%
17032006-3 590 150 25.4%
17032006-4 685 100 14.6%
17032006-5 800 361 45.1% 117.1 14.6%
20032006-1 765 275 35.9%
20032006-2 1219 230 18.9%
20032006-3 400 185 46.3% 15 3.8%
29032006-1 652 121 18.6%
29032006-2 938 165 17.6%
29032006-3 722 49 6.8%
29032006-4 963 156 16.2%
Average 700.5 302.4 42.2% 96.5 14.1%
count 17 8 8 16 16
SE 64.6 47.4 0.02 14.5 0.01
Table 3.1 Results of Mg2+ inhibition experiments at resting potential.
Details are given of each whole-cell recording from 16 recordings in this experiment, 
which include the steady state NMDA currents in response to application of two 
concentrations of Mg2+ (100 pM and 1 mM) of each cell. ATP (3 mM) and GTP (1 mM) 
were in the pipette solution. lOOpM of external Mg cause 60.3% inhibition of the 
whole-cell NMDA current and ImM of external Mg + inhibited the whole-cell NMDA 
current by 85.2%.
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3.4.2 Voltage-dependence of Mg2+ block of NMDAR in 
dopamine cells of SNc
In order to investigate the voltage dependence of Mg block of NMDA receptors on 
dopaminergic neurons and also to study the NMDA receptor subunit composition on 
doapminergic neurons, voltage-ramps from -lOOmV to +40mV were applied in the 
presence of lOpM NMDA, lOpM glycine and different concentrations of external Mg2+ 
(contaminating concentration, lOOpM and ImM Mg2+). A typical NMDA current trace is 
shown in Figure 3.1 A. The upright lines on the current trace indicate where voltage ramps 
from -lOOmV and +40mV were applied. Each protocol collected 4 ramps and the averaged 
data from the 4 ramps was used for analysis. All NMDA I-V relationships were obtained 
by subtracting control ramps from those ramps obtained in the presence of NMDA. Each 
NMDA I-V relationship obtained from one cell was normalized to +40 mV and averaged 
with I-V curves from other neurons (n=9). The averaged and normalized NMDA I-V 
relationships are shown in Figure 3.2 A and B.
Figure 3.2A shows typical exemplary NMDA I-V curves while averaged NMDA I-V 
curves obtained from 12 dopamine cells are shown in Fig.3.2 B. It is evident to see from 
the NMDAR I-V curves that NMDA receptors in 7-day-old rat dopaminergic neurons are 
already highly sensitive to extracellular Mg and undergo significant voltage-dependent 
Mg2+ block. In the presence of 1 mM of Mg2+, NMDAR channels were largely blocked at 
negative voltage and passed maximal inward current at about -25mV. When lOOpM and
“y j
contaminating concentration of Mg are present in recording solutions, the NMDAR 
maximal inward currents are found at -40mV and -60mV, respectively.
In order to quantify the voltage-dependent Mg block of NMDAR in dopaminergic
100
 ^I
neurons of P7 rat SNc, external Mg concentration-inhibition curves were constructed at 
-60mV, -80mV and -lOOmV, respectively. As shown in Fig.3.2 C, the Mg2+ IC50 values at 
-lOOmV, -80mV and -60mV were 7.9 pM, 18.8 pM and 74.4 pM, respectively (n=12).
Then the averaged and normalized NMDA I-V relations were fitted with four Mg2+ block 
models; simple sequential block, simple trapping block, potentiation and proton block 
models using the Solver function in Microsoft Excel. The curve fitting details and 
parameters selection were introduced in mpdelling and curve fitting section. The curve 
fitting results are shown in Figure 3.5 and Table 3.2. The /^ MgCOmV) was estimated to be 
432pM using the simple sequential block model while the values were found to be the 
6mM using the trapping block, potentiation and proton block models. The value of 8, 
however, was the same for all four models, being 0.82. In addition, although the 
contaminating Mg2+ concentration was set to vary during curve fitting, the same 
contaminating concentration of Mg2+ were estimated from all four models to be 23.4pM. 
The potentiation constant k+ was estimated to be 0.86. By comparing fitting results 
between different models (Figure 3.5), we can see there is no significant difference 
between fitting results obtained from different models. All models did not give ideal fitting 
results for the lOOpM Mg2+ I-V relationship.
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Figure 3.2 Voltage-dependence of Mg2+ block of NMDARs in dopamine cells of SNc
A. Example NMDA I-V curves recorded from P7 rat SNc dopaminergic neurons. The 
NMDA current trace was evoked by bath application of lOpM NMDA and lOpM glycine. 
3pM Nimodipine and 0.5pM co-conotoxin were used to inhibit voltage-gated calcium 
channel. 23 pM contaminating Mg2+concentration was estimated in the brain slice. Since 
there are alwayse some contaiminatng concentration of Mg2+ in the slices, the dashed line 
was obtained by reversely extending positive curve of NMDA I-V relationships to predict 
the control NMDA current in the absence of Mg2+.
B. Normalized and averaged NMDA I-V curves (n=9). In C, the predicted Mg2+ 
concentration-inhibition curves obtained from B are shown to estimate the Mg2+ I C 5 0  at 
selected voltages. (-100mV; ■ ,  -80mV; ▲, -60mV; ♦ )  The Mg2+ I C 5 0  value at -lOOmV, 
-80mV and -60mV were 7.9 pM, 18.8 pM and 74.4 pM, respectively.
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Figure 3.5 Comparison o f curve fitting between different M g2+ block models
Table 3.2 Sum mary o f curve fitting results for NM DAR I-V relations in the absence
o f ifenprodil
Simple sequential 
model
Simple trapping 
block model Potentiation model
Proton block 
potentiation model
KMa(0mV) 432 pM 6 mM 6 mM 6 mM
5 0.82 0.82 0.82 0.82
Contaminating [Mg2*] 23.4 pM 23.4 pM 23.4 pM 23.4 pM
, ________  W *-M ------------ ------------ 0.86 0.86
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3.4.3 Voltage-dependence of Mg2+ block of ifenprodil-insensitive 
NMDA currents in dopamine cells of SNc
Sensitivity of NMDA receptors to voltage-dependent Mg2+ block of NMDA receptors is 
largely determined by NR2 subunits. NMDA receptors composed of NR1-NR2A and 
NR1-NR2B have stronger voltage-dependent Mg2+ block than those composed NR1-NR2C 
and NR1-NR2D (Monyer et al. 1994; Kuner & Schoepfer 1996). For dopaminergic 
neurons from P7 rat SNC, it has been suggested that NR2B andNR2D subunits are 
expressed (Standaert et al. 1994; Dunah et al. 1996; Dunah et al. 1998; Jones & Gibb 
2005). If this is the case, when lOpM ifenprodil is applied to block current mediated by 
NR2B-containing receptors, the residual current will mainly be carried by 
NR2D-containing NMDA receptors and will display a lower sensitivity to 
voltage-dependent Mg2+ block than the whole-cell current before block by ifenprodil. In
i
order to investigate this, voltage-dependent Mg block was studied in the presence of
94-lOpM ifenprodil, 250pM NMDA, lOpM glycine and different concentrations of Mg . 
Four ramps were made during each drug application and the average data from the 4 ramps 
were used for analysis. Every single NMDA I-V relationship obtained from one cell was 
normalized to +40 mV and averaged with I-V curves from other neurons. The averaged 
and normalized NMDA I-V relationships are shown in Figure 3.3.
Figure 3.3A shows typical NMDAR I-V curves recorded in the presence of lOpM 
ifenprodil while averaged and normalized NMDA I-V curves obtained from 7 dopamine 
cells are shown in Figure 3.3B. As shown in Figure 3.3B, in the presence of ImM external 
Mg , the NMDA currents were largely blocked at negative voltage and passed maximal
94-inward current at about -30mV. When lOOpM or lOpM Mg are present in the recording 
solutiosn, the NMDA maximal inward currents are found at -60mV and -80mV, 
respectively.
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Averaged and normalized NMDA I-V relations were fitted with the four Mg2+ block 
models. The curve fitting results are shown in Figure 3.6 and Table 3.3. The A^Mg(0mV) is 
estimated to be 348pM using the simple sequential block model while this was 4.87mM 
using the trapping block, potentiation and proton block models. The values of 5, however, 
are the same for all four models, being 0.64. In addition, the contaminating concentration 
of Mg2+ was estimated from all four models to be 23.4pM. The potentiation constant 
was estimated to be 0.86. From Figure 4, we can see the four different models all 
give very good fitting results.
In addition, external Mg2+ concentration-inhibition curves were constructed at -60mV, 
-80mV and -lOOmV, respectively. As shown in Fig.3.2 C, the Mg2+ I C 5 0  values at -lOOmV, 
-80mV and -60mV were 46.6 pM, 97.3 pM and 259.3 pM, respectively (n=9).
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Figure 3.3 Voltage-dependence of Mg2+ block of ifenprodil-insensitive NMDAR in 
dopamine cells of SNc
A and B. Exemplary and averaged (mean ± S.E.; n=8) normalized NMDA I-V curves in the 
presence of 250pM NMDA, lOpM glycine and lOpM ifenprodil. The contaminating 
concentration of Mg2+ in the brain slice was estimated to be 23.4pM. (see methods) C. The 
predicted Mg2+ concentration-inhibition curves obtained from B to estimate Mg2+ I C 5 0  at 
selected voltages (-100mV; ■, -80mV; ▲, -60mV; ♦ ) .  The I C 5 0  values at - lOOmV, -80mV 
and -60mV were 46.6 pM, 97.3 pM and 259.3 pM, respectively.
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3.4.4 Comparison of Mg2+ sensitivity between residual current 
in the presence of ifenprodil and normal whole-cell current
In order to compare Mg2+ sensitivity between normal NMDAR whole-cell currents from 
dopamine cells and residual whole-cell currents obtained in the presence of lOpM 
ifenprodil, the NMDAR I-V relationships obtained in the presence of the same 
concentrations of Mg are ploted in the same figure (Figure 3.4).
It is clear to see that in Figure 3.4 at negative voltages the whole-cell NMDAR current 
evoked by lOpM NMDA and lOpM glycine ( I n0rm ai) is blocked more strongly by 
extracellular Mg than the residual whole-cell NMDAR current evoked by 250pM NMDA 
and lOpM glycine in the presence of lOpM ifenprodil ( Ijfen p ro d ii)-  For example, in Figure
I
3.4B at -60mV the I ifenprodii is blocked by lOOpM external Mg by about 10% while 
1 OOpM external Mg2+ significantly blocked I n0rmai by about 45%.
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Figure 3.4 Comparison of Mg2+ sensitivity between residual current in the presence of 
ifenprodil and normal whole-cell current.
A.B.C. Normalized and averaged current curves show a significant difference in 
voltage-dependence of Mg2+ block of NMDAR currents in the presence of lOpM 
ifenprodil. The dashed lines indicate the I-V curves in the presence of lOpM NMDA, 
1 OpM glycine and selected concentrations of Mg2+ whereas the solid lines show the I-V 
relations in the presence of 250pM NMDA, 10pM glycine and two concentrations of Mg2+ 
(lOOpM and ImM).
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Figure 3.6 Comparing the fitting results from the four M g2+ block models for N M D A  
I-V relations obtained in the presence o f  lO pM  ifenprodil
Table 3.3 Sum m ary o f curve fitting results for NM DAR I-V relations in the presence
o f ifenprodil
Simple sequential 
model
Simple trapping 
block model Potentiation model Proton block model
AWOmV) 348 pM 4.87 mM 4.87 mM 4.87 mM
8 0.64 0.64 0.64 0.64
Contaminating Mg2+ 23.4 pM 23.4 pM 23.4 pM 23.4 pM
W *-M ---- ---- 0.86 0.86
i l l
Table 3.4 Woodhull parameters for the block of NMDA channels by extracellular Mg2+
from early studies
Paper 6 K0.5 (OmV)mM Subtype
(Kuner & Schoepfer 1996) 1 4.8 NR1-NR2A
1 3.7 NR1-NR2B
0.73 3.5 NR1-NR2C
0.75 2.6 NR1-NR2D
(Ascher & Nowak 1988) 1 8.8 Cultured neurons
(Jahr & Stevens 1990) 0.8 1.8 Hippocampal neuron
(Antonov & Johnson 1999) 0.47 Unknown Cultured cortical neurons
(Strecker eta l. 1994) 0.93 4.85 CA1 cells in rat neonate
1.13 6.84 CA1 cells in two-week rats
1.24 12.3 Dentate Gyrus in neonate
1.03 5.52 Dentate Gyrus in four- week rats
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3.5 Discussion
3.5.1 Functional high Mg sensitivity and low Mg sensitivity 
NMDARs are present
The external Mg block of recombinant NMDA receptors has been characterized by 
Kuner and Schoepfer (1996) and Monyer et al.(1994). It has been shown that lOOpM 
extracellular Mg2+ blocked NMDA-evoked responses from recombinant NR1-NR2A or 
NR1-NR2B receptor by 79.8% at -60mV while for recombinant NR1-NR2C or 
NR1-NR2D receptors by about 48% (Kuner & Schoepfer 1996). Moreover, ImM 
extracellular Mg2+ blocked NMDA-evoked responses from recombinant NR1-NR2A or 
NR1-NR2B by 95.7% (Kuner & Schoepfer 1996) and by 92.8% (Monyer et al. 1994) and 
at -60mV while for recombinant NR1-NR2C or NR1-NR2D, by about 89% (Kuner & 
Schoepfer 1996) and 64% (Monyer et al. 1994), respectively.
In my experiments, the NMDA-evoked whole-cell current from dopamine cells in P7 rat 
SNc was significantly blocked by lOOpM external Mg2+by 57.8 ± 0.1% (Mean ± S.D., n=8) 
while ImM Mg2+ blocked NMDAR currents by 85.9 ± 0.1% (Mean ± S.D., n=16). 
Comparing the data presented here with previous studies, these results suggested that 
NMDA receptors on dopamine cells have less Mg2+ sensitivity than NR2A- and NR2B- 
containing NMDA receptors and have more sensitivity than NR2C and NR2D-containing 
NMDA receptors. Therefore, it is suggested that the dopamine neurons on substantia nigra 
compacta express both high Mg2+ sensitivity subunits (NR2A, NR2B) and low Mg2+ 
sensitivity subunits (NR2C, NR2D) and the data are strongly supported by previous in situ 
hybridization and immunochemical and patch-clamping experiments, which demonstrated 
that high levels of NR2D mRNA and NR2D protein and low levels of NR2B mRNA were
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found in SNc (Monyer et a l 1994; Dunah et al. 1996; Dunah et a l 1998). In addition, 
Patch-clamp single-channel recording experiments showed that both high and 
small-conductance NMDA channels (50pS, 41pS and 18pS conductance level) were found 
in outside-out patches form P14 rat dopaminergic neurons (See Chapter 4). The high 
conductance NMDA channels are ifenprodil-sensitive, which suggests NR2B subunits are 
present (Jones & Gibb 2005).
Previous studies also suggest that NR2B and NR2D may be present in the same NMDA 
receptor on dopaminergic neurons (Jones & Gibb 2005). These triheteromeric
y j
NR1-NR2B-NR2D complexes may have less sensitivity to Mg than recombinant 
receptors composed of NR1-NR2A, NR1-NR2B (Hatton & Paoletti 2005). Therefore, the 
low Mg2+ sensitivity NMDA receptor on dopamine cells are likely to be NR2D- containing 
NMDA receptors (they might be NR1-NR2D diheteromers or NR1-NR2B-NR2D 
triheteromers).
3.5.2 Functional NR2D-containing receptors might be expressed 
by dopamine cells in SNc
Voltage-dependent channel block by external Mg2+ is an NMDA receptor property of 
critical physiological importance (Nevian & Sakmann 2004). In addition to its functional
y  i
implications, block by external Mg provides a means to explore the subunit composition 
and gating of NMDA receptors (Monyer et a l 1994; Kuner & Schoepfer 1996; 
Vargas-Caballero & Robinson 2004).
y_i
In my experiments, partial Mg concentration-inhibition curves were constructed (Figure
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3.2.C) and the magnitude of the IC50 for Mg block at -60mV was estimated to be 74.4 
pM. Compared with previous studies (40-106pM for NR1-NR2A and NR1-NR2B, 
191-425pM for NR1-NR2C and NR1-NR2D) (Qian et a l 2005), these data suggest that 
although dopamine cells in SNc contain more than one type of NMDA receptor subunit, 
macroscopic NMDA-evoked currents exhibit more NR2B-like characteristics.
The coapplication of ifenprodil and Mg2+ reduced the voltage dependence of Mg2+ block of 
NMDA receptors, which suggests that both Mg2+-sensitive (likely to be NR2B) and
^ I
Mg -insensitive (likely to be NR2D) NMDA receptors are expressed in dopamine cells in 
SNc. This result is consistant with a previous single-channel study, which showed small 
conductance NMDARs (NR2D) with asymmetric direct transition between main opening 
and sub-conductance levels are present (Jones & Gibb 2005). The smaller currents 
recorded in the presence of ifenprodil mean that the series resistance error in these 
recordings will be smaller than in control recordings and so it is unlikely that differences in 
series resistance can account for the lower voltage-dependence of the Mg block in the 
presence of ifenprodil. In these experiments, the average series resistance was 19±4%  
(Mean±S.D., n=8) and in the presence ifenprodil 21 ± 3%  (M ean±S.D., n=9). The 
averaged current at -60mV in control experiments (lOpM NMDA) was 700.5 ± 54.6 (±S.E., 
n=17) and in the presence of ifenprodil (250pM NMDA) was 171 +  12 (n=17). These 
series resistance errors are likely to be similar in these two experimental conditions.
^ I
The low Mg sensitive and ifenprodil-insensitive current component may be from 
diheteromeric NR1-NR2D NMDA receptors or NR1-NR2B-NR2D NMDARs. The IC50 
values for the Mg -insensitive component determined in this study were 46.6.6 pM at 
-lOOmV, 97.3 pM at -80mV, and 259.3 pM at -60mV, respectively. These data are in good 
agreement with previous studies from recombinant NR1-NR2D NMDA receptors (Qian et
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al. 2005).
So far, there is no evidence showing the Mg2+ sensitivity of thiheteromeric 
NR1-NR2B-NR2D NMDAR. However, Hatton and Paoletti (2005) used an mutagenesis 
approach to produce a triheteromeric N R 1-NR2 An614R-NR2 B receptor. The mutation 
prevents external Mg2+ block for NR2A subunits while NR2B subunit sensitivity to Mg2+ 
has not changed. The results showed that although NR2B subunits still have high Mg2+ 
sensitivity, the triheteromeric N R 1-NR2 An614r-NR2 B has low Mg block properties due 
to NR2A subunits mutation. Thus, triheteromeric NR1-NR2B-NR2D NMDAR might have
^ I
low Mg sensitivity, which is similar to NR1-NR2D diheteromeric NMDA receptors.
The NR2D-containing receptors in dopaminergic neurons could have functional 
importance in excitotoxicity because of the long duration of NR2D receptor activations and 
high agonist affinity, as well as weak Mg2+ blockade and low sensitivity to inhibition by 
polyamines (Kuner & Schoepfer 1996; Cull-Candy et al. 2001). Our findings support the 
idea that NR2D subunits form functional NMDA receptors in dopaminergic neurons of 
SNc (possibly these are triheteromeric NR1-NR2B-NR2D receptors). These may provide a 
novel therapeutic target in Parkinson’s disease (Hallett & Standaert 2004).
3.5.3 NMDA concentrations applied during experiment
In order to study voltage dependent Mg2+ block of NMDA receptors on dopamine cells, 
lOpM of NMDA and lOpM of glycine were applied to activate whole-cell NMDA currents. 
However, when the NMDA-induced ifenprodil-insensitive current was studied, 200pM of 
NMDA and lOpM of glycine were applied. There are two reasons for this NMDA 
concentration difference. First, the mean value of whole-cell NMDA-induced current
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evoked by lOpM NMDA and IOjiM is approximately 700 pA. Ifenprodil block 
experiments showed that lOpM of ifenprodil causes 86% inhibition of NMDA-induced 
whole-cell current (see ifenprodil inhibition; chapter 5). Therefore, only about 70pA of 
whole-cell NMDA current remains when 1 OpM ifenprodil is applied. This current is too
^ i
small to quantify Mg block of the ifenprodil-insensitive whole-cell NMDA current. 
Secondly, it has been shown that ifenprodil block is noncompetitive and is associated with 
an increase in NMDA affinity (Kew et al. 1996). In order to avoid an increase in NMDA 
open probability caused application of ifenprodil (lOpM), a saturating concentration of 
NMDA (250pM) was applied during these experiments.
"7-4-
The trapping block model for Mg block of NMDAR is widely accepted, which suggests 
that the extent of Mg block of the steady-state NMDA whole-cell current is independent 
of NMDA concentration. Therefore, the concentration of NMDA used will not affect the 
voltage dependence of the NMDA receptor Mg block. Moreover, it has been suggested 
that ifenprodil inhibits NMDA receptors through shifting the pKa of the proton sensor to a 
more alkaline level, which means the application of ifenprodil also does not affect Mg2+ 
block behaviour.
3.5.4 Comparison with recombinant NMDA receptors
In the oocyte expression system, a clear result has shown that NMDA receptors composed 
of NR1-NR2A, NR1-NR2B show a higher voltage-dependence of Mg2+ block than 
receptors composed of NR1-NR2C and NR1-NR2D (Kuner & Schoepfer 1996; Wrighton 
et al. 2008). However, different values for the voltage-dependence of Mg2+ block (6) have 
been reported. Kuner and Schopfer (1996) reported that the 8 value for NR1-NR2A and
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NR1-NR2B NMDA receptors is about 1.05 and the 8 value for NR1-NR2C and 
NR1-NR2D NMDA receptors is about 0.75. In another group (Wrighton et al. 2008), a 
similar result was obtained for NR1-NR2A NMDA receptors (8=0.96) while a 8 value 
higher than that of Kuner & Schopfer (1996) was reported for NR1-NR2D NMDA 
receptors (8=0.91). We do not know what causes the 8 value difference between these 
experiments. Assuming permeant ions might affect the voltage-dependent Mg2+ block 
(Antonov & Johnson 1999), a possible explanation for this inconsistency is that different 
ion concentrations of recording solution and inside the oocyte were present. For example, 
in Kuner and Schoepfer’s experiment, 0.18mM Ca was used in the external solution 
while 1.8mM Ba used in the external solution in the experiments of Wrighton et al. 
(2008).
In my experiments, fitting NMDA I-V relations using different models permitted us to
^ I
quantify the voltage-dependent Mg block of NMDA channels in dopaminergic neurons. 
According to these models, the same 8 value was found (0.82) independently of the model 
used in the presence of 20 pM NMDA, 10 pM glycine while 8=0.64 in the presence of 200 
pM NMDA, 10 pM glycine and 10 pM ifenprodil. There are two reasons for different 
NMDA concentrations used in my experiments. Firstly, when a low concentration of 
NMDA was used, ifenprodil does not block NR2B-containing NMDAR-mediated currents 
but potentiates NMDA-induced whole-cell currents, because ifenprodil can increase the 
receptor affinity for agonists at the glutamate-site (Kew et al. 1996). (see also ifenprodil 
block chapter) Secondly, all Mg2+ block models derived from the traditional trapping block 
model suggest that the voltage-dependence of Mg2+ block will be independent of agonist 
concentration. This suggestion also was supported by experimental data (Qian et al. 2005; 
Wrighton et al. 2008). These results are consistent with the observation that Mg2+ does not 
alter channel gating in the sense that the durations of “bursts” of channel openings do not
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change in the presence of Mg2+ (Ascher & Nowak 1988; Qian et al 2005).
Comparing my data presented above with recombinant NMDA receptors reveals that the 6 
value (0.82) obtained in the absence of ifenprodil is in the range of previous studies and is 
higher than the 8 value for NR1-NR2C and NR1-NR2D recombinant NMDA receptors 
(0.75) (Kuner & Schoepfer 1996) but smaller than the NR1-NR2D 8 value obtained by 
Wrighton et al. (2008) and smaller than that for NR1-NR2A and NR1-NR2B recombinant 
NMDA receptors, 0.96 (Wrighton et a l 2008) and 1.05 (Kuner & Schoepfer 1996). This 
may suggest that native NMDA receptors on dopaminergic neurons express a mixed 
population of NMDA receptors, highly voltage-dependent Mg2+ block NMDA receptors 
(NR2A- and NR2B-containing NMDA receptors) and receptor less voltage-dependent 
Mg2+ block (NR2C- and NR2D- containing NMDA receptors). This evidence also is 
supported by previous electrophysiological experiments (Jones & Gibb 2005), in situ 
hybridization (Standaert et a l 1994) and western blot experiments (Dunah et a l 1996; 
Dunah et a l 1998). They suggested that both NR2B- and NR2D-containing NMDA 
receptors are expressed by dopaminergic neurons in adult SNc. If this is the case, in the 
presence of 1 OpM ifenprodil, the NMDA whole-cell current mediated by NR2D-containing 
NMDA receptors should be more obvious than before and the whole-cell current should 
display a lower voltage-dependence of Mg block. In agreement with this idea, a smaller 8 
value (0.64) was observed in the presence of lOpM ifenprodil, suggesting that 
NR2D-containing NMDA receptors are expressed by P7 dopamine cells. However, the 8 
value (0.64) in my experiments is smaller than that of NR1-NR2D recombinant NMDA 
receptors, being 0.91 (Wrighton et a l 2007) and 0.75 (Kuner & Schoepfer 1996). The 
discrepancy might be due to the experimental conditions, because in my experiments, 
ImM Ca2+ was added to the external recording solution and this external Ca2+ could cause 
an interaction between Ca2+ and Mg2+ (Mayer & Westbrook 1987; Ascher & Nowak 1988).
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The discrepancy also might be due to receptor expression system differences. Therefore, I 
compared my data with previous experimental results from native NMDA receptors (See 
section 3.5.5).
The Mg2+ affinity parameter for NMDA receptors (£ Mg2+(0mV)) also was obtained during 
fitting the NMDA I-V relations to different Mg2+ block models. Intriguingly, the traditional 
trapping block, potentiation and proton block models all gave the same results for Km% + 
(OmV), being 6mM (without ifenprodil) and 4.87mM (with ifenprodil) while the values of 
^Mg2+(0mV) obtained from fitting data using the simple block model are smaller than 
values obtained using the other models. They are 432pM (without ifenprodil) and 348pM 
(with ifenprodil), respectively. These results are due to the fact that both the potentiation 
model and proton block models are based on the trapping block model and also proton 
block effect and Mg2+ potentiation effect only affect NMDA receptor open probability and 
do not influence Mg2+ block voltage-dependence (8) and Mg2+ affinity at OmV. However, 
compared with the trapping block model, the simple block model has less NMDA receptor 
closed states, which could cause the difference in Mg affinity at OmV.
In the Kuner and Schoepfer (1996) paper, they reported that A^ Mg2+(0mV) values for 
NR1-NR2A and NR1-NR2B NMDA receptors are 4.87mM and 3.7mM, respectively and 
for NR1-NR2C and NR1-NR2D NMDA receptors are 3.5mM and 2.6mM, respectively. 
These results suggested that there are no significant differences in A^Mg2+ (OmV) between 
different NR2-containing NMDA receptors. In agreement with previous reports, my data 
(6mM and 4.87mM) from the trapping block, potentiation and proton block models are 
similar to (somewhat higher than) data from recombinant NMDA receptors. My data also 
suggested that the traditional simple block model cannot accurately explain Mg2+ block 
voltage-dependence of NMDA receptors, especially for Kug (OmV).
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3.5.5 Comparison with native NMDA receptors
Voltage-dependent Mg block has been widely investigated on native NMDA receptors in 
different brain areas during rat development. As indicated by previous studies, the values 
of 8 and A^Mg2+ (OmV) for exteral Mg block were estimated to be 1 and 8.8mM for 
NMDA receptors in cultured rat neurons (1-8 weeks) (Ascher & Nowak 1988), 0.8 and 
1.8mM for NMDA receptors in P3 rat CA1 hippocampal neurons (Jahr & Stevens 1990),
0.92 and 7.7mM for NMDA receptors in 180g rat CA1 pyramidal neurons and et a l (data 
from previous studies data were shown in Table 3). Table 3 shows that a large range of 
values of 5 and K^gi+ (OmV) have been reported, 8 being from 0.65 to 1.24 and ATMg2+(0mV) 
being from 1.6mM to 2 ImM. It is worth mentioning that Antonov and Johnson (1999) 
reported values of 8 and KMg2+(0mV) was 0.47 and O.lmM, respectively when the effect of 
permeant ions is taken into account. These data are considerably different from the data 
from other research groups because Antonov and Johnson introduced permeant ion effects 
into the study of voltage-dependent Mg2+ block of NMDA receptors and a new Mg2+ 
model was used in fitting their single-channel recording data. The values of 8 and 
^Mg2+(0mV) from my experiments are in the range of previous studies. It remains unclear 
what factors might be responsible for these wide ranges of reported 8 and A'Mg2+(0mV) 
values, however, given that permeant ions influence 8 and J^Mg2+(0mV) values (Antonov & 
Johnson 1999; Zhu & Auerbach 2001; Zhu & Auerbach 2001; Qian et a l 2002; Qian et a l 
2005), the experimental conditions could contribute to this large range of 8 and A^ Mg2+(0mV) 
values.
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3.5.6 Proton block and Mg2+ potentiation do not affect 
voltage-dependent Mg2+ block
In my experiments, two new Mg block models were developed to investigate whether
^ i
allowing for proton block of NMDA receptors and Mg potentiation effects on 
NR2B-containing NMDA receptors influence estimation of the voltage-dependent Mg2+ 
block parameters, 8 and A^ Mg2+(0mV).
Fitting NMDA receptor I-V relations using these two new models gave us the same results 
as those obtained from fitting data using the traditional trapping block model. This fact 
suggested that for estimating voltage-dependent Mg2+ block of NMDARs, there are no 
significant differences among these models; the trapping block, potentiation, and proton 
block models. In other words, allowing for the Mg2+ potentiation effect and proton block of 
NMDA receptors has no effect on voltage-dependent Mg2+ block of NMDA receptors.
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Chapter 4: Kinetics of NMDA receptors in P7
rat dopaminergic neurons
4.1 Summary
1. Single-channel recording and concentration jump experiments were made using 
outside-out patches from P7 rat dopaminergic neurons of SNc to study the kinetics of 
NMDA receptors.
2. Single-channel results show that both large- (49 pS and 38 pS) and small- (38 pS and 18 
pS) conductance NMDAR channels are expressed by P7 rat dopaminergic neurons. In the 
presence of 100 nM NMDA and 10 pM glycine, the mean open frequency was 7.5 ± 0.74 
openings s-1, the mean open time was 3.78 ± 0.64 ms and the mean open probability (Popen) 
was 0.026 ± 0.005.
3. Fast application (1-4 ms) of 1 mM glutamate to outside-out patches evoked macroscopic 
current responses with a main decay time constant of hundreds of milliseconds. The 
averaged macroscopic current response from 6 individual patches was well fitted with two 
exponential components with time constants of 129 ms (53%) and 1449 ms (47%). These 
results suggest that NR1-NR2D NMDA receptors are absent or at very low expression 
levels (less than 1% of total NMDA receptors) in extrasynaptic sites.
4. Four-second application of 1 mM glutamate to outside-out patches evoked a marked 
desensitization of NMDA receptors. The desensitization was well fitted with a mixture of
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two components; a fast component with a time constant of 82.2 ms (30.8% charge) and 
slow component with time constant of 259 ms (69.2% charge). The macroscopic NMDA 
current approached a steady state level (21.5% of the peak current value).
4.2 Introduction
4.2.1 Deactivation kinetics of NMDA receptors are largely 
determined by NR2 subunits and NR1 isoforms
The NMDA receptor is one type of ionotropic glutamate receptor that is widely expressed 
in central nervous system (CNS) contributing to both excitatory synaptic transmission 
(Collingridge et al. 1988; Forsythe & Westbrook 1988) as well as synaptic plasticity 
(Collingridge 1987; Bliss & Collingridge 1993). So far, three main families of NMDAR 
subunits have been identified, NR1, NR2 (NR2A to NR2D) and NR3 (NR3A and NR3B) 
(Cull-Candy et al. 2001). It has been shown that many of the NMDA receptor properties 
are determined by the identity of the glutamate-binding NR2 subunits (Cull-Candy & 
Leszkiewicz 2004). The NMDA receptors composed of N Rla and NR2A show the fastest 
deactivation time course (50ms) while the NMDA receptors formed by NRla/NR2B or 
NRla-NR2C exhibit a similar deactivation time course (about 300ms). Intriguingly, the 
NRla-NR2D NMDA receptors show a long deactivation time course, which is about 2-5 
seconds (Vicini et a l 1998; Wyllie et al. 1998). The variation in NMDAR kinetic 
properties among NR2 subunits implies functional differences during synaptic 
transmission and also the possibility to use kinetic properties investigate NMDA receptor 
composition.
In addition, the deactivation time course also is determined by the NR1 subunit isoform
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(Vicini et al. 1998). The NR1 subunit is the product of a single gene containing 22 exons 
with the possibility of alternative splicing of exons 5 (the N1 cassette), 21 and 22 (the Cl 
and C2 cassettes) where N1 and Cl can be present or absent and C2 can alternate with C2’, 
resulting in 8 different splice variants. Previous studies demonstrated that the NMDA 
receptor deactivation kinetics did not change when NR1 isoforms were expressed with the 
NR2A subunit (Vicini et a l 1998). However, when NR2B subunits were expressed with 
different NR1 isoforms, the NMDA receptors with N1 cassette-containing-NRl subunits 
show an about 4 times faster decay time course than NMDA receptor containing N1 
cassette-lacking NR 1-subunits.
In my experiments, the kinetics of extrasynaptic NMDA receptors in P7 rat dopaminergic 
neurons of SNc were investigated to determine the composition of NMDA receptors. From 
previous studies (Dunah et al. 1996; Dunah et al. 1998; Jones & Gibb 2005) (see also 
ifenprodil; chapter 5), we know that P7 rat dopaminergic neurons express NR2B subunits. 
Thus, the kinetics of NMDA receptors in dopaminergic neurons of SNc might be 
influenced by their NR1 isoform expression. Therefore, we reviewed previous studies 
about the expression of NR1 splice variants in SNc dopaminergic neurons (Laurie & 
Seeburg 1994; Standaert et al. 1994; Laurie et al. 1995; Albers et al. 1999). In situ 
hybridization experiments suggested that the expression of NR1 splice variants in rat SNc 
is development regulated. In P7 rat SNc neurons the NRl-2a isoform is dominant while 
SNc neurons in adult rat mainly express NRl-4a isoform (Laurie & Seeburg 1994; 
Standaert et al. 1994; Laurie et al. 1995). Similar results also were reported in 
immunohistochemistry experiments (Albers et al. 1999). Neither NRl-4a or NRl-2a 
subunits contain the N1-cassette. Thus, it may be concluded that the N1 cassette of NR1 
subunits is absent in dopaminergic neurons of SNc during rat development. The effect of 
the N1 cassette of NR1 subunits on the deactivation kinetics of NMDA receptors in 
dopaminergic neurons can be disregarded.
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4.2.2 Relationship between single-channel behavior of NMDAR 
and channel deactivation kinetics
Before Neher and Sakmann successfully observed single-channel openings (Neher & 
Sakmann 1976), it had been supposed that the synaptic current decay depended on the 
mean duration o f openings of the individual ion channels (Magleby & Stevens 1972). This 
idea had been common until the giga-ohm seal method was discovered (Hamill et a l , 
1980). The method makes it possible to get sufficient resolution to see the brief shuttings 
that separate individual openings (Colquhoun & Sakmann 1981). In this way, the mean 
opening duration was measured to be about 2 ms for acetylcholine, which was too brief to 
explain the frog endplate synaptic current decay.
Before this hypothesis was proposed that when the transmitter binds as fast as is physically 
possible, it will activate not just one channel opening, but that the channel will re-open a 
few times before the agonist dissociates (Colquhoun & Hawkes 1977). In other words, the 
event that underlies the synaptic current is actually a brief burst that consists of several 
openings separated by brief shuttings, though for NMDA receptors it wasn’t until the 
1990s that the formal relationship between burst length and synaptic current time course 
was elucidated (Gibb & Colquhoun 1991; Gibb & Colquhoun 1992; Wyllie et al. 1998).
4.2.3 Extrasynaptic and synaptic NMDA receptors
A comparison of synaptic and extrasynaptic NMDA receptors is shown in Table 4.1.
Extrasynaptic NMDA receptors are expressed in dendrites outside spines or on the soma of
neurons and they seem to be ubiquitously expressed throughout the nervous system. Thus
they have less chance to be activated during synaptic transmission.
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However, these extrasynaptic NMDA receptors can be activated by glutamate spillover 
induced by a high frequency trains of stimuli or by blocking glutamate uptake (Traynelis et 
al. 1993; Brickley et a l 2003) and they represent a potentially important threat to the 
neuron during stroke or some other pathologies. These extrasynaptic NMDA receptors can 
be investigated in membrane patches (Spruston et al. 1995; Clark et al. 1997; Jones & 
Gibb 2005) or in brain slices by using glutamate uncaging (Hayashi & Majewska 2005) or 
directly by activating extrasynaptic NMDA receptors by bath perfusion after block of 
synaptic NMDA receptors by a slow off-rate open channel blocker such as MK-801 (Tovar 
& Westbrook 2002). In contrast, the synaptic NMDA receptors are found in dendrite spines 
and can be activated during synaptic transmission. Therefore, they can be investigated by 
recording EPSCs (Brothwell et al. 2008) or spontaneous synaptic currents.
Table 4.1 Differences between synaptic and extrasynaptic NMDA receptors
Location Activation by synaptic transmission
Investigation
Method
Synaptic NMDAR Dendritic spines Yes EPSC, spontaneous NMDA current
Extrasynaptic
NMDAR
Dendrite outside spines 
or soma Difficult Membrane patches
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4.2.4 Aims of these experiments
In my experiments, to investigate the kinetics of extrasynaptic NMDA receptors and also to 
make inferences about the composition of extrasynaptic NMDA receptors, steady-state 
single-hannel recordings and concentration jump experiments were made for outside-out 
patches from P7 rat dopaminergic neurons of SNc. Three main results are reported here. 
First, NR1-NR2D NMDA receptors are absent or at very low expression levels (less than 
1% of total NMDA receptors) in extrasynaptic sites. Second, a mixed population of NMDA 
receptors (NR1-NR2B and NR1-NR2B-NR2D) is present in extrasynaptic sites. Third, the 
kinetics of extrasynaptic NMDA receptors is similar to these of synaptic NMDA receptors, 
suggesting they have similar subunit composition.
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4.3 Results
4.3.1 Single-channel recordings from outside-out patches of P7 
rat dopaminergic neurons
4.3.1.1 Both large and small conductance NMDA receptors are present
The conductance of NMDA receptor channels is mainly determined by NR2 subunits 
(Stem et al. 1992; Wyllie et al. 1996). The NMDA receptors composed of NR1-NR2A and 
NR1-NR2B have similar channel conductance, 50pS for the main channel open level and 
40pS for the main sub-conductance level while the NMDA receptors formed by 
NR1-NR2C and NR1-NR2D have smaller conductances, being 35pS for NR1-NR2C 
(Stem et al. 1992) and 39pS for NR1-NR2D (Wyllie et al. 1996; Chen et al. 2004) main 
open channel levels and 18pS for sub-conductance levels. Therefore, single-channel the 
conductance of NMDA receptor channels provides one possibility to investigate native 
NMDA receptor subunit composition.
Application of NMDA (lOOnM) and glycine (10 pM) to outside-out patches (n=5) from P7 
rat SNc dopaminergic neurones activated individual NMDA receptor channels at -60 mV 
with three different amplitudes: 1.13 ± 0.09 pA, 2.27 ± 0.3 pAand 2.94 ± 0.17 pA (details 
are shown in Table 4.2). An example recording of NMDA receptor channel openings to all 
three amplitudes is shown in Figure 4.1a, and the stability o f channel openings throughout 
a recording is shown in Figure 4.1b. In 5 patches, the mean opening frequency was 7.5 ± 
0.74 openings s_l,the mean open time was 2.78 ± 0.64 ms and the mean open probability 
C^ open) was 0.026 ± 0.005. The distribution of channel amplitudes activated by lOOnM 
NMDA in 5 patches was fitted with the sum of three Gaussian components (an example is
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shown in Figure 4.1c). The measured channel amplitudes correspond to chord 
conductances (and relative areas) of 18.8 ± 1.0 pS (6.28 ±3.25%, n= 5), 37.8 ± 4.9 pS 
(25.7 ± 55.2%, n=5) and 49.0 ± 2.8 pS (72.3 ± 5.1%, n= 5). The distribution of amplitudes 
for the recording illustrated in Figure 4.1a is shown in Figure 4.1c, with the superimposed 
fit of the three Gaussian components.
Analysis of the frequency of direct transition between conductance levels was used to test 
for evidence that NR2D subunits may be present in SNc dopamine cell NMDA receptors 
(Wyllie et a l 1996; Jones & Gibb 2005). In these data, transition from 19 pS to 38 pS were 
less frequent (44.3 ± 3.3%) than transition from 38 pS to 19 pS (55.7 ± 3.3%) and 
transition from 19 pS to 49 pS (46.5 ± 2.6% ) were less frequent than transition from 49 pS 
to 19 pS (53.5 ± 2.6%) while transitions between 38 pS and 49 pS levels were almost 
symmetrical (48.9 ± 1.3% and 51.1 ± 1.3%).
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Figure 4.1 Large and small-conductance NMDA receptor channels in SNc 
dopaminergic neurons
A. Examples of NMDAR single-channel recordings . B. .Stability plot of channel 
amplitudes throughout the duration of a recording. C. Amplitude distribution for the patch 
illustrated in A, fitted with the sum of three Gaussian components. The mean amplitude 
and relative area of each component are shown on the histogram, and correspond in this 
example to chord conductances of 20pS, 41 pS and 54 pS. D. Stability plots of P 0pen, mean 
open time and mean shut time for single-channel currents in the presence of 100 nM 
NMDA and 10 /*M glycine.
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Table 4.2 Summary of amplitude distribution Gaussian parameters
patch Number of events
Mean
(PA) SD Area % Mean (pA) SD Area % Mean (pA) SD Area %
i 2395 1.2 0.1 1.30 2.59 0.92 37 3.22 0.23 62
2 4990 1.29 0.39 4.4 2.99 0.57 28.9 3.18 0.27 66.7
3 2464 1.2 0.54 19.1 2.64 0.308 17.1 3.26 0.2 63.8
4 1032 0.8 0.289 2.6 1.45 0.228 6.4 2.44 0.35 91
5 2358 1.17 0.43 4 1.69 0.28 19.5 2.61 0.32 76.5
Average 1439 1.13 0.35 6.28 2.27 0.46 21.70 2.94 0.27 72.02
n 5 5 5 5 5 5 5 5 5 5
SE 643 0.04 0.03 1.45 0.13 0.06 2.31 0.08 0.01 2.40
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4.3.1.2 Open times and shut times
The open times here are referred to as open periods because it is likely they often contain 
unresolved brief channel closings. Single-channel current open periods of NMDA 
receptors activated by lOOnM NMDA and lOpM glycine were well fitted with a mixture of 
three exponential components (n = 5). An open period distribution from one recording is 
shown in Figure 4.2 and the summary details of open period distributions from 5 patches 
are shown in Table 4.3. The measured NMDAR channel open periods were well described 
by three components with time constants and relative areas of, 0.13 ± 0.04 ms (40.46 ±3.4 
%, n= 5), 1.52 ± 0.30 ms (29.7 ± 4.6 %, n= 5) and 3.9 ± 0.5 ms (29.3± 3.7 %, n= 5). The 
mean open time was 2.62 ms.
The shut time periods of single-channel current traces of NMDA receptors (n=5) evoked 
by lOOnM NMDA and lOpM glycine were fitted with a mixture of five exponential 
components; 0.36 ± 1.03 ms (5.3 ± 1.9%, n= 5), 1.04 ± 0.21 ms (28.6 ± 6.2%, n= 5), 11.4 ±
1.02 ms (30.1 ± 2.6%, n= 5), 152± 28 ms (14.2 ± 1.0, n= 5) and 541 ± 144 ms (19.6 ± 
3.6%, n -  5). The mean shut time was 122 ms. A summary of details of the shut time 
distributions from 5 patches is shown in Table 4.4.
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Figure 4.2 Analysis of the distribution of NMDA channel open periods and shut time
Figure 4.2 shows distributions of open periods to any amplitude level and and shut time 
from a single patch. The open time distribution has been fitted with a mixture of three 
exponential components with parameter shown in the inset. The shut time distribution has 
been fitted with a mixture of 6 exponential components (in the table 4.4, the shut time 
distribution for this patch has been fitted with 5 expoenential because the 1476 ms 
component is too small).
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Table 4.3 Sum mary o f open time distribution from 5 individual patches
Patch
Number
of
Trans.
Length
(min)
Resol.
(Us)
TT Popen
Opening
Frequency
(s'1)
Mean
Open
(ms)
1st
Exponential
(ms)
%
2nd
Exponential
(ms)
%
3rd
Exponential
(ms)
%
l 8125 5 80 485 0.02 9.48 2.17 0.05 47 0.48 14 2.87 38
2 14458 8.3 120 965 0.02 7.5 2.67 0.05 37.9 1.69 37.7 3.72 24.3
3 11233 4.8 110 527 0.015 8.9 1.69 0.25 45 1.9 36 3.57 18
4 2778 1 150 82 0.037 7.9 4.6 0.12 28.4 2.25 36.2 5.92 35.4
5 8760 5.5 120 514 0.015 7.77 1.97 0.19 44 1.29 24.5 3.27 30.7
Average 9070.80 4.92 514 0.024 8.31 2.62 0.13 40.46 1.52 29.68 3.87 29.28
N 5 5 5 5 5 5 5 5 5 5 5
SE 1927 139 0.002 0.38 0.52 0.04 3.38 0.30 4.58 0.53 3.66
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Table 4.4 Summary of shut time distributions from five individual patches
Patches
1st Exponential
(ms) %
2nd component
(ms) %
3rd component
(ms) %
4th component
(ms) %
5th component
(ms) %
1 0.182 11 0.80 24 11.1 36 163 16 425 14
2 0.112 9 0.71 39 11.0 23 158 13 546 17
3 0.588 4 1.32 8 11.1 36 162 11 289 31
4 0.09 3 0.64 28 8.7 30 51 14 355 25
5 0.836 1 1.72 44 15.0 26 225 17 1090 12
Average 036 53 1.04 28.6 11.4 30.1 151 14.2 541 19.6
N 5 5 5 5 5 5 5 5 5 5
SE 0.07 0.85 0.09 2.79 0.46 1.16 12.57 0.47 64.40 1.60
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4.3.2 Concentration jump experiments
In order to evaluate the deactivation kinetics of extrasynaptic NMDARs, outside-out 
patches containing multiple channels were obtained from P7 rat dopaminergic neurons of 
SNc and stimulated with a brief synaptic-like (l-4ms) pulse of ImM glutamate. Saturating 
concentrations of glycine (10 pM), DNQX (20 pM) and strychnine (lOpM) were always 
present both in control solution and in the solution containing glutamate (ImM).
Figure 4.3A and 4.3B show two individual responses recorded following a 1ms pulse of 
ImM glutamate and 10 pM glycine. Several channels were present in this outside-out 
patch and single-channel currents are clearly visible in the current traces, containing both 
large- and small- conductance NMDA receptor channels. The averaged NMDAR current 
trace from six individual patches is shown in Figure 4.3c. To evaluate the NMDA receptor 
deactivation parameters, we fitted the averaged NMDAR current decay with a mixture of 
two exponential components. The fast component and slow component time constants 
were 128.8 ms and 1449 ms, respectively. The relative areas of the two decay components 
were 53% and 47% (charge), respectively. Interestingly, we can see that there is a slow 
component to the decay time course, about 1449 ms for NMDA receptors in dopaminergic 
neurons. Although the slow component contributes only about 9% of the current peak 
amplitude, it carries about 47% of the charge.
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Figure 4.3 Macroscopic current response to brief pulses of agonist.
Figure 4.3A and B show two individual responses obtained from an outside-out patch 
following a 1 ms pulse of ImM glutamate in the presence of 10 pM glycine. Figure 4.3C 
shows the averaged macroscopic current response from a single patch which was obtained 
by averaging 24 single sweeps evoked by 1-4 ms application of 1 mM glutamate. The 
decay of the current was well fitted with the sum of two exponential components with time 
constants, 84.4 ms and 491 ms with relative area as indicated in the inset. Figure 4.3D 
shows average of macroscopic currents from 6 individual patches. The decay of the current 
was well fitted with the sum of two exponential components with time constants, 129 ms 
and 1449 ms with relative area as indicated in the inset.
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4.3.3 Desensitization experiments
During 4 seconds application of ImM glytamate and lOpM glycine to outside-out patches 
from P7 rat dopaminergic neurons, the NMDA receptors in dopaminergic neurons 
displayed a marked desensitization (Figure 4.4A and 4.4B). The averaged dsensitization 
current trace from 4 individual patches is shown in Figure 4.4D and the desensitization was 
well fitted with a mixture of two components; a fast component with time constant 82.2 ms 
(30.8% charge) and slow component with time constant of 259 ms (69.2% charge). The 
macroscopic NMDA current approached a steady state level (21.5% of the peak current 
value) and the decay time constants after switch off of glutamate were 151 ms (10% charge) 
and 709 ms (90% charge).
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Figure 4.4A and 4.4B shows two individual response obtained from an outside-out patch 
during a 4 second pulse of ImM glutamate in the presence of 10 pM glycine. Figure 4.4C 
shows an averaged macroscopic curmet from a single patch which was obtained by 
averaging 100 sweeps. The desensitization and decay time courses were well fitted with 
two exponential components, which are shown inset. Figure 4.4D shows average of 
macroscopic currents from 4 individual patches. The decay of the current to steady state 
level is well fitted with a mixture of two exponential components with time constants, 82.2 
ms and 258 ms with areas as shown inset.
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4.4 Discussion
4.4.1 Comparison of steady-state recording data with previous 
studies
4.4.1.1 Comparison of NMDAR channel conductance with recombinant 
NMDA receptors
Steady-state NMDAR single-channel currents from oocyte and HEK cells expressing NR1 
with NR2A, NR2B, NR2C or NR2D have been well characterized (Stem et a l 1992; Stem 
et a l 1994; Wyllie et a l 1996; Anson et a l 1998; Cheffings & Colquhoun 2000; Banke et 
a l 2005; Chen & Wyllie 2006). Recombinant NMDA receptors composed of NR1-NR2A 
and NR1-NR2B have large conductance channels (50 pS with 40 pS sublevel) while 
NMDA receptors formed by NR1-NR2C or NR1-NR2D exhibit smaller conductance 
channels (38 pS with 19 pS sublevel). In addition, when NR1, NR2A and NR2D subunits 
were co-expressed in Xenopus oocytes, not only channel openings characteristic of 
NR1-NR2A (50 pS and 40 pS) receptors and channels characteristic of NR1-NR2D 
receptors were found but also a novel channel with a conductance of 30 pS, 40 pS and 50 
pS was recorded, with direct transitions between all three levels (Cheffings & Colquhoun 
2000).
Previous reports about the single-channel conductance of native NMDA receptors are
summarized in Table 4.5. From Table 4.5, we know that single-channel properties of native
NMDA receptors also were mimicked by recombinant NMDA receptors. For example, the
outside-out patches obtained from dopaminergic neurons in P14 rat SNc contain NR2B
subunits and display large 50pS conductance channel openings (Jones & Gibb 2005) and
the patches excised from NR2D knock-out rat cerebellum containing only NR1 and NR2B
subunits also showed large conductance channel openings (50pS and 40pS) (Brickley et al
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2003). Moreover, the outside-out patches containing NR2C subunits such as patches from 
cerebellar granule neurons (Farrant et a l 1994; Momiyama et a l 1996; Cathala et al. 2000) 
or NR2D subunits such as patches from P6 rat cerebellar Purkinje cells display small 
conductance NMDAR channels (39 pS and 19 pS). In my experiments, outside-out patches 
from P7 rat dopaminergic neurons show three conductance levels; 18pS (6.3%), 38pS 
(21.7%) and 49pS (72%). Comparison of my data presented here with previous studies 
using recombinant NMDA receptors shows that the 18pS NMDA channel and 38 pS 
channel are consistent with NR2C- or NR2D- containing NMDA receptors while the 38 pS 
and 49 pS channels are consistent with NR2A- and NR2B- containing NMDA receptors. 
Then, comparing my data with native NMDA receptors reported by other groups, our data 
are very similar to single-channel data from Golgi cell and Purkinje cells in rat cerebellum 
(Momiyama et al. 1996; Misra et a l 2000; Misra et a l 2000; Brickley et a l 2003). The 
neurons in Golgi cells and Purkinje cells of rat cerebellum express NR2B and NR2D 
subunits (Watanabe et a l 1994) and the patches from these neurons display three NMDA 
channel conductance levels; 50 pS, 40 pS and 19 pS.
The 30 pS conductance of NMDAR channels may be a characteristic of triheteromeric 
NMDARs and the 30pS channel has been reported both in recombinant putative 
triheteromeric NR1-NR2A-NR2D NMDA receptors (Cheffings & Colquhoun 2000) and in 
native triheteromeric NR1-NR2B-NR2D NMDA receptors in P14 rat dopaminergic 
neurons (Jones & Gibb 2005). My data using ifenprodil (chapter 5) and my Mg2+ block 
data (see chapter 3) are consistent with the hypothesis that NR1-NR2B-NR2D NMDA 
receptors are expressed by P7 rat dopaminergic neurons. However, a distinct 30 pS 
NMDAR component was not evident in amplitude distributions from P7 rat dopaminergic 
neurons. The absence of 30 pS conductance NMDAR channel openings might be due to 
the low percentage of 30pS openings expected for a triheteromer reported in the work of
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Cheffings & Colquhoun (2000). There are two pieces of evidence to suggest that a lower 
level of functional NR2D-containing NMDA receptors are expressed in P7 rat 
dopaminergic neurons than in P I4 rat. First, in the single-channel amplitude distribution, 
the NR2D component (18 pS) from P I4 rats is larger than that in P7 rats, 13.3 ±4%  vs. 6.3 
±1.5%  (Mean+S.E.), suggesting a lower NR2D expression level for P7 rat dopaminergic 
neurons. Second, at P I4, 10 pM ifenprodil inhibits NMDA-EPSCs by 55.1 ±2.7%  which 
is significantly less than inhibition of EPSCs at P7 (73.5±2.7%) (Brothwell et al. 2008). 
These facts suggest that the percentage of functional NR2D-containing NMDA receptors is 
lower in P7 rat dopaminergic neurons and its level increases from P7 to P I4. These 
receptors may be triheteromeric NR1-NR2B-NR2D receptors. Since the 30 pS 
conductance of triheteromeric NMDARs contributes only a small component to the 
amplitude distribution when triheteromeric NR1-NR2B-NR2D NMDA receptors are 
co-expressed with diheteromeric NMDA receptors, the 30 pS conductance may not be 
obvious in amplitude distributions when the proportion of triheteromeric NMDA receptors 
is low. Similar results were reported in new-born rat hippocampal granule cells where a 
triheteromeric NR1-NR2B-NR2D receptor may also be expressed (Pina-Crespo & Gibb 
2002). Although the amplitude distribution is well fitted with four components, the 30pS 
conductance component is only about 3.7%, suggesting a low level of trimers is expressed 
extrasynaptically at this age.
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Table 4.5 A summary of NMDA receptor conductance from previous studies
Paper Receptor type Possible composition Conductance
(Cheffings & Colquhoun 2000) Recombinant NRla-NR2A-NR2D 20pS, 30pS, 40pS, 50pS
(Stem et al. 1992)
Recombinant
NR1-NR2A, NR1-NR2B, 50pS, 40pS
NR1-NR2C 36pS, 19pS
large cerebellar neurons in 
culture NR1-NR2C 38pS, 18pS
(Wyllie et al. 1996) recombinant NR1-NR2D 35pS,17pS
(Jones & Gibb 2005) Dopaminergic neuron in PI4 rat SNc NR1-NR2B-NR2D 18pS, 30pS, 41pS, 54pS
(Brickley et al. 2003) NR2DA- P7-P10 mice
NR1,NR2B and NR2D subunits 20pS, 40pS and 50pS
NR1, NR2B 50pS and 40pS
(Misra et al. 2000) Golgi cells in P7-P10 mice NR1, NR2B and NR2D 50pS, 39pS and 19pS
(Misra et al. 2000) P6 rat cerebellar Purkinje cells NR1-NR2D 20pS and 40pS
(Green & Gibb 2001)
In laminae I and 11 o f  the dorsal 
horn o f the neonatal rat spinal 
cord
NR1, NR2B and NR2D 19pS,32pS,42pS,53pS and 68pS
(Pina-Crespo & Gibb 2002) in new-bom rat hippocampal granule cells NR1, NR2B and NR2D 17pS, 33pS, 42pS and 50pS
(Farrant et al. 1994) Developing cerebellum NR1, NR2A or NR2B, NR2C, 48pS, 40pS, 30pS, 18 pS
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4.4.1.2 Comparison of macroscopic currents with previous studies
Similar concentration jump experiments were reported by Gotz et al. (1997). They applied 
100 pM glutamate, 10 pM glycine and 10 pM CNQX to outside-out patches from P10-P15 
rat dopaminergic neurons of SNc for 10 seconds to activate NMDAR-mediated 
macroscopic currents. The decay of the macroscopic currents was fitted with a mixture of 
two exponential components. The time constants of both the fast and slow component were 
150 ms and 1049 ms, contributing 66% and 34% to total current amplitude. Inspection of 
my decay time constants for macroscopic currents with this previous report shows that 
there are no significant differences in time constants between the two studies (128 ms vs 
150ms for the fast component and 1449 and 1049 for the slow component). However, the 
amplitude carried by the slow component (34% of total amplitude) in the study of Gotz et 
al. (1997) is much bigger than that in my experiment (8.5%). The discrepancy might be 
due to the different experimental conditions, such as glutamate concentration (ImM in my 
study and lOOpM in Gotz’s study), or concentration jump duration (1-4 ms in my study 
and 10 ms in Gotz’s study). Another possibility is that more NR2D-containing NMDA 
receptors are expressed by P10-P15 rat dopaminergic neurons or more heterotrimeric 
NR1-NR2B-NR2D receptors (Brothwell et al. 2008).
I also compared my results with previous studies from recombinant NMDA receptors. 
Table 1.2 shows that the decay time courses for NRla-NR2A NMDA receptors are in the 
range from 32 ms to 65 ms for the fast component and in the range from 202 ms to 312 ms 
for the slow component with the fast component, contributing about 90% of the amplitude 
and 10% for the slow decay component. The fast decay component for NRla-NR2B is in 
the range from 95 ms to 250 ms, contributing in the range from 59% to 83% of the 
amplitude, while the slow component is in the range from 569ms to 1281 ms. A large range
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of variation for NR1-NR2B NMDA receptors also was reported by Vicini et al. (1998). 
The NRla/NR2D NMDA receptors have the slowest decay time course, being in the range 
of from 1700 ms to 5162 ms. In my experiments, the fast decay component is 128 ms, 
which is much slower than NRla-NR2A NMDA receptors and is similar to NRla-NR2B 
NMDA receptors. Consistent with their ifenprodil sensitivity, this suggests that NR2B 
subunit containing NMDA receptors are expressed by P7 rat dopaminergic neurons. 
However, the slow decay component (1484 ms) from my experiments is slower than that 
for most recombinant NRla-NR2B NMDA receptors, suggesting that the NMDA receptors 
in dopaminergic neurons are not homogenous. Taken together with the results from 
experiments with ifenprodil (see chapter 5), these data are consistent with the idea that 
25% of NMDA receptors in P7 dopaminergic neurons may be NR1-NR2B-NR2D 
triheteromeric NMDA receptors with 75% being NR1-NR2B diheteromeric NMDA 
receptors.
4.4.2 Similar NMDA receptor composition for synaptic and 
extrasynaptic sites in P7 rat dopaminergic neurons
As mentioned before, extrasynaptic NMDA receptors in P7 rat dopaminergic neurons are 
suggested to be a mixture of NR2B- and NR2D-containing NMDA receptors with around 
75% of NMDA receptors being diheteromeric NMDA receptors and 25% being 
triheteromeric NMDA receptors. Since synaptic NMDA receptors are more important for 
excitatory synaptic transmission as well as synaptic plasticity, it is worthwhile to 
understand the composition of synaptic NMDA receptors in P7 rat dopaminergic neurons.
It also has been estimated that following the synaptic release of glutamate, the 
concentration in the synaptic cleft rises rapidly to around 1-10 mM and then decays with a
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time constant of about 1ms (Clements et al. 1992; Barbour 2001). Therefore, in my 
experiments, the protocol of a 1-4 ms application of glutamate (ImM) to outside-out 
patches pulled from P7 rat dopaminergic neurons was used to activate a synaptic-like 
NMDA receptor current and the kinetics of these extrasynaptic NMDA receptors were 
compared with the kinetics of excitatory postsynaptic currents to see whether synaptic 
NMDA receptors have similar kinetics and hence infer whether they have similar subunit 
composition to extrasynaptic NMDA receptors.
It has been reported that the EPSC of P7 rat dopaminergic neurons is described by a 
mixture of two exponential components. At 30°C the fast and slow component time 
constant are 43ms and 164 ms, respectively (Brothwell et al. 2008). Assuming a Q10 of 3.5 
the EPSC fast and slow components would be 164 ms and 494 ms at room temperature, 
respectively. The EPSC fast decay component is very similar to the fast decay for 
extrasynaptic NMDA receptors in my experiments, which is 128 ms. Also both fast 
components for EPSC and extrasynaptic NMDARs carry similar charges, being 56% and 
53%, respectively. These facts suggest that synaptic NMDA receptors have similar 
composition to extrasynaptic NMDA receptors, which are NR2B- and NR2D- containing 
NMDA receptors. This conclusion is supported by the results of Brothwell et al. (2008). 
They used UBP141, a selective NMDA antagonist with 7-fold higher selectivity for NR2C 
and NR2D NMDA receptors than NR2A and NR2B (Morley et al. 2005). EPSC from P7 
rat dopaminergic neurons were tested and an IC50 close to the Kd value for NR2C and 
NR2D-containing NMDA receptors was found. In addition, the EPSC in P7 rats was 
inhibited by 72% by 10 pM ifenprodil. Taken together the evidence suggests that NR2B- 
and NR2D- containing receptors are present at synapse and they might form triheteromeric 
NMDA receptors (Brothwell et al. 2008).
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Comparing the slow components of the macroscopic current with the EPSC slow 
component (Brothwell et a l 2008), shows that the slow decay of the macroscopic current 
(1449 ms) is slower than that for the EPSC (494 ms). There may be two possible 
explanations for this discrepancy. First, the EPSCs in their studies only were recorded for 
200ms or 1 second and the slow decay component was difficult to observe over this 
timescale. Second, the extrasynaptic sites might express a greater percentage of 
NR1-NR2B-NR2D NMDA receptors than synaptic sites, which could contribute to the 
slow decay component. In fact, Brothwell et a l (2008) estimate that for P7 neurons 53.4% 
of synaptic receptors are triheteromeric.
4.4.3 The absence of NR1-NR2D diheteromeric NMDA 
receptors at extrasynaptic sites
My ifenprodil experiments show that lOpM ifenprodil produced a 75% inhibition of 
NMDA-induced whole-cell current. Allowing for 90% maximum inhibition of recombinant 
NR1-NR2B whole-cell currents by lOpM ifenprodil, we can suggest there is about 16% of 
NMDA-induced whole-cell current which is carried by ifenprodil-insensitive NMDA 
receptors. Alternately, the ifenprodil insensitive current may be partly due to the presence 
of triheteromeric NR1-NR2B-NR2D receptors which are likely to have a maximum 
inhibition of about 50% (Hatton & Paoletti 2005)
In order to know if the ifenprodil-insensitive NMDA receptors are diheteromeric NMDA 
receptors or triheteromeric NMDA receptors, ImM glutamate and 10 pM glycine were 
applied for 1ms to outside-out patches from dopaminergic neurons of SNc. The results 
show that there is no NR2D-like long deactivation time course, suggesting that 
diheteromeric NR1-NR2D receptors are absent on dopaminergic neurons or are expressed
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at very low levels.
4.4.4 Extrasynaptic and synaptic NMDA receptors
The presence of NR2D-containing NMDA receptors at synaptic sites is interesting, 
suggesting that NR2D-containing NMDA receptors also mediate synaptic transmission and 
might contribute synaptic plasticity (Vicini & Rumbaugh 2000). Over the past few years 
several studies showed that NR2D-containing NMDA receptors are present at 
extrasynaptic sites rather than synaptic sites. 1-10 ms application of ImM glutamate to 
outside-out patches from cerebellar Purkinje neurons produces an extremely slow 
NR2D-like channel deactivation. This was the first report of an NRl-NR2D-like NMDA 
receptor deactivation in mammalian neurons (Misra et a l 2000). Excitatory synaptic 
transmission to neonatal cerebellar Purkinje cells does not involve NMDA receptors. 
Therefore, the presence of NMDA receptors in these neurons is likely to be mainly 
extrasynaptic (Misra et al. 2000). In addition, single-channel recordings from outside-out 
patches from cerebellar Golgi cells (Misra et al. 2000; Brickley et a l 2003), dopaminergic 
neurons of SNc (Jones & Gibb 2005) and new-born rat hippocampal granule cells 
(Pina-Crespo & Gibb 2002) suggested that NR2D-containing NMDA receptors are present 
at extrasynaptic sites. In my experiments, the results suggested that diheteromeric 
NR1-NR2D NMDA receptors are absence or present at very low percentage. Instead the 
NR2D subunits might form triheteromeric NR1-NR2B-NR2D NMDA receptors. It is likely 
that the triheteromer is also present at synaptic sites of dopaminergic neurons (Brothwell et 
a l 2008). Although the kinetics of triheteromeric NR1-NR2B-NR2D NMDA receptors are 
still not known, allowing for the NR1-NR2D NMDA receptor’s slow deactivation time 
course, we could suggest that the slow decay component of the synaptic current might be 
slowed down by the expression of NR2D subunits as these subunits have the highest
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glutamate affinity and the slowly decaying synaptic currents may increase the Ca influx
^ I
into neurons, have reduced voltage-sensitivity of Mg block and contribute to synaptic 
plasticity in a different way to NR2A and NR2B receptors.
In previous studies, it has been shown that NR2B subunits are widely expressed by the 
central nervous system in young animals and the level of protein and mRNA decreases 
during development (Monyer et al. 1994). In addition, NR2B subunits were found to be 
present both at synaptic and extrasynaptic sites (Misra et al. 2000; Brickley et al. 2003; 
Janssen et al. 2005; Jones & Gibb 2005; Brothwell et al. 2008). In brain slices from cortex 
and dentate gyrus, NMDAR antagonists for NR2B subunits reduce evoked synaptic 
NMDA currents more effectively than NMDA currents generated by spontaneously 
released glutamate (Stocca & Vicini 1998; Dalby & Mody 2003). In cerebellar Golgi and 
hippocampal pyramidal CA1 cells, a higher contribution of NR2B and NR2D at 
extrasynaptic sites has been indicated during high frequency trains but not during single 
stimuli when glutamate spillover is restricted (Cathala et al. 2000; Brickley et al. 2003; 
Lozovaya et al. 2004).
Furthermore, glutamate spillover from synapses on neighboring CA1 cells or glutamate 
released from astrocytes activates extrasynaptic NMDARs sensitive to NR2B antagonists 
(Fellin et al. 2004; Scimemi et al. 2004). The above observations in brain slices indicate 
that NR2B-containing receptors in adult neurons can be selectively activated at 
extrasynaptic sites. However, NR2B subunits do not exclusively segregate to extrasynaptic 
compartments when NR2A expression increases developmentally (Monyer et al. 1994). 
Instead, NR2B remains present in synapses of neurons coexpressing, for example, NR2A 
(Fujisawa & Aoki 2003; Kohr et al. 2003), allowing NR2B within synaptic NMDARs to 
bind to molecules important for NMDAR signaling or internalization, e.g., binding to 
CaMKII (Bayer et al. 2001), rasGRFl (Krapivinsky et al. 2003; Li et al. 2006), or to the
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clathrin adaptor protein AP-2 (Roche et al. 2001). Furthermore, NR2A is not exclusively 
synaptic but is also found extrasynaptically, even in cultured neurons of wildtypes (Li et al. 
1998) (Mohrmann et al. 2002; Thomas et al. 2006). Taken together, the segregation of 
NR2A, NR2B and NR2D to extrasynaptic or synaptic sites is not absolute. Therefore, the 
extrasynaptic NMDA receptors might provide a receptor pool that can transport to synaptic 
sites for receptor renewal or as part of synaptic plasticity.
153
Chapter 5: Ifenprodil inhibition of
NMDA-induced whole-cell currents in 
dopaminergic neurons
5.1 Summary
1. Whole-cell patch-clamp recordings were made from dopaminergic neurons to test 
ifenprodil sensitivity in dopaminerfic neurons of SNc to investigate if NR2B-containing 
NMDA receptors are expressed.
2. The whole-current NMDAR currents were evoked by bath application of 250 pM 
NMDA and 10 pM glycine. The coapplication of 1 pM and 10 pM ifenprodil significantly 
reduced the NMDA-induced current with IC50 of 0.32 pM, which is similar to recombinant 
NR2B-containing NMDA receptors. This result suggests that NR2B-containing NMDA 
receptors are expressed by P7 rat dopaminergic neurons.
3. The maximum effect of ifenprodil on P7 rat dopamine cells was predicted to be 78%, 
which is significantly smaller than that for recombinant NR1-NR2B NMDA receptors. 
Allowing for the triheteromeric NR2B-containing NMDA receptors have less ifeprodil 
maximum block, we suggest that a mixture population of NR1-NR2B and 
NR1-NR2B-NR2D NMDARs are expressed.
5.2 Introduction
Ifenprodil is an allosteric NMDA receptor antagonist with chemical structure unlike any of 
the common competitive or un-competitive antagonists. High affinity inhibition by 
ifenprodil depends critically on the presence of an NR2B subunit. It has significant affinity 
for NR1 -  NR2B receptors (IC50 = 0.29 pM), that is about 400-fold higher than NR 1-2A, 
NR1-NR2C or NR1-NR2D receptors (Williams 1993; Williams 1995). Ifenprodil inhibits 
NR1-NR2B recombinant NMDAR currents with a maximal inhibition of 91% (Williams 
1993; Mott et al. 1998; Hatton & Paoletti 2005).
Since the NR2B subunit can be coimmuniprecipitated with other NR2 subunits (Sheng et 
al. 1994; Chazot & Stephenson 1997), such as with NR2D in P7 rat dopamine cells of SNc 
(Dunah et al. 1998), it is important to know the NR1-NR2B-NR2D sensitivity to ifenprodil. 
Hattton and Paoletti (2005) used an approach combining mutagenesis and pharmacology 
which permits isolation of triheteromeric receptor populations when three subunits are 
expressed together in oocytes and they suggested that triheteromeric NR1-NR2A-NR2B 
NMDARs have similar ifenprodil sensitivity to diheteromeric NR1-NR2B NMDARs but 
they have a smaller maximum block (about 50%) than diheteromeric NR1-NR2B receptors 
(91%).
Ifenprodil, elipodril and some newer derivatives were found to be neuroprotective in whole 
animal models of cerebral ischemia (Gotti et al. 1988; Di et al. 1997) and traumatic brain 
injury (Zeevalk & Nicklas 1990; Toulmond et al. 1993; Okiyama et al. 1997; Dempsey et 
al. 2000), effects that may be due to blockade of NMDA receptors. These antagonists were 
also protective against glutamate- or hypoxia-induced toxicity in cultured neurons (Shalaby
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et a l 1992; Tamura et al. 1993; Fischer et a l 1997; Hess et a l 1998) and in the retina 
(Zeevalk & Nicklas 1990). Thus, the ifenprodil site on NMDA receptors, like glutamate, 
glycine, MK-801, and possibly other sites, represents a target for neuroprotective agents, 
that could be used, for example after ischemic stroke. Several characteristics of the 
ifenprodil-site antagonists, including their subunit-selectivity, use-dependence, and 
mechanism of action make them particularly attractive candidates as potential 
neuroprotectants. NMDA antagonists are also potential therapeutic agents for a number of 
other diseases or pathologies. For example, ifenprodil can reduce Parkinsonian symptoms 
in animal models of Parkinson’s disease (Mitchell & Carroll 1997; Blanchet et a l 1999; 
Nash et a l 1999) and a possible use for NMDA receptor antagonists as antidepressants 
also has been noted (Layer et a l 1995).
Previous studies suggested NR2B- and NR2D-containing NMDARs are expressed by P7 
rat dopamine cells and they might form triheteromeric NR1-NR2B-NR2D NMDARs 
(Dunah et a l 1996; Dunah et a l 1998; Jones & Gibb 2005). I used whole-cell patch-clamp 
recordings to test ifenprodil sensitivity in dopaminergic cells of SNc of P7 rat to 
investigate if NR2B-containing NMDARs are expressed and possibly if the triheteromeric 
complex is expressed. My results are consistent with previous studies (Dunah et a l 1998; 
Jones & Gibb 2005), suggesting that diheteromeric NR1-NR2B and triheteromeric 
NR1-NR2B-NR2D NMDA receptors are present on dopamine cells of SNc.
5.3 Results
All experiments were carried out upon dopaminergic neurons of substantia nigra pars 
compacta in coronal brain slices from P7 rats. Dopaminergic neurons were 
voltage-clamped at -60mV in the presence of lOOnM tetrodotoxin (TTX) to block action 
potentials in the slice and 1 pM strychnine to block glycine receptors.
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As mentioned in the introductory section of this thesis, ifenprodil potentiates 
NMDA-induced whole-cell currents when a low concentration of NMDA is used, because 
ifenprodil binding increases the receptor affinity at the glutamate-site for agonists, such as 
NMDA or glutamate (Kew et al. 1996). Thus, in my experiments, a saturating 
concentration (250pM) of NMDA was used to activate the whole-cell NMDA current 
without the complication of changes in agonist affinity caused by ifenprodil.
5.3.1 NMDA receptors in SNc dopaminergic neurons contain 
NR2B subunits
To determine the possible contribution of NR2B-containing receptors to the NMDA 
evoked response, I tested the effect of lpM  and lOpM ifenprodil on NMDA-induced 
whole-cell currents in 12 dopaminergic neurons. As shown in Figure 5.1, the first response 
was produced by bath application of 250pM NMDA and lOpM glycine, then 
co-application of lpM followed by lOpM ifenprodil significantly reduced the 
NMDA-induced current. The second and third responses are for lpM ifenprodil and the 
fourth and fifth responses are for lOpM ifenprodil, respectively. The first and second 
responses displayed a sharp peak on application of NMDA followed by a rapid decline or 
desensitization. However, the peak is absent for the rest of the responses. The details of 
whole-cell recording are presented in Table 5.1. 59.2 ± 3.1% (n=8) of the NMDA current 
was blocked by lpM ifenprodil while lOpM ifenprodil caused 75.7±1.9% (n=12) 
inhibition (Figure 5.2).
In order to characterize the NMDA receptor sensitivity to ifenprodil, the observed % 
inhibition was matched to an ifenprodil concentration-inhibition curve constructed
according to the Hill-equation using the Solver function in Microsoft Excel. At -60mV, in 
the presence of 250pM NMDA and IOjiM glycine, the IC50 for ifenprodil was estimated to 
be 0.32pM (n=12) and the maximum effect of ifenprodil was predicted to be 78% (Figure 
5.3).
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Figure 5.1 Ifenprodil inhibition of NMDA receptors on SNc dopaminergic neurons
An example NMDA-mediated current trace from a whole-cell patch-clamp recording from 
an SNc dopaminergic neuron. The dopaminergic neuron was clamped at -60mV and bath 
application of 250pM of NMDA (together with lOpM of glycine) evoked an inward 
current. The co-application of 1 pM and 1 OpM of ifenprodil caused a significant inhibition 
of the NMDA-evoked whole-cell current. The bars above the current trace show the time 
of application of individual solutions.
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Figure 5.2 Summary of results with ifenprodil inhibition
This figure shows a significant inhibition of NMDA-mediated whole-cell current with both 
lpM and lOpM ifenprodil. 59.2±3.1% (n=8) of NMDA current was blocked by lpM of 
ifenprodil while lOpM of ifenprodil caused 75.7±1.9% (n=12).
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NMDA 250pM lpM  ifenprodil + NMDA 250pM
% control lOpM ifenprodil 
+ NMDA250pM
% control Rs(M il)
1330 735 55.3% 339 25.5% 23.2
1030 253 24.6% 21
1500 609 40.6% 22
2114.7 353 16.7% 16.2
1375 609 44.3% 459 33.4% 17.5
775 362 46.8% 265 34.2% 21.6
2064 577 28% 270.3 13.1% 15.3
2226 757 34.1% 460 20.7% 12.8
1877 531.2 28.3% 21
1649 358 21.7% 16.9
1119 220 19.7% 24.2
1985 887.2 44.7% 596 30% 15.6
1879 607 32.3% 453 24.1% 13.9
Count 13 8 8 12 12 13
Average (pA) 1610 643 41% 380 24% 19
S.E. 128 55 3% 35 2% 1
Table 5.1 Details of whole-cell patch-damp recording to test the effect of ifenprodil on NMDARs of dopaminergic neurons
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Figure 5.3 Concentration-inhibition curve of ifenprodil inhibition of NMDA receptors
Concentration inhibition curve was obtained for ifenprodil inhibition of NMDA receptors 
to dopamine cells from P7 rat SNc. The NMDA-induced whole-cell currents were evoked 
by 250pM NMDA and 1 OpM glycine. And the coapplocation of 1 pM and 1 OpM ifenprodil 
significantly reduced the whole-cell current. The IC50 for NMDARs on dopaminergic 
neurons is estimated to be 0.32pM.
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5.4 Discussion
To assess the contribution of NR2B-containing NMDARs to macroscopic NMDA evoked 
currents, we have made use of the fact that ifenprodil selectively blocks recombinant 
NMDARs assembled with NR1-NR2B subunits (Williams 1993). It has been suggested 
that dopaminergic neurons in SNc express both NR2B and NR2D subunits (Monyer et al. 
1994; Standaert et a l 1994; Standaert DG 1994; Dunah et al. 1998; Albers et al. 1999; 
Chatha et al. 2000; Jones & Gibb 2005). As indicated by previous studies, at 
concentrations of lpM and lOpM, ifenprodil has little effect on recombinant receptor 
assemblies composed of NR1-NR2A, NR1-NR2C or NR1-NR2D (Williams 1993; 
Williams 1995) and on native NR1-NR2D receptors (Momiyama et al. 1996). Therefore, 
ifenprodil was used to confirm the presence of NR2B subunits and to also quantify the 
contribution of NR2B-containing receptors to the whole-cell NMDAR current.
Previous studies have shown that ifenprodil produces a maximal inhibition of 92% at 
pH=7.3 for recombinant NR1-NR2B receptors, with IC50 values of 0.34pM (Williams 
1993), 0.22-0.32pM (Avenet et al. 1997), 0.17pM (Chazot & Stephenson 1997; Mott et al. 
1998; Misra et al. 2000), when tested against NMDA- or glutamate- evoked responses. 
Inspection of the data presented here reveals that the IC50 from my experiments is in good 
agreement with previous data. The predicted maximum block by ifenprodil, however, is 
78%, which is significantly smaller than that for recombinant NR1-NR2B NMDA 
receptors. A possible explanation for this inconsistency is that dopaminergic neurons on 
dopaminergic neurons express NR1-NR2B diheteromeric receptors and NR1-NR2B-NR2D 
triheteromeric NMDA receptors. Since the diheteromeric or triheteromeric NMDA 
receptors have similar ifenprodil sensitivity but the triheteromeric NMDA receptors 
reduced maximal inhibition (about 50%) (Hatton & Paoletti 2005), NMDA-induced
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whole-cell currents from dopaminergic neurons would be expected to have the same 
ifenprodil IC50 as recombinant NR1-NR2B NMDARs. However, it can be hypothesized 
that the whole-cell current has less maximum block by ifenprodil because of the presence 
of triheteromeric NMDARs. Because the ifenprodil maximum effect on triheteromeric 
NR2B-containing NMDARs is approximately 50% (Hatton & Paoletti 2005), a mixture of 
expression of two kinds of NMDARs can explain the reduced maximum inhibition by 
ifenprodil in dopaminergic neurons.
The maximum block by ifenprodil on dopaminergic neurons could suggest that 14% of the 
NMDA-induced whole-cell currents were produced by ifenprodil-insensitive NMDA 
receptors (e.g. NR1-NR2D), assuming the other 86% of current is produced by 
diheteromeric NR1-NR2B receptors. One possibility is that all the NMDA current may be 
produced by a mixture of NR1-NR2B and NR1-NR2B-NR2D receptors. Assuming this is 
the case, these data suggest there are 75% NR1-NR2B and 25% NR1-NR2B-NR2D
I
receptors in P7 dopamine neurons. The Mg sensitivity of the residual currents in the 
presence of 10 pM ifenprodil (see Mg block; Chapter 3) show that the
 ^I t
ifenprodil-insensitive NMDA current has less Mg sensitivity than that for the normal 
NMDA-induced before application of 10 pM ifenprodil. The Mg2+ IC50 values after 
application of lOpM ifenprodil at -lOOmV, -80mV and -60mV were 25.1pM, 73.2pM and 
229.2pM, respectively. These IC50 values are in the range of Mg2+ sensitivity for 
NR2D-containing NMDARs (Table 3.3). There are two possible explanations for the
9+decrease in Mg sensitivity after the application of ifenprodil. First, diheteromeric 
NR1-NR2D NMDARs might be present on dopaminergic neurons, because NR1-NR2D 
NMDARs have less Mg2+ sensitivity than NR1-NR2B NMDARs (Monyer et a l 1994; 
Kuner & Schoepfer 1996; Hatton & Paoletti 2005). After causing 91% inhibition of 
NR1-NR2B NMDA receptors, a large proportion of the residual current would be carried
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by the NR1-NR2D NMDA receptors, as the residual ifenprodil-insensitive NMDA currents 
are less Mg2+ sensitive. By the same principle, a second explanation could be that after 
causing 90% inhibition of diheteromeric NR1-NR2B receptors and 50% inhibition of 
triheteromeric NR1-NR2B-NR2D receptors, the residual NR1-NR2B-NR2D current 
blocked by ifenprodil, has reduced Mg2+ sensitivity. However, the Mg2+ sensitivity of 
recombinant triheteromeric receptors has not been investigated in detail. To investigate the 
identity of the receptor by a different approach, concentration jump experiments were 
made on NMDARs of dopaminergic neurons to look at the deactivation and desensitization 
time course for these NMDARs to investigate which NMDA subtypes might be expressed 
by dopamine neurons (see concentration jump; chapter 4).
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Chapter 6: Memantine inhibition of
NMDA-induced whole-cell currents in 
dopamine neurons.
6.1 Summary
1. Whole-cell patch-clamp recording was used to characterize the voltage-dependence of 
memantine block of NMDA receptors of P7 rat SNc. NMDA receptor-mediated 
whole-cell currents were evoked by bath-application of 100 pM NMDA and 10 pM 
glycine. Coapplication of 5 pM and 50 pM memantine with NMDA and glycine 
significantly reduced the NMDA-mediated whole cell currents at the holding 
membrane potential of -60 mV.
2. Two memantine block models were used to characterize the voltage-dependence of 
memantine block: a sequential block model and a trapping block model. Both models 
estimate the same voltage-dependent parameter, 8, being 0.55-0.6. Compared with 8 for 
external Mg2+ (0.84), this result suggested that NMDA receptors undergo a weaker 
voltage-dependent block by memantine than by external Mg2+.
9+3. Memantine and Mg are both open channel blockers for NMDA receptors and they 
might compete for binding. In order to investigate competitive block between 
memantine and external Mg2+, voltage-ramp experiments were carried out in the
9 -1-presence of ImM Mg and 5 pM memantine or 50 pM memantine to obtain the
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NMDA I-V relationships.
4. Two new models were developed to investigate competitive block between external 
Mg2+ and memantine. Fitting NMDA I-V relationships with these models shows that 
Mg2+ and memantine do not compete for binding in the NMDA receptor channel.
6.2 Introduction
Memantine is an uncompetitive NMDA antagonist. It was first synthesized in the 1960s by 
a researcher at Eli Lilly in order to prepare an agent to lower elevated blood sugar level, 
and was found to affect the central nervous system (CNS) in 1970s (Parsons et a l 1999). 
In 1989, memantine was found to inhibit NMDA receptors with an IC50 of about lpM  at 
-60mV (Komhuber et al. 1989; Chen & Lipton 1997). In addition, high concentrations of 
memantine (10-500 pM) block many CNS targets, such as serotonin and dopamine uptake, 
nicotinic acetylcholine receptors, serotonin receptors and sigma-1 receptors (Danysz et al 
1997).
Memantine’s effects on NMDARs have been a focus of attention because memantine was 
recently approved by the European Union and the US FDA for use in moderate to severe 
Alzheimer’s disease (Lipton 2006). In addition, memantine might have other potential 
therapeutic utility for acute and chronic neurodegenetative diseases including stroke, acute 
trauma, Parkinson’s disease, and Huntington’s disease (Parsons et a l 1999; Beister et al 
2004; Lipton 2006).
It has been suggested that memantine is an NMDAR open channel blocker, which only 
binds when the NMDAR channel is open. In addition, Mg2+ application decreases the
167
apparent affinity of memantine for NMDA receptors (Sobolevsky et a l 1998) and the 
mutation of “N-site” asparagines (residues on the M2 region of NR1 and NR2 subunits that 
are crucial for Mg2+ block) also affect memantine block (Kashiwagi et al. 2002) which
*y I
suggested that the binding site for memantine overlaps with the Mg binding site. At 
physiological pH, memantine has +1 positive charge, which allows memantine to block 
NMDA channels in a voltage dependent manner.
Compared with other NMDA receptor open channel blockers, such as MK-801, 
phencyclidine and ketamine, memantine is well tolerated clinically (Lipton 2006). This 
may be due to memantine’s blocking properties. First, memantine inhibits NMDA 
receptors with higher affinity when the agonist concentration is higher and has less effect 
at low concentrations of agonist (Chen & Lipton 1997; Sobolevsky & Koshelev 1998; 
Lipton 2006). This property allows memantine to have the potential to selectively block 
NMDA receptors at higher (pathological) levels of glutamate release. Meanwhile, it has no 
or less effect at normal levels of glutamate release for synaptic transmission. Second, 
memantine has a moderate unbinding rate for NMDA receptors; too slow an off-rate such 
as Mk-801 causes the drug to accumulate in the channel, interfering with normal 
neurotransmission. In contrast, too rapid an off-rate (such as Mg2+) causes an inefficient 
blockade, especially with membrane depolarization, which rapidly relieves the block of 
positively charged Mg2+.
Most studies of memantine block have been performed in the absence of Mg2+. It is 
important to carefully examine the competition between external Mg2+ and memantine. 
Since external Mg2+ and memantine both bind in the NMDA receptor channel, then Mg2+ 
and memantine must compete for binding. Therefore, in my experiments, whole-cell 
patch-clamping recording was used to study voltage-dependent memantine block of
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NMDARs in dopaminergic neurons in SNc and the competition between external Mg and 
memantine on NMDA receptors in these neurons was considered.
6.3 Models and curve fitting methods
So far, there are two main memantine block models which have been developed 
(Sobolevsky et a l 1998; Lipton 2006) to explain memantine block of NMDA receptors: a 
sequential blocking model [Scheme 6.1b] and a trapping block model [Scheme 6.1a]. The 
main difference between these two models is that in the sequential block model [Scheme 
6.1b], memantine as an open channel blocker can only block the NMDA receptor channel 
open state (AR*) and the binding prevents NMDA channel closure and the channel only 
can close once memantine unbinds from the NMDA channel. In the trapping block model, 
however, agonist can unbind before memantine unbinds from the NMDA receptor; the 
NMDA receptor can close and trap memantine in the NMDAR channel. Then, the trapped 
memantine needs agonist help to leave the NMDA channel.
In order to investigate the competition between external Mg2+ and memantine for block of 
NMDAR channels, three main models were developed in my experiments to explain 
memantine block according to the original sequential block and trapping block models: a 
competition sequential block model [Scheme 6.2], a competition trapping block model 
[Scheme 6.3] and a competition sequential block model with two agonist binding sites 
[Scheme 6.4].
It has been shown that similar to memantine’s effects on NMDA receptors, external Mg2+ 
is an open channel blocker and blocks NMDA receptors in a voltage dependent manner 
(Nowak et a l 1984; Mayer & Westbrook 1985; Monyer et a l 1994). Therefore, in these
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new models, external Mg2+ was introduced into the original memantine block model and 
competition with memantine to block NMDA channels in the open state (AR*) was 
investigated.
Furthermore, in order to investigate whether a desensitized state and whether the number
^ I
of agonist binding sites affects memantine block, Mg block models with an NMDA 
receptor desensitized state [Scheme 6.2b, 6.3b, 6.4b] and models with two agonist binding 
sites [Scheme 6.4a, 6.4b] were developed.
In order to use these models to fit my experimental NMDAR I-V relations, the equations 
for calculating channel open probability and the whole-cell currents were obtained and are 
shown below.
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Scheme 6.1. Schematic models of channel blockade of NMDARs by memantine.
(a) Trapping block model: an NMDA receptor (R) must bind agonist molecule (A) to reach 
state AR. Subsequently, multiple structural rearrangements lead to channel opening (AR*). 
The blocker molecule then can bind in the open channel (AR*Memantine); the channel can 
close on the blocker (ARMemantine); and agonist can unbind, trapping the blocker 
(RMemantine).
(b) Sequential block model: because blocker binding prevents the channel closure 
conformational change, ARMemantine and Rmemantine states are not accessible in this 
blocking model.
171
(a)
A + R
(b)
AR — AR*
i
AR*Mem
AR*Mg2+
A + R —
A+d
r
a r d
t
h
r
AR*Mem
AR*Mg2+
Scheme 6.2. Schematic models of competition block between Mg2+ and memantine
^ I
(a) Competition sequential block model: Mg can compete for the NMDA channel open
state with memantine (AR*Mg2+). In this model, M g^ binding prevents channel 
closure; the channel can not close and agonist can not unbind until Mg2+ unbinds from 
the NMDA channel.
(b) In order to understand the effect of a desensitizated state on channel open probability 
and voltage dependent block by Mg2+ and memantine, NMDA receptor desensitization 
is taken into account by addition of a desensitized state (ARd) to the model.
2+
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Scheme 6.3. Schematic models of competition trapping block between Mg2+ and 
memantine
(a) Competition trapping block model: In this trapping block model, Mg2+ and memantine 
can compete for the NMDA channel open state and they can produce a trapping block 
(RMg2+, ARMg2+, AR, ARMem, RMem) where the blockers can not leave the NMDA 
channel without agonist assistance and with the channel in the open state.
(b) Competition trapping block model with desensitized state. In this competition trapping 
block model, three desensitizated states were introduced into the original trapping block 
model in order to investigate whether desensitized states have any effect on voltage 
dependent block by memantine and Mg2+.
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Scheme 6.4. Schematic models of competition sequential block model with two agonist 
binding sites
Competition sequential block model: in order to investigate whether the number o f  agonist 
binding sites will affect the quantification of voltage dependent block by and
memantine, models with two agonist binding sites were developed and model (b) imcludes 
NMDA receptor desensitization (A2Rd).
174
For the competition sequential block model without desensitization [Scheme 6.2],
NMDA channel open probability is expressed by equation 1.
= _________________ !__________________ [i]
_L + +1 + ] + — [Mem]
k, A, [A] k} k6 ks
All the parameters are defined on section 3.1.1.1.
^ I
The voltage dependence of Mg and memantine block is expressed as relation 2, 3:
lr S VFz
-^ = ^ ( 0 m r ) e x p ( ^ - )  [2]
k S VFz
-&■ = KUem( O m F )e x p (^ — ) [3] 
k7 RT
All the parameters are defined on the section 3.1.1.1.
Thus, the current at any particular voltage is described by equation 4:
N(Vh - V ret)yP,IIK„
[4]
=  _______________________________
k2 k, 1 , *4 , , , [Mg1*] [Mem]
+  — +  1 + ----------------------— 2 — 1------- n  +
k, k, [A] k, ... VSMgzF VSMemzF
Km,2AOm l/) exP( RT  ) Ku„(0m V )exp (— —
All the parameters are defined on section 3.1.1.1.
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For the competition sequential block model with a desensitized state [Scheme 6.2.b],
NMDA channel open probability is expressed by equation 5.
p  = = ------------------------------------- !------------------------------------- [5]
k , k, [A] k3 k_j k, k6 k%
All the parameters are defined on the section 3.1.1.1,
The voltage dependence of Mg and memantine block is expressed by relation 2, 3. 
Thus, the current at any particular voltage is described by equation 6:
lB=N{Vh-V nv)yPtH
[6]
r(vh- v KV)N
*, k3 [A] k3 k_d k3 „  ... y S M*zF.  ... VSMemz F
K Mg2+( 0 m V )e x p (  ^  ) K Mem(0 m V) exp (~ ^  )
All the parameters are defined on the section 3.1.1.1.
For the competition trapping block model without a desensitized state [Scheme 6.3.a], 
NMDA channel open probability is expressed by equation 7.
P „ „ = I ^ i  = ___________________ '___________________  [7]
[* r « J  ( ki k> -L  + ^£ + 1) ( — [M g2*] + [Mem])
*, *3 [y4] *3 *6
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All the parameters are defined on the section 3.1.1.1.
The voltage dependence of Mg and memantine block is expressed by relation 2, 3. 
Thus, the current at any particular voltage is described by equation 8:
h = N {y h-Vrev)yP(>pen
= _________________________ r(v>-Vr„W_________________________
L + k +1) ( -----------— + -------------------------— — )
*. k3 [A] k3 „  /n T/x VS gzF „  ,A VS zFK Mg2+(0mV)exv{  — ) K Mem(QmV)Qxv{— — — )
All the parameters are defined on the section 3.1.1.1.
For the competition trapping block model with a desensitized state [Scheme 6.3b], 
NMDA channel open probability is expressed by equation 9.
Po = 1 ^ * 1  = ------------------------------------------ !-----------------------------------------  [9]
[*;,„»/] ( *2- k±  _L + ^ 1- +1 + k~*A ) a  + b - [ Mg 2+} + ^L[Meni\)
k, ky [A] k, k_j ky k6 k%
All the parameters are defined on the section 3.1.1.1
The voltage dependence of Mg2+ and memantine block is expressed by relation 2, 3. 
Thus, the current at any particular voltage is described by equation 10:
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lB = m rh- v rev)yPopen [10]
= ________________________________ r iy \ -V rev)H________________________________
( ^ ^ - L  + ^L + l + ^ A )  ( i +  [M g2+] , [Mem] ^
*.*3 [A] ky k_d k 3 /A ^  , V S Mgz F ^  „  /A V S Memz F
K Mf,2A0m V)exp(  ) K MeJ 0 m V ) e x p (  ■ )
All the parameters are defined on the section 3.1.1.1.
For the competition sequential block model with one agonist binding site [Scheme 
6.4a], NMDA channel open probability is expressed by equation 11.
p  =  I - - * !  = ------------------------------------------------ !-------------------------------------------------[ i i ]
k, k, k,' [A] k, *,*M] *3 * /  *  k.
All the parameters are defined on the section 3.1.1.1. k{=2k2 and kx '=2k\.
The voltage dependence of Mg2+ and memantine block is expressed by relation2, 3. 
Thus, the current at any particular voltage is described by equation 12:
h = N(Vh-Ke.)rP^ n [12j
 ___________________________________r (vh - K e J N __________________________________
k2 kAk2' 1 | k4 k2' 1 | k4 | x | [M g 2+] ________ ^ ____ [Mem]
k\ ky V  [A]2 kykx'[A] ky zF. „ ( VSMemzF .
K Mg 2+(0w ^)exp(— — — ) K Mem(0mV)txp ( — — — ) 
K 1  K 1
All the parameters are defined on the section 3.1.1.1.
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For the competition sequential block model with two agonist binding sites and
desensitized state [Scheme 6.4b], NMDA channel open probability is expressed by
equation 13.
„ _______________________ !_______________________  n 3]
r °pe„ r n  1 k k k ' ] k k '  1 k k k k ,  kVRro,a,\ I + ^ L ^ J _  + ^4 + f[± ^ U + l  + ^ [ M g 2+ ] + lh [Mem]
k  k} V M 1  * , V M  1 *3 M , -  V  V
All the parameters are defined on the section 3.1.1.1.
The voltage dependence of Mg and memantine block is expressed by relation2, 3. 
Thus, the current at any particular voltage is described by equation 14:
/» = > '(!;-1 [i4]
= ___________________________________ /(>’„ - i m,)N___________________________________
k2 A4 k2' 1 + ^ V j _  + ^  + ^ i )<^ / +1 + _________ [Mg 2*] ^ [Mem]
kx k , k , ' [ A ] 2 k2 k {' [A] k , k3 k_{/ J ' S MgzF.  „ . .  ... V S Menz F .
R Mgi* (Owt )exp( —  ) KMem(0ml )exp( )
All the parameters are defined on the section 3.1.1.1. k2=2k2 and k\'=2k\.
During the optimization of the fit to block by Mg2+ and memantine, the number of NMDA 
receptors, N, reversal potential, Vrev, ^Mg2+(0mV), A^ Mem(OmV), S  Mg2+ and S  mem were 
allowed to vary. All values of parameters are shown in Table 6.1. The value of ki!k\ was set 
to be 10 based on previous reports (Benveniste & Mayer 1991; Sobolevsky et al. 1998). 
The values of £4/^ 3 and k^Jk.^ are fixed to be 2 and 5, respectively, based on a previous 
study (Lester & Jahr 1992).
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6.4 Results
In all memantine experiments, lOpM glycine and lOOpM of NMDA were used to activate 
the NMDA-induced whole-cell current. lpM  strychnine and lOOnM TTX were applied to 
block glycine receptors and action potentials, respectively. All experiments were carried 
out at room temperature and drugs were applied by bath perfusion.
6.4.1 Voltage-dependent memantine block of NMDA receptors
In order to characterize the voltage dependent memantine block of NMDA receptors in the 
absence of external Mg , voltage-ramps from -lOOmV to +40mV were been made in the 
whole-cell configuration in the presence of NMDA or in the absence of NMDA (control). 
An example NMDAR current trace from a whole-cell recording is shown in Figure 6.1. 
Ramps were made in groups of four and averaged data from the 4 ramps were used for 
analysis. The NMDAR I-V relations were obtained by subtracting averaged NMDA ramps 
(in the presence of NMDA) from control ramps (in the absence of NMDA).
Figure 6.2A shows an example of the averaged NMDAR I-V relationship obtained in the 
presence of lOOpM NMDA, lOpM glycine and 5pM memantine. The I-V curve shows a 
weak voltage-dependence of memantine block from +40mV to -70mV and passes 
maximum inward current at -70mV, then exhibits a negative slope from -70mV to 
-lOOmV. Figure 6.2B shows an example of an averaged NMDAR I-V curve evoked by 
voltage ramps in the presence of lOOpM NMDA, lOpM glycine and 50pM memantine. 
The NMDAR I-V relation for 50pM memantine showed a significant voltage dependence 
o f memantine block, passing maximum inward current at -50mV and exhibits a negative 
slope from -50mV to -lOOmV.
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20 nM glycine 20 |iM glycine
100 nM NMDA 5 memantine 50 nM memantine
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1200pA
J- I--------
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Figure 6.1 Memantine inhibition of NMDA-mediated whole-cell currents at -60mV in 
the presence of added Mg2+
The first NMDAR response was evoked by 100 pM NMDA, lOpM glycine and 
coapplication with 5pM or 50pM memantine significantly reduced the NMDA-evoked 
whole-cell currents, which are shown in the second and third responses, respectively. 
Upright lines on the NMDAR current trace represent the current traces evoked by 
voltage-ramps from -lOOmV to +40mV to study voltage-dependent memantine block of 
NMDA receptors.
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Figure 6.2 Voltage dependent block of NMDA receptors by memantine in the absence 
of added Mg2+
(A) An example of the NMDA-evoked I-V relation in the presence of lOOpM NMDA, 
lOpM glycine and 5pM memantine. The current curve shows a significant voltage 
dependent block by memantine and passes maximum inward current about -70mV. (B) 
From the same cell as illustrated in A, an example of the NMDAR I-V relation evoked by 
IOOjxM NMDA, 20pM glycine and 50pM memantine. It exhibits an almost linear relation 
between -40mV and +50mV and passes maximum current about -50mV, and shows a 
negative slope between -  lOOmV and -60mV.
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Figure 6.3 shows normalized and averaged NMDA I-V relations evoked by lOOpM 
NMDA, lOpM glycine and 5pM or 50pM memantine. The averaged NMDAR I-V curves 
(n=8) were normalized to the current at +40mV to compare voltage dependent differences 
between external Mg and memantine. It is obvious that NMDA receptors undergo a much 
stronger voltage-dependent block by ImM external Mg2+ than memantine. In order to 
investigate the interaction between external Mg2+ and memantine, I quantified the 
voltage-dependent Mg block of NMDA receptors in the absence of memantine and the 
results are shown in Table 6.2. The voltage-dependent Mg block parameter 8 does not 
depend on which model was used during the curve fitting and is 0.84. However, the value 
o f A'Mg2+ (OmV) depends on the model, being l . lmM for the sequential block model with a 
desensitized state (Scheme 6.2b), 4.3mM for Scheme 6.2a, and 14.7mM for the trapping 
block models (Scheme 6.3a and 6.3b). The two-agonist-binding-site model gives similar 
results to the simple sequential block model. These data are consistent with my previous
^ I
data about voltage-dependent Mg block in chapter 3.
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Normalized and Averaged data
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NMDA100|aM+Mem5|iM 0.5
NMDA100|iiM+Mem50^M
-25
Figure 63  Voltage dependent block by memantine and Mg2+
All I-V relations shown in this figure were evoked by voltage ramps from -lOOmV to +40 
mV in the presence of lOOpM NMDA and 10 pM glycine. lOOnM TTX and lpM 
strychnine were added to the external solution to block voltage gated soldium channels and 
glycine receptors on dopaminergic neurons. Compared to Mg2+, memantine shows a less 
voltage-dependent block.
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For the averaged and normalized NMDAR I-V relations of 5pM and 50pM memantine, 
maximum inward currents are found at about -75 mV and -55mV, respectively. Compared 
with the NMDAR I-V relation for voltage dependent Mg2+ block, which is shown in the 
red curve (Figure 6.3), memantine exhibits a weaker voltage dependent block of NMDA
"St
receptors than external Mg . In order to quantify the voltage dependence of memantine 
block of NMDARs, these NMDAR I-V relations were fitted with three memantine block 
models, individually; the sequential block model (Scheme 6.2a, 6.2b), the trapping block 
model (Scheme 6.3a, 6.3b) and the two-agonist-binding-site model (Scheme 6.4a, 6.4b). In 
order to compare the properties of voltage-dependent memantine block with previous
"St
studies, the contaminating Mg concentration was set to be 0 during curve fitting and the 
values of the parameters which were used in curve fitting are shown in Table 6.1. All 
models can fit the data very well and the fitting results are shown in Table 6.3 for 5pM 
memantine, Table 6.4 for 50pM memantine, and fitting curves are shown in Figure 6.4.
From the results of fitting the models to the data, we can see that the presence of a 
desensitized state in the sequential block model which reduces the control P open largely 
influences the estimated A^mem(0mV) value, while the 6 value is independent of the 
desensitized state. In contrast, the presence of a desensitized state does not affect 
voltage-dependent parameters for the trapping block model. As metioned before, the 
two-agonist-binding-site model gives similar fitting results to the sequential block model.
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Table 6.1 Equilibrium constants used for curve fitting
ki/k\ 10
k^/ky 2
Ld/Ld 5
zF/RT (Mg2+) 0.079171
zF/RT (Memantine) 0.039586
Conductance (pS) 50
4-
During optimization of the fit for inhibition by Mg and memantine, the number of 
NMDA receptors, reversal potential, ATMg2+(0 mV), £ Mem(0mV), 8 Mg2+ and 5mem were 
allowed to vary. All values of fixed parameters are shown in Table 6.1. The value of ki!k\ 
was set to be 10 based on previous reports (Benveniste & Mayer 1991; Sobolevsky et al. 
1998). The values of and k+Jk_d are fixed to be 2 and 5, respectively (Lester & Jahr
1992).
Table 6.2 Summary o f voltage-dependent parameters o f K\ (OmV) and 6 for Mg2+ action
! Sequential block model Trapping block model Two binding sites models
Models With Without With Without With Without
desensitization desensitization desensitization desensitization desensitization desensitization
!f!\i£2+(0mV) 1.1 mM 4.3mM 14.7mM 14.7mM l.lm M 4.2mM
6 0.84 0.84 0.84 0.84 0.84 0.84
The data for voltage dependent parameters of Mg2+ block of NMDAR are from fitting of 
averaged and normalized NMDAR I-V curves. The NMDAR I-V relation is obtained from 
a total of 7 sets of experiments. During curve fitting, reversal potential, A^Mg2+(0mV) and 
$Mg2+ were allowed to vary. The value of k^k\ was set to be 10 based on previous reports 
(Benveniste & Mayer 1995; Sobolevsky et al. 1998). The values of k^ /k?, and k+Jk-d are 
fixed to be 2 and 5, respectively (Lester & Jahr 1992).
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Table 6.3 Summary of voltage-dependent parameters of K \ (OmV) and 6 for S pM memantine action
models
Sequential block model Trapping block model Two binding sites models
With
desensitization
Without
desensitization
With
desensitization
Without
desensitization
With
desensitization
Without
desensitization
AWm(OmV) 2.8 pM 11.5 pM 36.7 pM 36.6 pM 2.73 pM 10.7 pM
6 0.6 0.6 0.6 0.6 0.6 0.6
The data for voltage dependent parameters of memantine block are from fitting of 
averaged and normalized NMDAR I-V curves. I-V relations were obtained from a total of 
7 sets of experiments. During curve fitting, reversal potential, A^Mem(0mV) and §Mem were 
allowed to vary. The external Mg2+ concentration was fixed to be 0. The value of k^kx was 
set to be 10 (Benveniste & Mayer 1991; Sobolevsky et al. 1998). The values of k jk i  and 
k+d/k.d are fixed to be 2 and 5, respectively (Lester & Jahr 1992).
Table 6.4 Summary of voltage-dependent parameters of Ai (OmV) and 6 for 50 pM memantine action
models
Sequential t)lock model Trapping block model Two binding sites models
With
desensitization
Without
desensitization
With
desensitization
Without
desensitization
With
desensitization
Without
desensitization
A\Ieni(0mV) 5.96 pM 24.55 pM 78.7 pM 78.2 pM 5.82 pM 22.8 pM
6 0.55 0.55 0.55 0.55 0.55 0.55
The data for voltage dependent parameters of memantine block are from fitting of an 
averaged and normalized NMDAR I-V curve. NMDAR I-V relations were obtained from a 
total of 7 sets of experiments. During curve fitting, reversal potential, ATMem(0mV) andSMg 
were allowed to vary. The external Mg2+ concentration was fixed to be 0. The value of k^k\ 
was set to be 10 (Benveniste & Mayer 1991; Sobolevsky et a l 1998)). The values of £4/^ 3 
and K+d/k-d are fixed to be 2 and 5, respectively (Lester & Jahr 1992).
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Figure 6.4 Curve fitting results for normalized and averaged NMDAR I-V relations in the 
absence o f  added M g2+ which were obtained from 7 sets o f  experiments. The NMDAR  
currents were evoked by 100 pM NM DA, 10 pM glycine and 5pM memantine. The results 
o f  the curve fitting are summarized in Table 6.3 and 6.4.
S e q u e n tia l m o d e l with d e s e n s i t iz e d  s ta te  
Normaized and averaged data
 NMDA100uM+Mem5 nM Q>5_
—  -  fitting curve
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6.4.2 Voltage-dependent memantine block in the presence of 
physiological concentrations of external Mg2+
Most previous studies were focused on memantine block of NMDA receptors in the 
absence of external Mg2+ (Chen et a l 1992; Chen & Lipton 1997; Sobolevsky et a l 1998). 
However, in normal physiological conditions, NMDARs on neurons are blocked by
^ I
l-3mM external Mg . In addition, during synaptic transmission, following glutamate
release by the presynaptic terminal, the postsynaptic membrane is depolarized by
1
activation of AMPA and kainate receptors. The depolarization decreases external Mg 
block of the NMDA receptors. Some evidence suggests that memantine and external Mg2+ 
compete for the same binding site (Chen & Lipton 2005) but this is unlikely to be true 
given the differences in their structure although their binding in the channel may still be 
mutually exclusive. Therefore, it is very important to define memantine block properties in 
the presence of a physiological concentration of external Mg .
In order to investigate the competition between external Mg and memantine, the same
^ I
voltage-ramp experiments were done in the presence of ImM Mg and 5pM or 50pM 
memantine using lOpM glycine and lOOpM NMDA to activate the receptors. lOOnM TTX 
and 1 pM strychnine were added to external solutions to block action potentials and glycine 
receptors, respectively.
Figure 6.5 shows examples of NMDAR current-voltage relations recorded in the presence 
of lOOpM NMDA, lOpM glycine, ImM Mg2+ and 5pM memantine or 50pM memantine, 
respectively. Surprisingly, (as previous described by Sobolevsky et al, 1998) the voltage 
dependent block of NMDA-induced whole-cell currents by 5pM memantine and ImM
^ I ^ I
Mg is stronger than the block by 50pM memantine and ImM Mg . The NMDAR I-V 
curves for 5pM memantine and 50pM memantine pass maximum inward currents at 
-3  OmV and -45mV, respectively.
In order to investigate competition between external Mg and memantine, the NMDA 
receptor I-V relations were fitted with different models. Since the presence of external 
Mg can not change the binding sites for memantine (unless both could be bound at the 
same site), 8 for external Mg2+ and 8 for memantine were fixed to be 0.84 and 0.6 
during fitting, respectively (the values obtained from fitting each alone). Because both 
curves were from the same cell, the number of NMDA receptors was set to be the same for 
both curves during fitting. The results of the fitting are shown in Table 6.5 and Figure 6.6.
Averaged NMDA receptor I-V relations were obtained by averaging a total of 8 sets of 
experiments (Figure 6.7). Because the two-agonist-binding-site model always gives similar 
fitting results to the simple sequential model, these averaged NMDA receptor I-V relations 
were fitted with the competition sequential block model (Scheme 6.2a, 6.2b) and the 
competition trapping block model (Scheme 6.3a, 6.3b). The 8 for Mg2+ and 8 for 
memantine were fixed to be 0.84 and 0.6, respectively. The number of NMDA receptors 
was set to be same for both curves during fitting. The results of the fitting are shown in 
Table 6.6 and Figure 6.8.
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Figure 6.5 Competitive block between external Mg2+ and memantine
An example of NMDA I-V relations evoked by lOOpM NMDA and 10 pM glycine in the 
presence of ImM Mg2+, 5 pM or 50 pM memantine. The intriguing result is that in the 
presence of ImM Mg2+, the NMDA I-V curve for 50 pM memantine shows a weaker 
voltage dependent block than with 5 pM memantine.
191
Fitting of simple model with desensitized state Fitting of simple model vwthout desensitizated state
Current (pA) 160°-
----- MemSnM+Mg2* 1mM 10°°-
----- Curs® ftrtg Mem5 nM+Mg2* 1mM
----- Mem 50 nM+Mg2* 1mM
----- Curve filling Mem50nM+Mg2* ImM*"
JF  m V
10cPl--*ie-^> -60 -40 -20 V 1 I20 40
v -v
-1000-
•1S0O-
Current (pA) 150°-
i
---- MemSnM+Mg^ ImM
— ■ Curve fitting Mem5 jiM+Mg^ ImM
---- MemSOnM+Mg^ ImM soo.
—' -Curve fitting M em50nM+Mg*1mM//  mV
* * ' A 20 40
\ T - f -_1000.
•1600.
Fitting of two binding site model with desensitized state Fitting of two binding site model without desensitized state
Current (pA) 1«*
i
---- MemSnM+Mg^ImM 1000,
” “ CuvefiingMem5 (jM+Mg I^mM
---- MemSOjiM+Mg I^mM
— - Curve fitingmemSO nM+Mg^ImM//  mV
1 1 1 1 1 A
v
20 40
-1600-
Current (pA) isoo-
---- Mem5(iM+ Mg2* 1 mM
— -l-cal
•~“ Mem50nM+Mg2*1mM wq, 
— -l-cal
/  mV1 ■ i ■ ■ J-40 JO J 20 40
-1000-
-1600-
Fitting of trapping model with desensitized state Fitting of trapping m odel without desensitized state
Current (pA) isoo-
-----Mem5 nM+Mg2* 1rrM
----- Cirve Wing Mem5 t^M+Mg ^ ImM
----- Mem50 nM+Mg2* 1nnM 500.
— "CuvefiingMemSO ^M+Mg^lrrM
/  mV
-1 0 ^ — 140 ^ - 4 0  J o  -20 j J 20 40
-1000-
-1500-
Current (pA) i«oo-
- 1AQQ-
---- Mem5pM+Mg1mM
™  "Curve fitting Mem5nM+Mg2*1mM
-----Mem50nM+Mg2*1mM ^
~  "Curve fitting Mem50|iM+Mg2*1mM
#  mV
I Q ^ ^ O e .^  -60 -40 -20 4 20 40
^  jUoo-
-1000-
-1600-
Figure 6.6, Curve fitting results for examplary NMDAR I-V relations, which were evoked 
by 100 p M NM DA, IQ p M glycine and ImM Mg2+ with 5 pM and 50 pM memantine.
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Table 6.5 Summary of competition curve fitting results
Sequential block model Trapping block model Two binding sites models
With
desensitization
Without
desensitization
With
desensitization
Without
desensitization
With
desensitization
Without
desensitization
JSrMen,(0inV) for 5uM 
Memantine (^M)
1.17 4.8 10.7 6.5 0.98 3.9
^Mg2+(0mV) for 5uM 
Memantine (mM) 0.56 2.3
8.6 8.6 0.65 2.6
^Mem(OmV) for 50uM 
Memantine (mM) 0.041 0.17 0.44 0.50 0.31
0.12
^Mg2+(0mV) for 50uM 
Memantine (mM) 2.8 11.36 44.5 44.5 3.4
13.3
Number of receptors 9757 2424 10434 2926 10091 2571
The data for competition block between Mg2+ and memantine are from fitting o f  an exanple NMDAR I-V curve. The value o f k2/kx was set to be 10 based on previous reports (Sobolevsky and Koshelev, 
1998, Benveniste and Monyer, 1991). The values o f  k j k 2 and k . J k ^  are fixed to be 2 and 5, respectively, based on a previous study (Lester and Jahr, 1992). Since the presence o f Mg2+ should not 
change the binding sites for memantine, 8 o f Mg2+ and 8 o f memantine were fixed to be 0.84 and 0.6, respectively. Because both curves were from the same experiment, the number o f  NMDA 
receptors was set to be the same for both curves during fitting.
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Figure 6.7 N M D A R  com petition  block between M g2+ and m em antine
Averaged N M D A  I-V relations were evoked by lOO^M NM DA and lOpM glycine in the 
presence o f  ImM M g2+ and 5pM  or 50pM  memantine. These NM DA I-V relations were 
obtained from a total o f  8 sets o f  experiments.
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Figure 6.8, Curve fitting results for averaged NM DAR I-V relations, which were obtained 
by averaging 8 individual recordings in the presence o f  100 pM NMDA, 10 pM glycine, 
ImM Mg2+ and 5 pM or 50 pM memantine.
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Table 6.6 Summary of competition curve fitting results for averaged data
models
Sequential block model Trapping block model
With
desensitization
Without
desensitization
With
desensitization
Without
desensitization
^Mem(OmV) for 5uM 
Memantine (pM ) 0.68
1.9 7.9 4.2
^Mg2+(0mV) for 5uM 
Memantine (mM) 1.8 13 24.8 48.6
^Mem(OmV) for 50uM 
Memantine (pM ) 22.3 51.4 314 187
J^Mg2+(0mV) for 50uM 
Memantine (mM) 4 27.7 58.6 86.1
Number of receptors 6664 1777 6987 2139
The data for competition block between Mg and memantine are from fitting of averaged 
NMDAR I-V curves. The value of k^k\ was set to be 10 based on previous reports 
(Sobolevsky and Koshelev, 1998, Benveniste and monyer, 1991) and the values of k^k?, 
and k+Jk.d were fixed to be 2 and 5, respectively (Lester and Jahr, 1992). Since the 
presence of Mg2+ does not change the binding sites for memantine, 6 of Mg2+ and 8 of 
memantine were fixed to be 0.84 and 0.6, respectively. Because both curves were from the 
same experiments, the number of NMDA receptors was set to be same for both curves 
during fitting.
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6.5 Discussion
6.5.1 Models for estimating voltage-dependent memantine block 
of NMDA receptors
6.5.1.1 Number of agonist binding reactions in the model does not affect 
the estimated voltage-dependent parameters of memantine block
In my experiments, three memantine block models were used to fit NMDAR I-V relations 
to estimate the parameters of voltage-dependent memantine block. These models were the 
simple sequential block model (Scheme 6.2a and Scheme 6.2b), the trapping block model 
(Scheme 6.3a and Scheme 6.3b), and the two-agonist-binding-site model (Scheme 6.4a and 
Scheme 6.4b) (This model was developed from the simple block model to investigate 
whether the number of agonist binding reactions in the sequential block model will affect 
the results). In addition, in order to investigate whether a desensitized state will affect the 
fitting results, each model was fitted with a desensitized state (Scheme 6.2b, Scheme 6.3b 
and Scheme 6.4b) or without a desensitized state (Scheme 6.2a, Scheme 6.3a and Scheme 
6.4a) to the NMDAR I-V relations. The results of the model fitting show that the 
two-agonist-binding-site model always gives similar fitting results to these obtained with 
the simple block model (Table 6.2, Table 6.3, Table 6.4, Table 6.5), suggesting that the 
number of agonist binding reactions in the models does not affect estimation of the 
blocking parameters. Therefore, in this discussion the results of fitting with the 
two-agonist-binding-site model fitting are omitted and the difference between the simple 
block model and the trapping block model considered further.
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6.5.1.2 The absence of a desensitized state in the sequential block model 
over-estimates the Jfmem(OrnV) value but not in the trapping block model.
Tables 2,3,-4,5,6 show that when the sequential block model is used to estimate parameters 
of voltage-dependent memantine block, the estimated /Cmem(0mV) value is affected by the 
presence of a desensitized state in the model. The £ mem(0mV) value estimated using the 
model without a desensitized state is about 4 times higher than the value from the model 
with a desensitized state when the desensitization equilibrium constant {Kd=k.Jk+&) is set 
to be 0.2. In contrast, the presence of a desensitized state in the sequential block model 
does not affect estimating the 5 value.
However, for the trapping block model, the voltage-dependent blocking parameters, 5 and 
^mem(OrnV), are independent of the presence of a desensitized state.
6.5.2 Comparion with previous studies
It is widely accepted that memantine is an NMDA receptor open channel blocker and 
displays a weakly voltage-dependent block not only in oocyte expression systems but also 
with native NMDA receptors in different brain regions (Komhuber et a l 1989; Chen et al 
1992; Blanpied et a l 1997; Chen & Lipton 1997; Sobolevsky et al. 1998; Chen et a l 1999; 
Kashiwagi et a l 2002; Chen & Lipton 2005; Wrighton et a l 2007). Its voltage-dependent 
parameters, 8 and A^mem(0rnV), from previous studies are shown in Table 6.7.
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Table 6.7 Summary of previous studies about voltage-dependent memantine block
Paper Animal Cell type 8 * mem(0mV) (pM) IC50 (-60m V) (pM) Possible subunits
(Chen & Lipton 2005) Oocyte
N R l-la/N R 2A 0.84 4.89 0.79
NR1-NR2AN R l-lb/N R 2A 0.85 6.99 0.94
NRl-4a/NR2A 0.84 4.30 0.87
NRl-4b/NR2A 0.83 5.37 1.1
(Wrighton et al. 2008) Oocyte
NR1-NR2A 0.84 1.7 NR1-NR2A
NR1-NR2D 0.62 0.42 NR1-NR2D
(Kashiwagi et al. 2002) Oocyte NR1-NR2B 0.89 7.1 0.46 NR1-NR2B
(Blanpied et al. 1997)
Cultured neurons 
NR1-NR2A 
NR1-NR2B
superior collicular and 
hippocampal
0.87 14.2
(Chen & Lipton 1997) 4 day old rat Retinal ganglia cell 0.82
(Sobolevsky & Koshelev 1998) C A 1 Pyramidal cell 0.73 18.5
(Sobolevsky et al. 1998) 2 weeks old rat Hippocampal slice 0.73 17.9
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6.5.2.1 Comparison of dopamine cell results with recombinant NMDA
receptor studies
‘y.
It is known from previous studies that, similar to voltage-dependent Mg block of NMDA 
receptors, memantine block NMDA receptors is NR2-subunit dependent. The NMDA 
receptors composed of NR1-NR2A and NR1-NR2B are blocked more strongly by 
memantine than NMDA receptors formed by NR1-NR2D (Table 6.7). The value of the 
voltage-dependent parameter 6 for NR1-NR2A and NR1-NR2B NMDA receptors is in the 
range from 0.83 to 0.89 while the value of ^ mem(0mV) is in the range from 4.3 pM to 
7.1pM. However, the 8 value for the NR1-NR2D NMDA receptor is much less than for 
NR1-NR2A and NR1-NR2B NMDA receptors, being 0.62 (Wrighton et a l 2007).
In my experiments, fitting averaged and normalized NMDA I-V relations obtained in the 
presence of lOOpM NMDA, lOpM glycine and 5 or 50pM memantine gives us an estimate 
of the voltage-dependence parameter 8 to be 0.55-0.6. The value of ^ mem(0rnV) is affected 
by which model is used during the curve fitting. For the sequential block model, the 
A i^em(OmV) values are 2.8-5.96 pM (with a desensitizated state) and 11.5-24.6 pM (without 
a desensitized state) while for the trapping block model, the £ mem(0mV) values were 
independent of desensitized states and were found to be 36.6-78 pM. Inspection of my data 
presented here reveals that the 8 value (0.55-0.6) from my experiments is much smaller 
than the 8 value for NR1-NR2A and NR1-NR2B NMDA receptors (0.83-0.89) and is very 
close to the value for NR1-NR2D recombinant NMDA receptors (0.62) (Wrighton et al
2007). This result supports the idea that dopaminergic neurons in SNc express a mixture of 
NR2B- and NR2D- containing NMDA receptors. Here we see that the 8 value is somewhat
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smaller than data from recombinant NR1-NR2D NMDA receptors. This difference might 
be due to differences in the receptor expression systems or a permeant ion effect, because
^  L
in my experiments ImM Ca was applied in the external solution while in Wrighton’s 
experiments 1.8mM Ba2+ was added instead of Ca2+. In addition, in the present 
experiments the main intracellular cation is Cs+ while in Wrighton’s oocyte experiments, 
this is likely to the K+.
In addition, XmemCOrnV) value (2.8-5.96 pM) obtained from the sequential block model 
with a desensitized state is very similar to data from recombinant NMDA receptors. This 
result might be because the same sequential block model was also used to fit data from 
recombinant NMDA receptors in previous studies (Chen & Lipton 1997; Wrighton et a l
2008).
6.5.2.2 Comparison with other native NMDA receptors
Table 7 shows that the 6 value for voltage-dependent memantine block of native NMDARs 
is in the range from 0.73 to 0.87 while the A^mem(0mV) value is from 14.2-18.5pM. The 
wide range o f 8 values might be due to the percentage difference of the native NMDA 
receptors which have a less voltage-dependent memantine block (NR2C-, NR2D- 
containing NMDA receptors). Compared with other native NMDA receptors, a smaller 8 
value was obtained from my experiments. One possible explanation could be a larger 
percentage o f NR2D-containing NMDA receptors is expressed by dopaminergic neurons 
than neurons in the hippocampal CA1 region or retinal ganglion cells. Another explanation 
could be that different models were used during estimation of the voltage-dependent 
memantine block parameters. For example, Blanpied et a l  (1997) suggested that when
201
memantine and the agonist are washed off after steady-state block, one-sixth o f blocked 
channels released rather than trapped the blocker and a partial trapping block model was 
used to fit their data. Also as mentioned before, ionic differences in internal and external 
solution between experiments also can cause a difference, as Chen et a l  (1997) reported 
that when internal CsCl was replaced by NMDG, the 8 value was reduced from 0.83 to
0.53 (Chen & Lipton 1997).
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Chapter 7: Functional NR2B- and
NR2D-containing NMDA receptor channels in 
P7 rat subthalamic nucleus
7.1 Summary
1. Single-channel recording experiments have been made from outside-out patches which 
were pulled from P7 rat STN neurons to study the kinetics and composition o f NMDA 
receptors.
2. Application o f NMDA (200 pM) and glycine (10 pM) to outside-out patches activated 
NMDA receptor channels with four different amplitudes: 1.15pA, 2.53pA, 3.14pA, 4pA. 
Both large- (52 pS and 42 pS) and small- (42 pS and 19 pS) conductance NMDAR 
channels are expressed by P7 rat STN neurons. Meanwhile, a unique large conductance 
(66.7 pS) NMDA channel is found.
3. The application o f 10 pM ifenprodil reduced the mean open time from 2.78 +  
0.64ms to 2.2 ±  0.98ms and increased the mean shut time from 35.3 ±  15.8ms to 64.9 
±  29ms. Therefore, the decrease in Popen (from 0.2 to 0.03) is accounted for by a 
significant increase in mean shut time and decrease in mean open time. This result suggests 
that NR2B-containing NMDA receptors are expressed by STN neurons.
4. Analysis o f the frequency o f direct transitions between the small-conductance states 
showed that transitions from 42 pS to 19 pS levels occur more frequently than transitions 
froml9 pS to 42 pS. While 32.6% o f direct transitions were from 19 to 42 pS, 67.7% were 
from 42 to 19 pS. This asymmetry of direct transitions is unique to NR2D-containing 
NMDARs, indicating that STN neurones contain NR2D subunits.
7.2 Introduction
The subthalamic nucleus (STN) is one part o f the basal ganglia circuits in the midbrain 
which play a very important role in controlling movement (Kitai & Deniau 1981; Kita & 
Kitai 1987; Bolam et a l 2000; Chatha et a l  2000). The subthalamic nucleus receives its 
main inputs from the striatum, cortex, thalamus, and brainstem (Kita & Kitai 1994; Chatha 
et a l  2000) and via its glutamatergic projections plays a key role in controlling the output 
nuclei o f the basal ganglia; the substantia nigra pars reticulata (SNr) and the internal 
segment o f the globus pallidus (GPi). In addition, a crucial output to substantia nigra pars 
compacta mediated by glutamate also has been found which may contribute to excitotoxic 
dopamine neuron death during Parkinson’s disease (Blandini et a l 2000).
It has been shown that functional NMDA receptors are expressed by STN neurons (Gotz et 
a l 1997). NMDA-mediated afferent input has an important role in controlling the activity 
of the STN (Nakanishi et a l 1988; Gotz et a l 1997). Blockade of STN NMDA receptors 
interrupts excitation of the GPi after cortical stimulation, suggesting that these receptors 
are important in physiological modulation o f the basal ganglia outflow pathway (Nambu et 
a l 2000). In Parkinson disease (PD), it has been hypothesized (Blandini et a l 2000) that 
one result of the loss o f dopamine is an increased excitatory drive from the STN to the
remaining dopamine neurones o f the substantia nigra to compensate for the loss o f some 
dopamine neurones by driving the remaining dopamine neurones much harder. The 
hyperactivity o f STN neurons has been already observed in animal models o f Parkinsonism 
and this abnormal activity is partially mediated by NMDA receptors and is reduced by the 
NMDA antagonist MK-801. These observations suggest that inhibition o f NMDA 
receptors in STN neurons might be o f therapeutic benefit in PD (Blandini et al. 2000).
Although STN neurones express functional NMDA receptors (Gotz et a l  1997), their 
subunit composition is not known. High levels o f NR2D subunit mRNA (Monyer et al. 
1994; Standaert et al. 1994) and low levels o f NR2B mRNA are expressed in adult rat STN 
neurons.
My experiment was to characterize functional NMDA receptor subtypes which are present 
in STN neurones, and to investigate whether NR2D and NR2B subunits form functional 
NMDA receptors, using single-channel recordings from outside-out patches. The results 
support the idea that NR2B- and NR2D-containing NMDA receptors are expressed in 
subthalamic nucleus neurons. It is o f interest to determine the NMDA receptor subtypes in 
this nucleus. This information is relevant to the use o f NMDA receptor antagonists in 
Parkinson’s disease (Del Dotto et a l  2001).
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7.3 Results
7.3.1 NMDA activates channels with four distinct conductance 
levels in STN
Application o f NMDA (200 pM) and glycine (10 pM) to outside-out patches (n=6) from 
subthalamic nucleus activated individual NMDA receptor channels with four different 
amplitudes: 1.15pA, 2.53pA, 3.14pA, 4pA. Two example recordings showing NMDA 
receptor channel openings to these four amplitudes are shown in Figure 7.1A a, b. The 
stability o f channel amplitudes is shown in Figure 7.1C. In 6 patches, in the presence of 
200 pM NMDA and 10 pM glycine, the mean open time was 2.78 ±  0.64ms and the mean
open probability was 0.09 ±0.014. The distribution o f channel amplitudes activated by 200 
pM NMDA in 3 o f 6 patches was fitted with the sum o f three Gaussian components 
(1.15pA, 2.53pA, 3.14pA) (Figure 7.1B) while the other 3 patches also showed unusually 
large conductance openings (4pA). The measured channel amplitudes correspond to chord 
conductances (relative areas) o f 19.2 ± l.lp S  (5.43 ± 0.43%), 42.1 ± 1.8pS (18.2 ± 9.4%), 
52.4 ± 1.4pS (65.1 ± 11.2%), and 66.7 ± 1.0 (34.0 ±22.1% ).
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Figure 7.1 Large and smail-conductance NMDA receptor channels in STN neurons
A ,  e x a m p l e  c u r r e n t s  r e c o r d e d  f r o m  o u t s i d e - o u t  p a t c h e s  f r o m  S T N  n e u r o n e s  a t  a  m e m b r a n e  
p o t e n t i a l  o f  - 6 0  m V  i n  t h e  p r e s e n c e  o f  2 0 0  p M  N M D A  a n d  1 0  p M  g l y c i n e  s h o w i n g  t h r e e  
d i f f e r e n t  c u r r e n t  a m p l i t u d e s  c o r r e s p o n d i n g  t o  t h e  t h r e e  c o n d u c t a n c e  l e v e l s  i n d i c a t e d  i n  B ;
B ,  a m p l i t u d e  d i s t r i b u t i o n  f o r  t h e  p a t c h  i l l u s t r a t e d  i n  A ,  f i t t e d  w i t h  t h e  s u m  o f  t h r e e  
G a u s s i a n  c o m p o n e n t s .  T h e  s t a n d a r d  d e v i a t i o n s  w e r e  c o n s t r a i n e d  t o  b e  t h e  s a m e  ( 0 . 2 5 3  p A )  
f o r  e a c h  c o m p o n e n t .  T h e  m e a n  a m p l i t u d e  a n d  r e l a t i v e  a r e a  o f  e a c h  c o m p o n e n t  a r e  s h o w n  
o n  t h e  h i s t o g r a m ,  a n d  c o r r e s p o n d  t o  c h o r d  c o n d u c t a n c e s  o f  1 9  p S ,  4 2  p S  a n d  5 2  p S .
C ,  E x a m p l e  r e c o r d i n g  f r o m  a  d i f f e r e n t  p a t c h  t o  t h a t  i l l u s t r a t e d  i n  A  s h o w i n g  a  l o n g  b u r s t  o f  
h i g h - c o n d u c t a n c e  o p e n i n g s  w i t h  a  m e a n  c h o r d  c o n d u c t a n c e  o f  6 6 . 7 p S .
D ,  s t a b i l i t y  p l o t  o f  c h a n n e l  a m p l i t u d e s  f o r  o n e  p a t c h  t h r o u g h o u t  t h e  d u r a t i o n  o f  t h e  
r e c o r d i n g .
207
7.3.2 NMDA receptors in STN neurons contain NR2B subunits
Ifenprodil is a non-competitive NMDA receptor antagonist that acts by increasing 
proton-inhibition o f the receptor (Mott et a l 1998). Ifenprodil has approximately 350-fold 
higher affinity for NR2B-containing NMDA receptors than for other NR2 subunits 
(Williams 1993; Williams 1995). In these experiments on STN neurons the effect o f 10 
pM ifenprodil was investigated in eight patches and example recordings in the presence 
and in the absence o f 10 pM ifenprodil were shown in Figure 7.2A. In the presence o f 200 
pM NMDA and 10 pM glycine in control conditions, open probability (Popen) mean 
opentim eandm eanshuttim ew ereO .il ±  0.05,2.63 ±  0.52 ms and 35.3 ±  15.8ms, 
respectively (w=8). However, coapplication o f 10 pM ifenprodil reduced Popen to 0.06 ±  
0.03 (66.7 ±9.3%  of control, n =8). In addition, the 10 pM ifenprodil significantly 
decreased the proportion o f 54 pS and 67pS channel openings observed in the amplitude 
distributions and reduced the mean amplitude from -2.99 ±  -1.33pA to -2.48 ±  -1.1 pA 
(n=8) (Figure 7.2C). The application o f 10 pM ifenprodil also reduced the mean open time 
from 3.78 ±  0.64ms to 2.2 ±  0.98ms and increased the mean shut time from 35.3 ±  
15.8ms to 64.9 ±  29ms (an example was shown in Figure 7.2B). Therefore, the decrease 
in Popcn is accounted for by a significant increase in mean shut time and decrease in mean 
open time.
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Figure 7.2 Large-conductance NMDA receptor channels in STN neurones contain 
NR2B subunits
A y e x a m p l e  c u r r e n t s  r e c o r d e d  a ,  i n  t h e  p r e s e n c e  o f  2 0 0  p M  N M D A ;  by i n  t h e  p r e s e n c e  o f  
2 0 0  p M  N M D A  a n d  1 0  p M  i f e n p r o d i l ;
By s t a b i l i t y  p l o t s  o f  P o p e n ,  m e a n  o p e n  t i m e  a n d  m e a n  s h u t  t i m e  f o r  s i n g l e - c h a n n e l  c u r r e n t s  
i n  a ,  2 0 0  p M  N M D A  a n d  b ,  i n  t h e  p r e s e n c e  o f  2 0 0  p M  N M D A  a n d  1 0  p M  i f e n p r o d i l  
s h o w i n g  t h a t ,  i n  t h i s  p a t c h ,  i n  a d d i t i o n  t o  d e c r e a s i n g  c h a n n e l  o p e n  t i m e ,  i f e n p r o d i l  a l s o  
d e c r e a s e d  P 0 p e n  a n d  i n c r e a s e d  i n  c h a n n e l  s h u t  t i m e .
C ,  e x a m p l e  a m p l i t u d e  d i s t r i b u t i o n s  f r o m  t h e  s a m e  p a t c h  i l l u s t r a t e d  i n  B .  a ,  i n  t h e  p r e s e n c e  
o f  2 0 0  p M  N M D A ;  b ,  i n  t h e  p r e s e n c e  o f  2 0 0  p M  N M D A  a n d  1 0  p M  i f e n p r o d i l ,  s h o w i n g  
t h a t  i f e n p r o d i l  s i g n i f i c a n t l y  r e d u c e s  t h e  p r o p o r t i o n  o f  h i g h  c o n d u c t a n c e  N M D A  c h a n n e l  
o p e n i n g s .  I n  C a ,  t h e r e  w e r e  1 6 8 7  o p e n i n g s  i n  a  r e c o r d i n g  p e r i o d  o f  1 2 0  s e c o n d s  a n d  i n  C b ,  
i n  t h e  p r e s e n c e  o f  i f e n p r o d i l  t h e r e  w e r e  6 4 6 2  o p e n i n g s  i n  a  r e c o r d i n g  p e r i o d  o f  8 0 0  
s e c o n d s .
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7.3.3 NMDA receptors in STN neurons contain NR2D subunits
The 41 pS and 18 pS conductance levels are characteristic of NR2C or NR2D-containing 
NMDA receptor channels, while 54 pS and 41 pS are characteristic of NR2A or 
NR2B-containing NMDA receptor channels (Stem et al. 1992; Wyllie et al. 1996). Direct 
transitions between conductance levels were analysed in 3 patches and the results are 
shown in Figure 7.3A. Analysis o f the frequency of direct transitions between the 
small-conductance states showed that transitions from 42 pS to 19 pS levels occur more 
frequently than transitions from 19 pS to 42 pS (Figure 7.3 B.C.). While 32.6% o f direct 
transitions were from 19 to 42 pS, 67.7% were from 42 to 19 pS. This asymmetry o f direct 
transitions is unique to NR2D-containing NMDARs (Wyllie et al. 1996), indicating that 
STN neurones contain NR2D subunits. In the patch illustrated in Figure 7.3A, 52.3% of 
direct transitions between 53 and 42 pS levels were from 52 to 42 pS while 47.7% were 
from 42 to 53 pS (Figure 7.3B and C).
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Figure 7.3 NMDA receptors in STN neurones contain NR2D subunits
A, examples of direct transitions a, between 18 pS and 52 pS and b, between 18 pS and 42 
pS. Transitions were identified using ACTn values of 1.72 pA, 2.18 pA and 2.90 pA, 
calculated from the fit to the amplitude distribution shown in Fig. 1C.
B , plot of channel amplitudes before and after direct transitions from the same patch 
illustrated in A. Each point on the graph represents a single direct transition. The density of 
points illustrates that direct transitions between 42 pS and 52 pS occur with equal 
frequency, while transitions between 19 pS and 42 pS are asymmetric, occurring more 
frequently from 42 pS to 19 pS than from 19 pS to 42 pS.
C, Three-dimensional plot of the same data shown in B.
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7.4 Discussion
7.4.1 Four NMDA receptor channel conductances are observed 
in STN neurons
NMDA receptor single-channel properties are determined by the NR2 subunits (Stem et al. 
1992; Wyllie et al. 1996; Anson et al. 1998; Cull-Candy & Leszkiewicz 2004). 
Recombinant NMDA receptors composed of NR1/NR2A subunits or NR1/NR2B subunits 
show large-conductance channels of 38 pS and 50 pS while NMDA receptors composed of 
NR1/NR2C subunits or NR1/NR2D subunits show small conductance channels of 19 pS 
and 36 pS.
Functional NMDA receptors have previously been described in midbrain STN neurons
with kinetic properties suggestive of NR2B-containing receptors (Gotz et al. 1997)
although their subunit composition was not investigated. Here single-channel recordings
from outside-out patches in P7 rat subthalamic nucleus were made to investigate NMDA
receptor subunit composition. The results show that four different channel conductances
are found, suggesting the receptor population is not homogeneous. The 19pS and 42pS
NMDA channels are similar to NR1-NR2C or NR1-NR2D NMDA channels while the
42pS and 52pS NMDA channels are similar to NR1-NR2A and NR1-NR2B recombinant
NMDA channels. In addition, an unusual large conductance NMDA channel (67pS) was
observed during application of 200 pM NMDA and 10 pM glycine that was inhibited by
ifenprodil (See section 7.3.3). According to previous studies, large conductance channels
of 69pS and 62pS have been described in spinal cord motomeurons and intemeurons
(Palecek et al. 1999; Abdrachmanova et al. 2000; Green & Gibb 2001). In the
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motomeurons, Abdrachmanova et a l  (2000) suggested that the 69pS channel might be 
activated during synaptic transmission and Green & Gibb (2001) suggested that the 69pS 
might be a phenomenon associated with the developing spinal cord. Since a medium level 
o f NR3A mRNA is expressed in STN neurons in the adult pig-tail macaque brain (Mueller 
& Meador-Woodruff 2005) and in rat NR3 A protein expression peaked between postnatal 
days 7 and 10 in the midbrain, it may be that these receptors contain NR3A, although when 
combined with NR1 and NR2A, NR3A gives mainly 28 pS channels (Perez-Otano et a l 
2001).
Therefore, observations in my experiments suggest that functional NMDA receptors in 
STN contain NR2B subunits and either NR2C or NR2D subunits and NR3A subunits 
might be present in STN but not in all individual NMDA receptors.
7.4.2 Functional NMDA receptors in STN dopaminergic 
neurones contain NR2D subunits
NR2C and NR2D subunits can be distinguished by analysis of direct transitions between 
conductance levels (Wyllie et a l  1996; Wyllie et a l 1998; Cull-Candy & Leszkiewicz 
2004). In STN neurons, direct transition analysis showed that transitions from 42 pS to 19 
pS levels occur more frequently (67.7%) than transitions from 19 pS to 42 pS (32.6%) that 
is consistent with the presence of NR2D rather than NR2C subunits (Wyllie et a l 1996). 
This same method which has been used to identify NR2D subunits has been reported by 
several groups. Misra et a l reported that in cerebellum Purkinje cells, 63% of direct 
transitions between 21pS and 34 pS went from 34pS to 21pS. In another Pukinje cell study, 
72% o f direct transition between 18pS and 38pS went from 38pS to 18pS (Momiyama et a l 
1996). In addition, in cerebellar Golgi cells, 64% of direct transitions between 19pS and
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39pS went from 39pS to 19pS (Misra et al. 2000) which is similar to the single-channel 
results from dopaminergic neurons in substantia nigra compacta (Jones & Gibb 2005). Our 
data are in good agreement with previous studies, suggesting the presence of NR2D 
subunits.
The presence of NR2D rather than NR2C subunits in NMDA receptor channels in STN 
neurons is also consistent with expression studies. No NR2C mRNA was detected in rat 
brain STN, but high levels o f NR2D mRNA were found in the same experiment (Standaert 
et al. 1994). Our findings support the idea that NR2D subunits form functional NMDA 
receptors in STN neurones. Thus, NR2D-containing NMDA receptors may provide a novel 
therapeutic target in the basal ganglia.
7.4.3 Functional NMDA receptors in STN neurones contain 
NR2B subunits
Ifenprodil is a non-competitive NMDA receptor antagonist with high affinity for 
NR2B-containing NMDA receptors rather than those containing NR2A, NR2C or NR2D 
subunits (Williams 1993; Williams 1995; Cull-Candy & Leszkiewicz 2004). In the 
presence of saturating concentraions o f agonist, NMDA or glutamate, 10 pM ifenprodil 
causes about 92% inhibition o f NR1-NR2B mediated whole-cell current (Williams 1993; 
Mott et al. 1998) but only 50% inhibition for triheteromeric NR2B-containing receptors 
(Hatton & Paoletti 2005). In STN neurones, 10 pM ifenprodil reduced open probability of 
single-channel openings by 67%, suggesting a mixed population of NMDA receptors 
(diheteromeric and triheteromeric NR2B-containing NMDA receptors are expressed by P7 
rat STN neurons. The same situation has been found in several brain regions such as
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dopaminergic neurons in SNc (Jones & Gibb 2005) and Golgi cells in cerebellum 
(Brickley et al. 2003) . Interestingly, in my experiements a large conductance NMDA 
receptor (67pS) has been found in 3 of 6 patches from STN neurons and the application of 
10 pM ifenprodil significantly reduced the open probability of this large conductance 
channel. Such a large conductance channel has not been described in SNc or cerebellar 
Golgi or Purkinje cells. It could be that the large conductance NMDA receptor might be 
the NR2B-containing NMDA receptor. In addition, direct transitions from 52pS to 19pS 
have been found in my experiments, suggesting triheteromeric NMDA receptors might be 
expressed by STN neurons.
In summary, we have shown that NMDA receptors in STN neurons contain NR2D and 
NR2B subunits. They might be a mixed population of diheteromeric NR1-NR2B NMDA 
receptor and triheteromeric NR1-NR2B-NR2D NMDA receptors.
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Chapter 8: Future experiments
Since Parkinson’s Disease is generally considered a disease of late middle age with the 
average age o f onset at around 60 years of age, it is necessary to know the NMDA receptor 
composition on dopaminergic neurons of adult animals (in rats more than 6 weeks old). In 
addition, the NMDA receptor composition in SNc in animals with Parksinson’s disease 
models is of interest. This information may contribute to revealing the pathogenetic 
mechanism underlying Parkinson’s disease and also they can provide more accurate 
therapeutic target information for Parkinson’s disease. Therefore, to extend this project, the 
NMDAR composition of SNc on adult animals and animals with Parkinson’s disease 
(Parkinson’s disease models) could be investigated using similar methods to those 
described in this thesis.
In addition, some relatively selective NMDA antagonists have been reported recently, such 
as UBP-141, PPDA and PBPD (Morley et a l 2005). It has been suggested that the PPDA 
and PBPD would have roughly 40-100 fold higher selectivity for NR2D subunits than 
NR2A and NR2B (Feng et a l 2004). Therefore, these drugs might be used in PD models to 
determine possible synaptic functions of NR2D-containing NMDA receptors (Brothwell et 
a l 2008).
In P7 subthalamic neurons, analysis o f NMDA receptor single-channel properties revealed 
firstly, that activation o f NMDA receptors produced a high conductance pattern of 
single-channel activity characterized by 42 pS and 52 pS single-channel currents and a low 
conductance pattern of single-channel activity characterized by 18 pS and 42 pS
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single-channel currents. In addition, an unusual conductance, 68 pS single-channel current, 
was observed. Secondly, 10 pM ifenprodil significantly reduced NMDA receptor open 
probability by 66.7 ±  9.3% , suggesting that NR2B-containing NMDA receptors are
present on P7 STN neurons. Finally, direct transition analysis between open levels suggests 
that NR2D-containing NMDA receptors are expressed by P7 STN neurons. These findings 
were consistent with evidence showing that mRNA (Monyer et a l 1994; Standaert et al. 
1994) and protein (Dunah et a l  1996; Dunah et a l 1998) encoding high levels o f NR2D 
and low levels of NR2B subunits are expressed in STN neurons.
Since both NR2A- and NR2B-containing NMDA receptors show a similar 
large-conductance pattern of single-channel activity, which are 50 pS and 40 pS, it is 
necessary to know if functional NR2A-containing NMDA receptors are present on P7 rat 
STN neurons. It has been shown that high affinity Zn2+ inhibition of NR2A-containing 
NMDA receptors (Chen et a l  1997; Paoletti et a l 1997) can be removed by chelating 
extracellular contaminating Zn2+ with TPEN
(N,N,N’,N’-tetrakis-(2-pyridilmethyl)-ethylenediamine), a non-reducing metal chelating 
agent (Paoletti et a l 1997). The effect of TPEN is described as a potentiation of 
macroscopic currents produced by NMDA receptors in cultured cells and by NRla/NR2A 
recombinant NMDA receptors expressed in HEK 293 cells and Xenopus oocytes (Paoletti 
et a l 1997) but not by NRla/NR2A receptors expressed in Chinese hamster ovary (CHO) 
cells (Brimecombe et al., 1997). If a sub-population of NR2A-containing NMDA receptors 
with high Zn2+ sensitivity is present in P7 STN neurons then an increase in single-channel 
activity will be expected after contaminating Zn2+ is removed by adding TPEN or
^ I
inhibition may be seen when extra Zn is added to the external solution. Similar 
approaches could be used to assess the potential contribution of NR2A subunits to NMDA 
receptors in P7 rat STN neurons and the results compared with similar results from adult
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neurons.
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